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Chapter 1 of this dissertation shows a brief overview of fundamental concepts and classic 
synthetic routes of BODIPY dyes. The synthetic strategies and various application (e.g. PDT 
sensitizers and fluorescent indicators) of halogenated BODIPYs are also presented in this chapter.  
Chapters 2-4 describe the synthesis of three new polyhalogenated BODIPY platforms and their 
regioselective functionalization. Such new platforms provide new methodologies for producing 
both symmetric and asymmetric BODIPYs. Pd(0)-catalyzed cross-couplings and aromatic 
substitution reactions were applied to investigate the reactivity and regioselectivity of different 
halogen groups on the BODIPY platforms.  The studies showed that the reactivity order of the 
halogens under both these reaction conditions is: 8-Cl ≈ 1,7-Br > 3,5-Cl > 2,6-Cl > 4,4-F. This 
breakthrough in BODIPY chemistry allowed the global stepwise functionalization (up to nona-
functionalization) using various organometallic reagents and (or) N-, O-, and S-centered 
nucleophiles. During the investigation, more than fifty new BODIPYs were prepared via Pd(0)-
catalyzed cross-coupling and nucleophilic substitution reactions, which are usually very difficult 
or impossible to prepare using traditional methods. In summary, the synthetic method developed 
and the new polyhalogenated BODIPY platforms provide a facile way to introduce special groups 
for various applications. 
Chapter 5 reports the synthesis of a series of 2,2’-(o-carboranyl)bisthiophene oligomers with 
bromo, trimethylsilylethyne, vinyl, N-methylpyrrole or thienyl group by bromination, Sonogashira 
and Stille cross-coupling reactions. Among those compounds, the di(thienyl-N-methylpyrrole)-o-
carborane and di(bisthienyl)-o-carborane  can be successfully electropolymerized on a suitable 
anode to produce the corresponding conducting polymers. DFT calculations are also performed, 
which is consistent with the electrochemical data. 
1 
CHAPTER 1: INTRODUCTION 
1.1 Properties of BODIPY 
Over the last several decades, due to their convenience, low cost, high selectivity, and high 
sensitivity, the probes and sensors that are prepared from fluorescent dyes (e.g. Figure 1) attracted 
more and more attention in the fields of bio-imaging and environmental-imaging.1-4 For example, 
various kinds of fluorescein and rhodamine dyes with rigid structures and high quantum yields 
have been designed and synthesized for biological applications. However, relatively short λabs and 
λex and the counter ions of these dyes have hindered the further applications.
5-7 Because in the 
“biological window” (the 650-1000 nm region), there is minimal interference from the 
autofluorescence of tissue and cells, and absorption of water, NIR dyes that absorb and emit in the 
near-infrared (NIR) are always preferred. In addition, the deep penetration of NIR dyes provides 
the advantages in the clinical applications.8-12 Therefore, cyanine dyes13 are often used as alternates 
because they emit and absorb in the NIR region. However, several challenges in the chemistry of 
cyanine dyes are still remaining, mainly including poor photostability and low quantum yields 
resulting from their flexible structures.13-15 
4,4-Difloro-4-bora-3a,4a-diaza-s-indacenes (BODIPYs) have attracted a lot of attention in 
both the research and academic fields, since it was first reported in 1968.16 Due to its remarkable 
properties (i.e. being a small molecule with a strong fluorescence and high quantum yields, high  
 
Figure 1-1: The structures of several fluorophores 
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Figure 1-2: Structures of s-indacene and BODIPYs 
chemical and physical stabilities, and high tunability17-19), BODIPY dyes are now widely used in 
drug delivery,20-22 protein21, 23-24 and DNA21, 25-26 labeling, light harvesting arrays,27-28 and 
fluorescent switches.29-30 
4,4-Difloro-4-bora-3a,4a-diaza-s-indacenes are also named as boron dypyrromethanes 
(BODIPYs), due to their structural relationship to as s-indacene, as shown in Figure 1.2. BODIPYs 
with rigid tricyclic systems are usually prepared from dipyrromethene by complexation with boron 
trifluoride diethyl etherate. During the complexation, the cis/trans confirmation of 
dipyrromethenes is locked as the cis confirmation.  In addition, the complexation of “BF2” endow 
BODIPYs with aromaticity, although it does not fit Huckel’s (4n+2) rule.19 In the nomenclature 
systems, the 4-position is also referred as the boron position; the 1,7-positions, 2,6-positions, and 
3,5-positions at the pyrrolic part of BODIPYs are also named as β’, β and α- positions; the 8-
position of BODIPY is named as the meso-position, as the labeling systems of porphyrin 
nomenclature.17  
Previous results31 of DFT calculation showed that the HOMO to LUMO transition mainly 
determines the S0 to S1 transition, which is associated with the absorption maxima (λabs). Thus, it 







Figure 1-3: Nadal patterns of the LUMO and HOMO of an unsubsituted BODIPY.(Reproduced 
from Ref. Lu, H.; Mack, J.; Yang, Y.; Shen, Z., Structural modification strategies for the rational 
design of red/NIR region BODIPYs. Chem. Soc. Rev. 2014, 43 (13), 4778-4823.with permission 
from the Royal Society of Chemistry, see Appendix E)  
 
modification of λabs. Figure 1-3 shows the Nadal patterns of the LUMO and HOMO of an 
unsubsituted BODIPY.19 In the LUMO, MO coefficients mainly are loacted at the 8, 1,7 and 3,5-
positions; the largest MO coefficients is at the 8-position. In the HOMO, MO coefficients are only 
distributed at the 3,5 and 2,6- positions, while there is larger MO coefficient at the 3,5-positions 
than that at 2,6- positions. In addition, at the 3,5- positions, there are MO coefficient in both LUMO 
and HOMO, while there is larger MO coefficient in the HOMO than that in the LUMO.19  Thus, 
appropriate functionalizations at the 3, 5, 8-positions could significantly affect the HOMO and 
LUMO, which then brings a big change in the spectroscopic properties of the BODIPYs.  
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Figure 1-4: Absorption and fluorescence spectra of 1,3,5,7-tetramethyl-8-phenyl BODIPY. 
(Reproduced from Ref. Lu, H.; Mack, J.; Yang, Y.; Shen, Z., Structural modification strategies for 
the rational design of red/NIR region BODIPYs. Chem. Soc. Rev. 2014, 43 (13), 4778-4823.with 
permission from the Royal Society of Chemistry, see Appendix E)  
 
BODIPYs usually absorb strongly and narrowly in the visible region. The classic 
absorption and fluorescence spectra of 1,3,5,7-tetramethyl-8-phenyl BODIPY are shown in Figure  
1-4. The most intense peak around λ= 500 nm is assigned to the S0 to S1 transition, and the shoulder 
around λ= 480 nm is assigned to the 0-1 vibrational transition.19 In addition, a weaker absorption 
around λ= 350 nm is usually assigned to the S0 to Sn (n≥2) transition.
19 On the other hand, the 
narrow fluorescence spectra is usually a mirror image of absorption spectra, as shown with dash 
curve in Figure 1-4.19  It is widely accepted that the flexible structures of cyanine dyes result in 
nonradioactive decay, which usually greatly decrease the quantum yields.32 However, due to 
complexation of “BF2”, the rigid π-system provides the BODIPYs relatively high quantum yields. 
Furthermore, the low efficiency of intersystem crossing (ISC) to the triplet state is another widely 
accepted reason for the high quantum yields.  
5 
1.2 Synthesis of BODIPYs 
1.2.1 Traditional synthesis of BODIPYs 
There are four types of widely-used synthetic methods to approach most of the BODIPY 
dyes, as shown in Scheme 1-1. The most common approach to BODIPY scaffolds is synthesis via 
a condensation reaction between a large excess α-free pyrroles and aldehydes,33-34 in the presence 
of Lewis acids, to give dipyrromethane (not isolated), followed by oxidation using 2,3-dichloro-
5,6-dicyano-1,4-benzoquinone (DDQ), and subsequent treatment with base (usually triethylamine) 
and boron trifluoride diethyl etherate (BF3
.OEt2). An alternative method using α-free pyrroles 
involves with acid chlorides35 or anhydrides,36-37 followed by deprotonation with triethylamine 
(TEA) and complexation with BF3
.OEt2. Besides these routes, a more efficient method to  
 
Scheme 1-1: Traditional Approaches to BODIPYs. 
6 
synthesize both asymmetrical and symmetrical BODIYs is to employ a condensation between 2-
formyl38 or 2-ketopyrrole39 and with another (same or different) α-free pyrrole fragment in the 
presence of phosphorus oxychloride (POCl3) followed by treatment with Et3N and BF3.OEt2.  
1.2.2 Synthesis of BODIPYs from dipyrroketones 
Over the last several years, a new synthetic route utilizing dipyrro(thio)ketone to synthesize 
BODIPYs was developed and investigated. Also, it can provide a functionalizable meso-group, as  
 
Scheme 1-2: Synthesis of BODIPYs from dipyrro(thio)ketones. 
7 
shown in Scheme 1-2.40-43 The BODIPY synthesis started from the condensation of α-free pyrrole 
and thiophosgene (CSCl2), which can provide a dipyrrothioketone. Further treatment with 
iodomethane (CH3I), organic base, and BF3
.OEt2 can afford a meso-thioester BODIPY.
40 The 
dipyrrothioketone could be converted to a dipyrroketone by employing the oxidation reaction with 
KOH/H2O2 in ethanol using a steam bath. Oxidative halogenation by POX3 (X = Cl, Br) or 
phosgene (COCl2), followed by deprotonation and complexation by BF3
.OEt2 yielded 8-halo 
BODIPYs.41, 43 Besides, Smith and coworkers42 reported another alternative way to synthesize 
dipyrroketone from dipyyromethane via the Pb(OAc)4/PbO2 oxidation. Such dipyrromethanes 
could be prepared by the condensation of readily available 2-methylpyrrole in the presence of 
bromine, and followed by heating in the methanol.42 
1.3 Synthesis of Halogenated BODIPYs 
Since the first halo BODIPY44 was reported in 1990, halogenated BODIPYs, both as 
synthetic precursors and terminal compounds, continue to attract a lot of attention. As is widely 
known, most of BODIPYs are non-phototoxic, but some special types of halogenated BODIPYs 
(usually iodinated or brominated BODIPYs) were suitable for photodynamic therapy. It was 
resulted from the enhancement of intersystem crossing that is induced by the heavy atom effect.45-
48 On the other hand, due to good reactivity (especially for Pd(0) catalyzed coupling and 
substitution reactions) of halogenatedgen groups, a large number of functionalized BODIPYs can 
be achieved from the halogenated BODIPY platforms.49 Furthermore, previous work41, 43, 50-51 has 
been shown that halogen groups can be introduced to all the positions. This allows the sequential 
functionalizations occurring at all the pyrrolic and meso positions.  
1.3.1 Halogenation at 2,6 (α)-positions 
2,6-Dihalogenated BODIPYs are the most easily obtained BODIPYs, because the 2,6-  
8 
positions are the least positive compared with other positions17. There are two different strategies 
to synthesize 2,6-halogenated BODIPYs. One is exploiting direct electrophilic substitution 
reactions at the 2,6-positions. 2,(6)-(Di)brominated BODIPYs could be prepared via an 
electrophilic substitution reaction with bromine,44, 51 or N-bromosuccinimide (NBS)52-53 in suitable 
solvents (DCM or DMF), as shown in Scheme 1-3. CuBr2 also could be an efficient alternate 
reagent for the bromination at the 2,6-positions of BODIPY, which was reported by Hao and 
coworkers54. In this reaction, the author proposed that the mechanism could be roughly divided by 
two steps; (1) in situ-formation of bromine from CuBr2; (2) electrophilic substitution by bromine 
that generated from the first step. In 2012, Ortiz55 reported a chlorination method to access to 2,(6)-
(di)chloro BODIPYs from 2,6-free BODIPY using N-chlorosuccinimide (NCS) in THF at the 
room temperature. Futhermore, 2,(6)-(di)iodo BODPYs can be prepared by the reaction between 
BODIPYs and ICl,52 HNO3/I2,
45 and N-iodosuccinimide (NIS)56 in good yields. 
Scheme 1-3: Synthesis of 2,(6)-halogenaed BODIPYs 
9 
On the other hand, 2-halogenated BODIPYs could be prepared from halogenated pyrroles. 
4-Halo (chloro-, bromo-, and iodo-) 2-acylpyrroles55, 57-59 could be prepared via a halogenation 
reaction between 2-acylpyrroles and NXS (X= Cl, Br, I). Such pyrroles could react with another 
α-free pyrrole fragment and POCl3, followed by a basic complexation with BF3OEt2 to produce 2-
halogenated BODIPYs. 
1.3.2 Halogenation at 3,5-position 
In 2005, Boens and coworkers reported the synthesis of 3,5-dichloro BODIPY60. In this 
work, a 1, 9-dichlorodipyrromethane was obtained regioselectively by treating dipyrromethane 
with 2 equivalent of NCS at -78 oC. Following oxidation by DDQ, deprotonation by triethylamine, 
and complexation by BF3OEt2 yielded the first 3,5-dichloro BODIPY, as shown in Scheme 1-4. 
By employing the same methods but with NBS (1 or 2 equiv), 3,(5)-(di)bromo BODIPY could be 
obtained in good yields.61-62 To conclude, halogenation at the dipyrromethane stage is the preferred 
synthetic route to avoid the halogenation at the 2,6-positions, instead of direct halogenation at the 
BODIPY. The reason is that at the dipyrromethane, the 1,9-positions are more reactive compared 
with 2,8-positions for the aromatic electrophilic substitution reactions, which is opposite from that 
at the BODIPYs. 
Scheme 1-4: Synthesis of 3,(5)-(di)halogenated BODIPYs 
10 
Vicente and coworkers reported an alternate synthetic route to approach the symmetric and 
asymmetric 3,5-diiodo-BODIPYs63-65 via the same strategy, as shown in Scheme 1-5. The 1,9-
diester dipyyromethane could be prepared by two different synthetic routes; (1) acid-catalyzed 
condensation of α-free pyrroles with aldehydes, as shown in Section 1.2.1; (2) bromine-induced 
condensation of α-methylpyrroles, and followed by heating in the methanol, as shown in Section 
1.2.2. 1, 9-diiododipyyromethanes were obtained via de-esterification with Pd/I2 or potassium 
hydroxide (KOH) followed by HCl (aq), iodination with I2, and oxidation with DDQ. Subsequent 
basic complexation with BF3OEt2 gave 3,5-diiodo BODIPYs in good overall yields.  
Another approach to 3,(5)-(di)halogenated BODIPYs is by utilizing 5-halo 2-
acylpyrroles,58-59, 66 as shown in Scheme 1-6. One of the reported methods is applied to 
halogenation of α-free pyrroles by NXS (X= Cl, Br, I), followed by trifluoroacetylation and 
Vilsmeier–Haack reaction, which smoothly provided the desired halogenated pyrroles in fair-good 
yields. The alternate method to access to this type of halogenated pyrroles involves a Vilsmeier- 
 
Scheme 1-5: Synthesis of 3,5-diiodo BODIPYs 
11 
Haack reaction of isoindolin-1-one followed by basic hydrolysis in ethanol.66 3-Halogenated 
BODIPYs could be obtained from the condensation between 5-halopyrrole and another α-free 
pyrrole fragment by using the same method as mentioned in the synthesis of 2-halogenated 
BODIPYs. 
Furthermore, Hao and coworkers54 unprecedentedly developed a new method of 
regioselective halogenation at 3,5-positions by using CuCl2 as the chlorination reagent, as shown 
in Scheme 1-7. As is known, a large amount of previous work has already shown the reactivity 
order of the aromatic electrophilic substitution of BODIPYs: 2,6-positions > 3,5-positions > 1,7-
positions51, 67.  In order to explain this unusual regioselectivity in this reaction, the authors 
proposed a two-step mechanism: (1) formation the radical-cation (at the 3, 5-positions) BODIPY 
intermediate in a single electron transfer process; (2) nucleophilic addition reaction of a chloride 
anion (Cl-).  
 
Scheme 1-6: 3,5-halogenated BODIPYs from pyrroles 
 
Scheme 1-7: Synthesis of 3, (5)-dichloro BODIPYs 
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1.3.3 Halogenation at 1,7-positions 
The BODIPY 1,7-positions bear the most positive charge, which causes difficulty  
introduction the halo groups via electrophilic aromatic substitution reactions. The first 1,7-
dihalogenated BODIPY was reported by Dehaen and coworkers in 201168. In their work, two 
different strategies were used for the preparation of 1,7-dihalogenated BODIPYs, as shown in 
Scheme 1-8. The principle of the first strategy is to block the other positions with methyl groups. 
Thus, the synthesis was started with the condensation of 2,3-dimethylpyrrole in the presence of 
acetyl chloride (AcCl), followed by complexation under the basic conditions to provide the 1,7-
free BODIPY. Excess bromine in DCM was then used for the bromination of 1,7-free BODIPY 
yielding the 1,7-dibromo BODIPY in good yield. In the second strategy, the key intermediate--2-
formyl-3-halopyrrole was synthesized by the formylation of 2,3-dimethylpyrrole via a Vilsmeier- 
Scheme 1-8: Synthesis of 1,7-dihalogenated BODIPYs 
 
Scheme 1-9: Synthesis of 1-iodo BODIPY 
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Haack reaction, and followed by bromination at the 3-position using NXS (X= Br or Cl); The 
generated 2-formyl 3-halo pyrroles were condensed in the presence of POCl3/DCM, followed by 
complexation in the trimethylamine to provide 1,7-dibromo (chloro) BODIPYs in good yields.  
Ziessle and coworkers reported the synthesis of 1-iodo BODIPY as a byproduct in 2012,69 
as shown in Scheme 1-9. In their work, the original plan was to introduce the iodo group at the α-
positions of 2,6-thienyl groups. However, this electrophilic substitution reaction lacks 
regioselectivitity, and produced undesired 1-iodo BODIPY in 32% yield, as well as the desired 
product in 20% yield.  
1.3.4 Halogenation at 8-position 
As discussed in Section 1.1, the 8-position is a very important position, with the largest 
LUMO MO coefficient, the functionalization at this position will greatly affect the spectroscopy 
properties of BODIPYs. However, there is a lackof methods for functionalization at the 8-position. 
The most common way (almost the only way) to modify the 8-position is to use modified aldehydes 
or 2-ketopyrroles for the synthesis of BODIPYs, as discussed in Section 1.2.1. Also, a large 
amount of work may be needed for the synthesis of modified aldehydes or 2-ketopyrroles. Thus, a 
functionable group at 8-position was necessary for various applications. Halo groups were 
excellent candidates and were finally introduced at the 8-position via the dipyyroketone synthetic 
route,41, 43 as shown in Section 1.2.2. The dipyrroketone can be prepared in two major steps, as 
shown in Scheme 1-10: (1) formation of dipyrrothioketone via the condensation of α-free pyrrole 
in the presence of thiophosgene (CSCl2); (2) basic oxidative hydrolysis by using H2O2/KOH in the 
ethanol. Treatment of dipyrroketones with POX3 (X= Cl or Br) or phosgene (COCl2) provides the 
corresponding 5-chloro-dipyrrin salts, followed by complexation under basic conditions, and 8-
chloro (bromo) BODIPYs were obtained in high yields. Furthermore, 8-iodo BODIPY could be  
14 
 
Scheme 1-10: Synthesis of 8-halogen BODIPY 
synthesized from the addition/elmination reaction between 8-chloro BODIPY and NaI in refluxing 
acetone in good yield. 
1.3.5 Halogenation at two different positions of BODIPY 
1.3.5.1 Halogenation at 2,6(β) and 3,5(α) –positions 
Based on the previous results, the 2,6-positons at BODIPYs are the most reactive for the 
electrophilic aromatic substitution, followed by the 3,5-positions and the 1,7-positions. Thus, 
halogenation at the both α and β positions can be easily achieved by using an extra amount of 
halogenation reagents. Over the last several years, many papers have reported that direct 
chlorination by using NCS55 or SO2Cl2
70, bromination by using bromine,51 and iodination by using 
I2/HIO3 or ICl
67 at the 2,3,5,6-free BODIPYs can yield the desired 2,3,6-trihalo and 2,3,5,6-
tetrahalo BODIPYs in good yields, as shown in Scheme 1-11. One exception among these 
examples is  trihalogenation using a small excess of NCS in THF, which gave the 2,3,5-trichloro 
BODIPY as the major product with the confirmation of X-ray analysis.67 Additionally, in the 
iodination reaction, by increasing the amount of ICl to 4.5 or 8 equiv, 3-chloro 2,5,6-triiodo 
BODIPY and 3,5-dichloro 2,6-diiodo would be formed and isolated in different yields. However, 
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Scheme 1-11: Synthesis of α,β-halogenated BOIDPYs 
Scheme 1-12: Synthesis of α,β-tribromo and tetrabromo BODIPYs 
there was no formation of chlorinated BODIPYs when I2/HNO3 was used the iodination reagents. 
Ravikanth and coworkers71 reported the synthesis of 2,3,5,6-tetrabromo-BODIPY by 
treating a dipyrromethane with 4 equiv of NBS at -78 oC, followed by oxidation withDDQ and 
basic complexation with BF3OEt2, as shown in Scheme 1-12. In this case, regioselectivity of 1,9-
positions and 2,8-positions over the 3,7-postions was observed and confirmed.  
Utilizing dihalogenated pyrroles to synthesize α,β–polyhalogenated BODIPYs is a  
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convenient method, as shown in the Scheme 1-13. Treatment of 2-ketopyrrole with 3 equiv of NCS 
yielded 3,5-dichloro pyrrole and 4,5-dichloropyrrole as a mixture, in moderate isolated yields.55 
Subsequent treatment of 4,5-dichloropyrrole with 3-ethyl-2,4-dimethylpyrrole in the presence of 
POCl3, followed by complexation with BF3OEt2 in basic conditions yielded the asymmetric 2,3-
dichloro BODIPY in good yields. Additionality, direct iodination on the asymmetric BODIPY by 
using 2.5 equiv ICl also provided the 2,3-diiodo-BODIPY with a fair yield, also with 1,2-diiodo 
BODIPY as a byproduct.67 
 
Scheme 1-13: Synthesis of 2,3-dihalogenated BODIPYs 
1.3.5.2 Halogenation at 2,6 (β) and 1,7 (β’)-positions 
Since the 3,5-positions are more reactive than the 2,6-positions toward aromatic 
electrophilic substitution, β,β’-halogenated BODIPYs are difficultly obtained if 3,5-position is not 
blocked. Thus, the most reasonable strategy is to exploit the dihalogenated pyrroles, as shown in 
Scheme 1-14. From Section 1.3.4.1, 4,5-dichloro-2-ketopyrrole could be prepared by the 
chlorination of a 2-ketopyrrole. Subsequent treatment of such pyrroles with POCl3, and followed 
by basic complexation with BF3OEt2 provides the 1,2-dichloro BODIPY in good yield.
55 On the 
other hand, 1,2-diiodo-BODIPY was formed as an undesired products from iodination reaction  
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Scheme 1-14: Synthesis of 1,2-dihalo BODIPY 
 
Scheme 1-15: Synthesis of 3,5,8-trichloro BODIPY. 
with ICl in moderate yield.67 As a good leaving group, 3-iodo group is not so stable, which may 
explain the formation of the 1,2-diiodo BODIPY. 
1.3.5.3 Halogenation at 3,5,8-positions 
In 2014, Vicente and coworkers reported the synthesis and functionalization of 3,5,8-
trichloro BODIPY,42 which was the first attempt to introduce 8-chloro and 3,5-chloro groups into 
the same BODIPYs. The key intermediate of total synthesis is a dibenyl 5-dipyrroketone-2,9-
dicarboxylate, which was prepared from an oxidation reaction of dipyrromethane by using 
Pb(OAc)4/PbO2 in acetic acid. The dipyrromethane precursor was synthesized from the 
condensation of α-methylpyrrole in the presence of bromine, and followed by heating inmethanol. 
Debenzylation by Pd/H2 and iodination with I2/MeOH yielded the diiododipyrroketone. Such a 
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compound was subject to excess phosgene in chloroform to give the trichloro dipyrromethene 
hydrochloride salt. After immediate complexation with BF3·Et2O in the presence of N,N-
diisopropylethylamine, 3,5,8-trichloro BODIPY was obtained in a good overall yield. 
1.3.6 Halogenation at three different positions 
In these cases, regioselectivity was not an issue to be considered. Thus, 1,2,3,5,6,7-
hexachloro (bromo) BODIPY, as well as 1,2,3,5,6-pentabromo BODIPY can be easily obtained in 
good yields via halogenation of dipyrromethane using excess NCS or NBS,50, 67, 71 as shown in 
Scheme 1-16. Additionally, direct electrophilic bromination with (40 equiv or 300 equiv) bromine 
at pyrrolic-position-free BODPY can directly provide pentabromo- and hexabromo- BODIPYs in 
good yields.51  
 
Scheme 1-16: Synthesis of α,β,β’-polyhalogenated BODIPYs. 
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As shown in Scheme 1-17, asymmetric 1,2,3-triiodo BODIPY could be obtained as the 
major product when I2/HNO3 was used as the iodination reagent.
67 However, the iodination 
reaction using ICl yielded 1,2,3-triiodo BODIPY, as well as 1,2-diiodo 3-chloro BODIPY as 
abyproduct in fair isolated yields. The 3-chloro group may be formed from substitution reaction 
by chloride anion on the 1,2,3-triiodo BODIPY.  
 
Scheme 1-17: Synthesis of α,β,β’-polyhalo BODIPYs 
1.4 Applications of Halogenated BODIPYs 
A wide range of reactions, including metal-mediated cross-coupling and substitution 
reactions, are found to work well with the halogen groups at the BODIPY. The versatility of 
Suzuki,41, 56, 68, 72-74 Stille,41-43, 68, 72 Sonagashira,41, 56, 64, 68, 72-73 Heck,41, 68, 72, 75 and Negishi76 cross-
coupling reactions are well investigated on the 1,2,3,5,6,7,8-halo groups at the BODIPYs. 
Furthermore, C-, O-, N-, S- centered nucleophiles could be introduced into the 3,5-positions of the 
3,5-dichloro-BODIPY under basic conditions.41, 51, 77-78 However, only S-centered nucleophiles 
works for 1,7-substitution reactions.51, 68 No publication has shown the successful aromatic 
substitution reactions at 2,6-dihalo BODIPYs. 
1.4.1 Extended Conjugations 
Traditional BODIPYs usually absorb and emit in the region of 470-530 nm. Near-infrared 
(NIR) BODIPYs (e.g. as shown in Figure 1-5) were needed for the various applications. In the last 
decade, several strategies have been developed to the synthesis for NIR dyes.19 Among them, aryl 
fused BODIPYs with rigid structures are particular interesting, due to their high quantum yields 
and strong π-π interactions. Usually, these types of aryl-fused BODIPYs were prepared by multi- 
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Figure 1-5: Structures of aryl-fused BODIPYs 
step synthesis from aryl-fused pyrroles.79-88 On the other hand, bicyclo[2.2.2]octadiene-fused 
pyrroles89-93 or cyclohexane-fused pyrroles65, 94 are important precursors for the aryl-fused 
BODIPYs, which usually involved in a retro-Diels-Alder reaction or oxidation reaction using 2,3-
dichloro-5,6-dicyano-1,4-benzoquinone (DDQ). Additionally, FeCl3-mediated oxidation at the 
pre-made BODIPYs95-98 is also an alternate way to prepare aryl-fused BODIPYs.  
It should be noted that halogented BODIPYs99-103 provided a facile method to synthesized 
aryl-fused BODIPYs. Dehaen,99 Hao102 and their coworkers applied the same strategy to approach 
the aryl-fused BODIPYs. “N” or “O”-centered nucleophiles were easily introduced at the 2,6-
positions of dichloro- or tetrabromo- BODIPYs. Palladium-catalyzed intramolecular coupling 
(between the bromo-β-position of BODIPY and free-α-position of a phenoxyl group, or the free-
β-position of a BODIPY and bromo-α-position of phenoxyl group) was accomplished in good 
yields, as shown in Scheme 1-18. Another strategy that approach aryl-fused BODIPY is to firstly 
introduce a suitable aryl groups at the 2,6-positions by using Suzuki-Miyaura coupling reactions  
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Scheme 1-16: Synthesis of aryl-fused BODIPYs 
on 2,6-dibromo BODIPYs. Subsequent FeCl3-mediated or bis(trifluoroacetoxy)iodobenzene 
oxidation reaction100-101 or H2SO4-induced cyclization
103 will provide the desired aryl-fused 
BODIPYs in good to excellent yields. π-System extension of aryl-fused BODIPY leads to a 
significant red-shift both at maximum absorption (up to 673 nm) and emission (692 up to 692 nm) 
in dichloromethane.  
1.4.2 Fluorescent Indicators 
Since the first 2,6-dicholo-BODIPY was reported by Dehean and coworkers, halogenated 
BODIPYs have been widely applied as fluorescent indicators.104-105 Due to their high tenability, 
halogenated BODIPY have allowed various functionalizations to approach a wide range of  
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Scheme 1-17: Synthesis of fluorescent indicators from 3,5-dichloro BODIPY. 
florescent probes, as shown in Scheme 1-17. Ratiometric fluorescent indicators for Pd2+,106 Ca2+,106 
Cu2+,63, 107 Cu+,108 K+,109 Zn2+,110 and some other metal ions111 could be prepared by substitution 
reaction between dihalo-BODIPYs with azacrown ether or other nucleophilies in high yields. In 
2012, Yang and coworkers reported the ratiometric fluorescent indicators for glutathione detection, 
which was also synthesized via SNAr substitution reactions from the dichloro-BODIPY.
112 The 
working mechanism of this sensors was utilizing the different reactivity of “S” and “N” centered 
nucleophilies for the SNAr substitution reactions, as well as the different spectroscopy properties 
between 5-“S” or “N” substituted BODIPYs. By employing the same strategy and BODIPY 
platforms, probes for the discrimination of cysteine from homocysteine and glutathione113-116 and 
for the discrimination of glutathione from homocysteine and cysteine117-119 have been prepared in 
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high yields. Also, several probes120-123 for the simultaneous detection of glutathione, cysteine and 
homocysteine have been reported by several research groups in 2014 and 2015. Furthermore, 2,6-
dichloro-BODIPYs could also be applied for the probes for detecting γ-glutamyltranspeptidase in 
the ovarian cancers,124 as well as nano-materials for imaging125 with a wide range from blue to 
near infrared and detection of H2S
126 from endogenous generation based on Förster resonance 
energy transfer (FRET) mechanism. Finally, Jeyaraman and coworkers reported several probes for 
the detection of anions (e.g. N3
-),127 NH3 vapor,
128 and aliphatic amines129 based on 2,6-dibromo-
BODIPYs.  
1.4.3 Photodynamic Therapy (PDT) 
As a promising class of PDT reagents, BODIPY derivatives possess several characteristics 
found in a perfect photosensitizer, including strong resistance toward the photobleaching, high 
extinction coefficients, and low dark-toxicity.46, 48 As mentioned above, there is very low 
efficiency of intersystem crossing from singlet states to triplet states for most BODIPY dyes. With 
development of BODIPY chemistry, 2,6-diiodo-BODIPY,47 as well as brominated BODIPYs,130 
were firstly reported as efficient photosensitizers in 2005 and 2006. The heavy atom effect that is 
induced by bromo or iodo atoms was a widely accepted explanation for the enhance quantum yield 
of singlet oxygen generation. In recent decades, several groups dedicated to the development of 
ideal BODIPY photosensitizers, which were mainly prepared modified based on 2,6-diiodo-
BODIPY platforms, as shown in Scheme 1-18. Knoevenagel condensation could be employed to 
introduce styryl groups at the 3,5-positions of 2,6-diiodo (bromo) BODIPYs,130-135 which not only 
significantly red-shifted the dye to the NIR, but also allowed introduction of the PEG groups to 
increase their water solubility. Meanwhile, such styryl BODIPYs maintained the same level of the 
singlet oxygen generation of as 2,6-diido-BODIPs.  Borggraeve136 and Burgess137 have exploited  
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Scheme 1-18: Several types of 2,6-diiodo BODIPY analogues. 
the “click” chemistry to introducepeptides at the 8-position of the BODIPY. Conjugated BODIPYs 
possessto localize lysosomes or target TrkC, respectively. Furthermore, from the diiodo-BODIPY, 
Zhao and coworkers56, 73, 88 synthesized a serious of iodo-BOIDYs and BODIPY dimers by using 
Pd(0) cross-coupling reactions, some of which possessed the long life triplet excited states with. 
As shown in Scheme 1-12, 2,3,5,6-tetraiodo- and 2,3,6-triiodo-BODIPYs could be synthesized by 
Ortiz and coworkers.67 Interestingly, by increasing the numbers of iodo groups at the 3,5-positions, 
no significant enhancement of singlet oxygen generation was observed. On the other hand, by 
employing different aldehydes for the BODIPY synthesis, a large number of 2,6-diiodo-BODIPYs 
could be prepared with different 8-substitutents.45, 138 For example, a 3-alkylcarboxylic acid 
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BODIPY was found to localize at the mitochondria of HSC-2 cells, as well as a slightly increasing 
singlet oxygen generation.138 
1.5 Research Outlook 
Despite a large amount of published BODIPY chemistry research, most of BODIPY-based 
sensors and probes are prepared based on simple BODIPY platforms, such as dichloro BODIPY. 
There are several disadvantages of such BODIPY platforms: (1) those BODIPY dyes emit and 
absorb usually at λ≤ 600 nm; (2) there are limited functional groups at the BODIPY for further 
functionalization to improve preperties, such as quantum yields or water solubility. Thus, in order 
to overcome these problems, novel BODIPY platforms that allows uccessive functionalization are 
designed, synthesized, characterized, and investigated, as shown in the following Chapters in this 
Dissertation.  
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CHAPTER 2: SYNTHESIS OF 3,8-DICHLORO-6-ETHYL-1,2,5,7-
TETRAMETHYL-BODIPY AND REACTIVITY STUDIES AT THE 3,5,8,-
POSITIONS* 
2.1 Introduction 
Based on reported methods in Chapter 1, a number of BODIPY platforms, such as those a-
b in Figure 1, have been prepared and their reactivity investigated.1-3 BODIPY platform a that was 
reported in 2005 bearing 3,5-dichloro groups undergoes SNAr and reactive Pd(0)-catalyzed cross-
coupling reactions at these positions, which yields a variety of functionalized BODIPYs for 
various applications,4-7 as discussed in Chapter 1. On the other hand, Knoevenagel condensations 
that were widely used to react with the α-methyl groups on BODIPY platform b various aldehydes 
produce the corresponding styryl BODIPYs with significant red shift in both the absorption and 
emission.8-12 Such a method is widely applied for the development of various NIR BODIPY probes 
with the extended conjugation.1-3, 8, 11, 13-15 In the traditional routes, the lack of functionalizable 
groups at the meso position made meso-functionalization a challenge, until platform c16-20 with 8-
thioester group and platform d21-23 bearing an 8-chloro group were reported. The 8-thioester group 
at platform c was reported to undergo the elimination/addition with N-centered nucleophiles17-18 
and a later reported Liebeskind-Srogl cross coupling reactions with aryl-, alkenyl- bornic acids and  
               
Figure 2-1: Several different BODIPY platforms. 
* Reproduced from Ref. Zhao, N.; Vicente, M. G. H.; Fronczek, F. R.; Smith, K. M. Synthesis of 
3,8-Dichloro-6-ethyl-1,2,5,7-tetramethyl–BODIPY from an Asymmetric Dipyrroketone and 
Reactivity Studies at the 3,5,8-Positions. Chemistry-A European Journal, 2015, 21, 6181. with the 
permission of John Wiley and Sons.  
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Figure 2-2: Structure of 3,8-dichloro-6-ethyl-1,2,5,7-tetramethyl-BODIPY 1a. 
organostannanes.16, 20 However, as discussed in Chapter 1, more versatile platform d can react with 
various types of nucleophiles. Also, a wide range of Pd(0)-catalyzed coupling reactions, including 
Stille, Suzuki, and Sonogashira coupling reactions, work well on the platform d. 
In order to introduce all there three valuable groups into one BODIPY core, as discussed 
above, we report the design and synthesis of a versatile, asymmetric BODIPY 1a bearing 3-chlor 
and 8-chloro groups, as well as a reactive 5-methyl group. BODIPY 1a was found to be 
regioselectively functionalized using four different types of reactions, at all the 3-, 5- and 8-
positions, to yield new BODIPYs. The Stille cross-coupling and nucleophilic addition/elimination 
reactions both occur regioselectively at the 8-position, followed by the 3-position, which allows 
stepwise functionalization using N-, O-, and S-centered nucleophiles and various commercial 
available tin reagents. Addtionally, regioselectivity of meso- versus α-position toward 
addition/elimination reactions at the BODIPY was firstly investigated. Furthermore, 5-formyl and 
styryl BODIPYs can be produced by further functionalization of the Knoevenagel and oxidation 
reaction at the 5-methyl group of BODIPY 1a.  
2.2 Synthesis of 3,8-Dichloro-6-ethyl-1,2,5,7-tetramethyl-BODIPY 
The synthetic route to asymmetric dipyrroketone 5 as a fundamental precursors of 
BODIPY platefrom 1a is oulined in Scheme 2-1, started with readily available pyrrole 4, that could 
be synthesized from commercial available compounds 2 in two steps using published procedure.24 
The conversion of α-methyl group of pyrrole 424 to a carboxylic acid 525-26 is accomplished by 
36 
using sulfonyl chloride (SO2Cl2) for the chlorination and followed by hydrolysis reaction with 
sodium acetate in 1,4-dioxane. An acylation reaction with thionyl chloride (SOCl2), followed by 
an amidation reaction with dimethylamine gas26 produced 2-amide pyrrole 6 in 85% yield. 
Asymmetric dipyrroketone 8 was obtained by reactions of pyrrole 6 with phosphoryl chloride 
(POCl3), followed by addition of 2,4-dimethyl-5-ethyl pyrrole and sequential hydrolysis with 
aqueous sodium acetate solution27 in a good overall 86% yield for total 3 steps. The formation of 
intermediate 7 was confirmed by HRMS. The key dipyyroketone 8 was well characterized by 1H 
NMR, 13C NMR and HRMS (ESI-TOF).  
Scheme 2-1: Synthesis of asymmetric dipyrroketone 8. 
As shown in Figure 2-3, the peaks at δ = 8.78 and 9.20 in the 1H NMR spectra can be 
assigned to NH of the dipyrroketone, showing this asymmetric structures. The structure was also 
further confirmed by X-ray analysis, as shown in the Figure 2-4. Suitable crystals of 8 was grown 
37 
by slow evaporation in CHCl3, the result is shown in Figure 2-4. The NH group of one pyrrole is 
syn to the central carbonyl (N-C-C-O torsion angle 15.5°) in the conformation of dipyrroketone 8, 
while the other one is syn to benzyl ester carbonyl with a torsion angle of 6.0°.  
Figure 2-3: 1H NMR (400 MHz) of dipyrroketone 8 in CDCl3 at room temperature.  
                                                                             
Figure 2-4: X- ray structure of dipyrroketone 8 with 50% probability ellipsoids. 
8 
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Scheme 2-2: Chlorination of dipyrroketone 8. 
Figure 2-5: 1H NMR of dipyrromethene 10. 
Oxidative chlorination reaction excess phosgene (15% in toluene)28 with was performed to 
convert dipyrroketone 8 to dipyrrolmethene 9, as shown in Scheme 2-2. However, after 
recrystallization in diethyl ether, the reaction afforded an undesired product 5-chlorodipyrrin salt 
10, instead of 9. The structure of this compound was determined by 1H NMR (Figure 2-4) 
spectroscopy and X-ray analysis (Figure 2-5). In 1H NMR spectra of 10, the NH peak shifted 
downfield to δ = 13.32 ppm; one signal is missed at δ = 2.0 ppm, while one singlet (integration is 




                                                                               
Figure 2-6: X- ray structure dipyyromethene 10 with 50% probability ellipsoids. 
Scheme 2-3: Synthesis of asymmetric BODIPY 1a and 1b. 
ppm is around 6. I believe the peak of 8-H (Hb) was overlapped with the peaks of the phenyl ring 
of the 3-COOBn group. In the X-ray analysis, 5-chlorodipyrrin salt 10 is confirmed as the 
hydrochloride salt with both N atoms protonated. There are hydrogen bonds forming between two 
“NH” atoms to the chloride ion. The dipyrryl C9N2 core is exactly planar to with a mean deviation 
of 0.017 Å. 
We believed that the observed regioselectivity of the chlorination was due to the presence 
of electron withdrawing group benzyl ester (-COOBn), so an alternative approach was employed, 
as shown in Scheme 2-3. The benzyl ester group was converted to a much less electron- 
10 
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Figure 2-7: 1H NMR spectra of 1a and 1b. 
withdrawing iodo group via a debenzylation reaction with Pd/H2, followed by an iodination 
reaction with I2/NaHCO3.
29 The newly generated dipyrroketone 11 then reacted with excess 
phosgene (15% in toluene) for the oxidative chlorination. Several observation suggested a 
successful reaction: (1) the color of reaction mixture was changed from yellow to dark red; (2) the 
UV-Vis spectra showed the formation of new peaks of 485/499 nm that belong to dipyrromthene; 
(3) the “NH” peaks shifted downfield in the 1H-NMR spectra of the crude product. Subsequent 
deprotonation with N,N-diisopropylethylamine (DIEA, 7 euqivalents) and complexation with  
boron trifluoride diethyl etherate (10 equivalents) successfully yielded the fluorescent BODIPY 
dye 1a  in a 78% isolated yield (over 2 steps), along with a minor monochloro-BODIPY 1b in 6% 
yield. BODIPYs 1a and 1b were both characterized by 1H NMR, 13C NMR, and HRMS (ESI-
TOF), as well as X-ray analysis. 
Figure 2-7 shows 1H-NMR spectra of BODIPYs 1a and 1b. BODIPY 1a has almost similar 





Figure 2-8: X-ray structures of BODIPYs 1a-b. Only one of the independent molecules is shown 
for both 1a and 1b. 
example, the triplet at around δ 1.1 ppm is almost overlap with each other. The difference that 
distinguish these two BODIPYs is the singlet δ 7.4 ppm, which belongs to the α-H group of 1b at 
the unshielding area of aromatic BODIPY core. At the same time, 1a has one chloro group at 3-
position, so no signal is shown at that area.  
Suitable crystals of 1a-b grown by slow evaporation in the chloroform were used for X-
ray analysis, and the results are shown in Figure 2-8. There are two independent and almost 
identical molecules of 1a, and a disordered molecule of chloroform in the structure of 1a. In both 
molecules, there are the mean diviations of 0.027 and 0.036 Å from planarity of their 12-atom 
BODIPY cores, and a torsional difference (9.8°) in the conformation of 6-ethyl group. On the other 
hand, there are four independent molecules in the structure of BODIPY 1b. The mean deviations 
of their 12-atom BODIPY cores are in the range of 0.023 – 0.054 Å. In such molecules, the 
conformations of β-ethyl group are almost perpendicular to the planes of the BODIPY core, with 
C-C-C-C torsion angles in the range of 88.3-89.7°.  
2.3 Reactivity Studies at the 3,5,8-positions of BODIPY 1a 
Previous work from both our group and other groups showed meso-chloro or α-chloro 
group of BODIPYs has a high reactivity towards Pd(0)-catalyzed cross-coupling reactions.23, 28, 30-
31 Since base is not required, and the high yielding,21, 23, 28 Stille cross-coupling32 reactions are also  
1a 1b 
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Scheme 2-4: Synthesis of asymmetric BODIPY 12a-c. 
Figure 2-9: X-ray structures of BODIPY 12a-c (50% probability ellipsoids). Only the major 
conformer is shown for disordered groups. 
 
very attractive among the Pd(0)-catalyzed cross-coupling reactions. We recently reported that 
Stille cross-coupling reactions occurring first at the most reactive 8-chloro site, followed by at the 
3,5-positions.28 BODIPY 1a showed a high reactivity towards Stille coupling reactions in the 
presence of a small excess amount of tin reagents, and catalyzed by 10 mol% of Pd(PPh3)4 in 
toluene and smoothly produced the desired diaryl-BODIPYs 12a-c in good yields (63% to 86%), 
as shown in scheme 2-4. Of the three tin reagents used, 2-(tributylstannyl)thiophene showed the 
highest reactivity that the reaction gave the highest yield after two hours. 
Suitable crystals of 12a-c grown by slow evaporation in the chloroform were used for X-
ray analysis, and the results are shown in Figure 2-9. All these three structures show the disorder 
with the thiophene at 8-position, both furan groups, and 6-ethyl group in BODIPYs 12a, 12b, and 
12c. There are the mean deviations of 0.072, 0.087 Å, and 0.054 Å Å from planarity of the 12-
atom BODIPY cores for 12a, 12b, and 12c. The 8-aryl substituents forms different dihedral angles 
12a 12b 12c 
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with the cores in the range of 87.78 - 79.78°, to minimize steric interactions with the 1,7-dimethyl 
groups. On the other hand, dihedral angles between the aryl substituents at the 3-position and the 
BODIPY core are 41.78° for 12a, 36.98° for 12b, and 42.78° for 12c, respectively.  
    
Scheme 2-5: Synthesis of asymmetric BODIPYs 13a-c. 







Figure 2-11: X-ray crystal structures of asymmetric BODIPY dyes 13c (50% probability 
ellipsoids). Only the major conformer is shown for disordered groups. 
 
On the other hand, using 1 equiv of tin reagents with dilute mixture solutions, the 
corresponding 8-aryl-BODIPY dyes 13a-c were obtained in high yields (77-84%), as shown in 
Scheme 2-5. 8-Chloro group at BODIPY 1a showed higher reactivity over 3-chloro group towards 
the Stille cross-coupling reaction, which agrees with previous report.28   
The mono-coupled products 13a-c were confirmed by HRMS (see experimental part). 1H 
NMR spectral comparisons among BODIPYs 1a and 13a-c are outlined in Figure 2-10. The 
singlets of Hd and He at the 1,7-positions appear upfield-shift from δ 2.4 ppm (1a) to 1.5 ppm (13a-
b) and 1.3 ppm (13c). It can be explained that Hd and He both locate in the shielding areas of the 
8-aromatic rings, which can verify the regioselectivity of this reactions. A suitable crystal of only 
13c that was grown by slow evaporation in the chloroform was used for X-ray analysis, and the 
results are shown in Figure 2-11. Mean deviations from planarity of the C9BN2 cores of 13c is 
0.013 Å. 8-phenyl group forms dihedral angles of 75.68° for 13c with the BODIPY cores to 
minimize steric interactions with the 1,7-methyl groups.  
In order to further investigate the regioselectivity observed above, step-wise Stille cross-
coupling reactions with two different types of organotin reagents were performed on BODIPY 1a, 
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as shown in Scheme 2-6. Therefore, first Stille reaction introduced a thienyl or furanyl group at 
the 8-position of BODIPY 1a, followed by a thienyl, furanyl, or trimethylsilylethynyl group that 
were introduced at the 3-poisiton using a second Stille reactions, to produce BODIPYs 14-16, in 
good to excellent yields (58–91%). It should be noted that is 8-furanyl group seemed to deactivate 
3-chloro group, which caused the difficulty to introduce aryl group under the same conditions. 
Extending the reaction time slightly improve the yields, while a large excess amount of tin reagents 
and higher concentration in the reaction mixture both significantly improved yields, and decreased 
the reaction time at the same time. Besides, the intermediate compound 13a with a 8-thienyl group 
showed a high reactivity with 2-(tributylstannyl)furan with the highest yield.  
                      
Scheme 2-6: Synthesis of asymmetric BODIPYs 14-16. 
 
Figure 2-12: X-ray structures of BODIPYs 14-16, 50% probability ellipsoids.  
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Suitable crystals of 14-16 that grown by slow evaporation in the chloroform were used for 
X-ray analysis, and the results are shown in Figure 2-12. In BODIPY 14, both the 3-furan and 8-
thiophene rings displayed rotational disorder. The planarity of the C9BN2 core of BODIPYs 14-16 
and the dihedral angles formed by 3- and 8- aryl groups are similar to that in the crystal structures 
of 12a-c and 13c.The Mean deviations for the C9BN2 cores are 0.082 Å for 14, 0.071 Å for 15, 
and 0.018 Å for 16. In BODIPY 14, the 8-thienyl group forms a dihedral angle of 87.2°with the 
BODIPY core, and the 8-furanyl group form slightly lower angles of 84.8° and 78.0° in BODIPYs 
15 and 16. On the other hand, the 3-furanyl and thienyl groups in the BODIPYs 8 and 9 form 
dihedral angle of 38.6 and 39.6° with the BODIPY core plane. 
                
Scheme 2-7: Synthesis of asymmetric BODIPYs 17-19. 
                                          
Figure 2-13: X-ray structures of BODIPYs 17 and 18, 50% probability ellipsoids.  
 17  18 
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Moreover, the regioselectivity of BODIPY 1a towards nucleophilic addition/elimination 
reactions was also investigative three different types of nucleophiles, as shown in Scheme 2-7. 
Treatment of BODIPY 1 with a large excess amount of phenol or aniline in the presence of 
potassium carbonate overnight at room temperate yielded only the 8-substituted BODIPYs 17-18 
in high yields (87-95%). 1H NMR (see Appendix A) and HRMS spectra (see experimental part) 
were used to confirm mono-substitution. However, regioselevtivity of these two reactions was not 
verified until X-ray analysis was conducted, as shown in Figure 2-13. Under similar conditions, 
stronger nucleophiles p-methylthiophenol were used to react with BODIPY 1a produced 3,8-di-
substituted product 19, isolated in 93% yield.  
As mentioned above, X-ray analysis further verifies the regioseletivity of nucleophilic 
addition/elimination reactions. The structures of BODIPYs 17 and 18 both exhibit a disorder, in 
which 3-chloro and 5-methyl groups are swapped. In both cases, there is about 8% population of 
the minor component. There are the mean deviations of 0.033 and 0.061 Å from coplanarity of the 
C9BN2 core for BODIPYs 17 and 18. Interestingly, 8-aniline plane forms a dihedral angle of 68.6° 
with BODIPY core, while 8-phenoxy group forms an angle of 86.7°.  
Furthermore, in order to investigate the versatility of BODIPY 1a, step-wise 
functionalization using both nucleophilic addition/elimination and Stille cross-coupling reactions 
was performed on such platform, as shown in Scheme 2-8. Therefore, BODIPY 20 could be 
prepared by a Stille coupling reactions with tributylphenylstannane, followed by a SNAr reaction 
with excess amount of SH-carborane in THF in 56% overall yields. On the other hand, under the 
similar conditions, BODIPY 21 could be obtained in good yield (86% for steps) by a nucleophilic 
addition/elimination and a subsequent Stille coupling reaction. The crystals of 20 was obtained for 
the X-ray analysis, as shown in Figure 2-14, which further confirm the regioselectivity of this  
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Scheme 2-8: Synthesis of asymmetric BODIPYs 20 and 21. 
 
Figure 2-14: X-ray structure of BODIPYs 20, 50% probability ellipsoids.  
reaction. The mean deviation of 0.019 Å of the BODIPY core and a dihedral angle of 77.98 Å 
between the 8-phenyl group and C9BN2 core were observed, respectively. 
Finally, the reactivity investigation of 5-methyl group of BODIPY platform 1a by using 
classic Knoevenagel condensations and oxidation reactions was conducted, as shown in Scheme 
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2-9. A reaction between BODIPY 12c and 10 equivalents of 4-formylbenzoate in the presence of 
TsOH, piperidine and refluxed toluene for 72 hours afforded a monostyryl-BODIPY dye 22 as the 
major product, along with a small amount of dipyrromethene 23 as byproduct, maybe due to long 
time heating in a slightly acidic condition. Treating 23 with TEA, followed by a complexation 
reaction with BF3
.OEt2 reproduced styryl BODOPY 22. On the other hand, an oxidation reaction 
of BODIPY 12c with DDQ in the refluxed toluene produced the desired 5-formyl BODIPY 24 in 
26% isolated yield, along with a large amount of unknown byproduct. Besides, longer reaction 
time and a larger amount of DDQ did not lead to the further oxidization of the α-formyl group to 
a carboxylic acid group of BODIPY 24.  
Scheme 2-9: Knoevenagel and oxidation reactions of BODIPY 12c. 
Suitable crystals of BODIPY 22 and 24 that were grown by slow evaporation in the 
chloroform were used for X-ray analysis, and the results are shown in Figure 2-15. There are two 
independent molecules and the chloroform solvate presented in the both structures of BODIPY 22 
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and 24. Two independent molecules in BODIPY 22 have the mean deviations of 0.064 and 0.078 
Å from coplanarity of BODPY 12-atom core. Additionally, in such two molecules, the 8-phenyl 
group, the 3-phenyl group, and the 5-styryl group form dihedral angles of 84.0 and 75.08º, 59.8 
and 65.98º, and 26.2 and 22.78º with the BODIPY core. In BODIPY 24, the mean deviation of 
0.075 Å from coplanarity is observed.  The 8-phenyl group and the formyl C-C=O group form 
dihedral angles of 72.78 and 6.28º with the BODIPY core. 
 
Figure 2-15: X-ray structures of BODIPYs 22 and 24, 50% probability ellipsoids.  
2.4 Spectroscopic Properties 
The spectroscopic properties of BODIPYs 1a-b, 12a–c, 13a–c, 14–21, 22 and 24 in 
dichloromethane namely their maximum absorption (λabs) and fluorescence wavelengths (λem), 
Stokes shifts, molar extinction coefficients (log ε) and fluorescence quantum yields (Φf), are 
summarized in Table 1. Figures 2-16, 2-17 and 2-18 show the normalized absorption and 
fluorescence spectra of all the new BODIPYs. Such BODIPYs showed the characteristic strong 
and narrow absorption bands (log ε = 4.22–4.95) and emission bands. Compared to 3,8-chloro- 
22 24 
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log ε (M-1cm-1) Emission 
λem (nm) 
Φf Stokes shift 
(nm) 
1a 517 4.80 540 0.52 23 
1b 513 4.95 536 0.33 23 
12a 547 4.64 591 0.097 44 
12b 586 4.78 611 0.022 25 
12c 523 4.71 551 0.46 28 
13a 529 4.73 548 0.09 19 
13b 535 4.78 555 0.0097 20 
13c 515 4.71 536 0.48 21 
14 577 4.53 592 0.097 15 
15 556 4.66 577 0.011 21 
16 563 4.84 582 0.022 19 
17 505 4.52 521 0.89 16 
18 487 4.52 531 0.0017 44 
19 582 4.35 610 0.13 28 
20 512 4.41 532 0.41 20 
21 521 4.62 570 0.94 49 
22 587 4.22 617 0.73 30 
24 538 4.46 562 0.24 24 
*For BODIPYs 1a,b, 12c, 13a,c, 17, 18, 20 and 21 the calculation of fluorescence quantum yield 
used rhodamine 6G in ethanol (0.95) as standard; for BODIPYs 12a, 13b, and 24, rhodamine B in 
ethanol (0.49) was used as a standard; for BODIPYs 12b, 14-16, 19 and 22, crystal violet 
perchlorate in methanol (0.54) was used as standard.  
 
 
Figure 2-16: Normalized UV-Vis (solid lines) and fluorescence (dash lines) spectra of BODIPYs 







Figure 2-17: Normalized UV-Vis (a) and fluorescence (b) spectra of BODIPY 12a (red), 13b 
(blue), 18 (black), 20 (green), 21 (magenta) and 24 (yellow) in dichloromethane at room 
temperature. 
 
Figure 2-18: Normalized UV-Vis (a) and fluorescence (b) spectra of BODIPY 12b (black), 14 
(yellow), 15 (green), 16 (red), and 19 (Blue), 22 (magenta) in dichloromethane at room 
temperature.  
 
BODIPY 1a, 8-phenoxy and 8-phenylamino substitution at the BODIPYs 17 and 18 both led to a 
blue-shift of 12 nm and 30 nm, as previously reported for 8-aryloxy and 8-arylamino-BODIPYs.16, 
20-23 A widely accepted explanation is that electron-donating groups at the 8-position destabilize 
the LUMO, which then increases the gap of HOMO–LUMO. Due to the large dihedral angles 
between their 8-phenyl groups and the BODIP core, 13c and 20 gave a slight blue-shift in the both 




with thienyl or furanyl groups at the 3,8-positions provided the largest red-shift, which may be due 
to the decreased HOMO-LUMO gap. For example, there is a red shift of 60 nm in the absorption 
of 14, compared with 1a. Additionally, compared with 12c, the 64 nm and 66 nm of red-shift in 
the absorption and emission were observed for 5-styryl BODIPY 22, respectively.   
The range of Stokes shifts is ranged from by 16-49 nm. As previously reported,28, 33-35 the 
largest Stokes shifts were observed for α-thienyl functionalized BODIPYs 21 due to increased 
geometry relaxation.37-38 Also, a Stokes shift of 44 nm was observed for 8-phenylamino BODIPY 
18, which is in agreement with previous studies.17  
The quantum yields vary greatly among different BODIPYs. As reported, 8-phenoxyl 
BODIPYs 17 and 21 provided the largest quantum yields (0.89 and 0.94) of all BODIPYs 
synthesized, whereas BODIPY 18 bearing 8-phenylamino was almost nonfluorescent (Фf <0.002), 
probably due to intramolecular charge transfer (ICT) in the excited state, as reported.17 On the 
other hand, 3,8-(di)thienyl-, or 3,5-(di)furanyl-functionalized BODIPYs 12a-b, 13a-b, and 14-16 
possessed the dramatically decreased fluorescence quantum yields (< 0.1), which may be due to 
increased energy lost that resulting from free motion of all the thienyl or furanyl groups at the 3- 
or 8-positions.33-34  
2.5 Conclusion 
In conclusion, a versatile BODIPY platform 1a was designed and successfully synthesized from 
commercial available compounds in this Chapter. Excellent regioselectivity for the 8-chloro over 
3-chloro group on the BODIPY 1a was studied using Stille cross-coupling reactions with several 
different organotin reagents and nucleophilic addition/elimination reactions with N-, O-, and S-
centered nucleophiles. Additionally, Knoevenagel condensation and DDQ oxidation reactions 
were used to investigate the reactivity of the 5-methyl group. 16 crystal structures were obtain to 
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confirm the regioselectivity of those reactions, as well as the structures of the newly obtained 
asymmetric BODIPYs, which were also fully characterized by 1H NMR, 13C NMR, HRMS (ESI-
TOF), and spectroscopy studies in dichloromethane.  
2.6 Experimental 
2.6.1 Synthesis 
General: All reagents and solvents were purchased from Sigma-Aldrich, Fisher Scientifics or Alfa 
Aesar as reagent grades and used without further purification. Argon was used to protect the air-
sensitive reactions. Analytical TLC (polyester backed, 60Å, 0.2 mm, precoated, Sorbent 
Technologies) was used to monitor the reactions. Column chromatography was performed on silica 
gel (60Å, 230-400 mesh, Sorbent Technologies). All 1H NMR and 13C NMR spectra were obtained 
using Bruker AV-400 nanobay or AV-500 spectrometers (400 MHz or 500 MHz for 1H NMR and 
100 MHz for 13C NMR) in CDCl3 with trimethylsilane as an internal standard, at 300K. Chemical 
shifts (δ) are given in parts per million (ppm) with CDCl3 (7.27 ppm for 
1H NMR, 77.0 ppm for 
13C NMR). All high-resolution mass spectra (ESI-TOF) were obtained using a 6210 ESI-TOF mass 
spectrometer (Agilent Technologies). All UV-Visible spectra were recorded on a Varian Cary 50 
(solutions) spectrophotometer at room temperature. Fluorescence spectra were studied on a PTI 
QuantaMaster4/2006SE spectrofluorimeter collected emission spectrum. Spectroscopic grade 
solvents and a 10 mm path length quartz cuvette were used for both measurements. The 
determination of optical density (ε) was used the solutions with absorbance of λmax between 0.5—
1. The dilute solutions with absorbance of particular excitation wavelength between 0.03-0.08 
were used for fluorescence quantum yield measurement. Rhodamine 6G (0.95 in ethanol), 
rhodamine B (0.49 in ethanol) and crystal violet perchlorate (0.54 in methanol) were used as 
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external standards for calculation of relative fluorescence quantum yields of BODIPYs. All 
fluorescence quantum yields (Φf) were determined using the following equation:
39 
Φx= Φs× (Fx/Fs)× (As/Ax)× (nx/ns)
2
 
where Φx and Φs are the fluorescence quantum yields of the test samples and standards; Fx and Fs 
are the areas under the test samples’ and standards’ emission peaks; Ax is the absorbance at which 
test samples were excited; As the absorbance at which stands were excited; nx and ns are refractive 
indexes of test sample and standards.  
5-((Benzyloxy)carbonyl)-3,4-dimethyl-1H-pyrrole-2-carboxylic acid 5. Benzyl 3,4,5-
trimethyl-1H-pyrrole-2-carboxylate 424 (4.34 g, 17.84 mmol) was dissolved in carbon tetrachloride 
(270 ml). Sulfuryl chloride (7.69 g, 57 mmol) was added dropwise and the resulting solution was 
stirred overnight at room temperature. The reaction was stopped when the signals for RCH2Cl (δ≈ 
4.6) and CHCl2 (δ≈ 6.7 ppm) disappeared from the 
1H NMR spectra measured in CCl4. Organic 
solvents were removed under reduced pressure to give a red oil residue. The oil residue was 
dissolved in dioxane (70 ml) and a solution of sodium acetate (11 g) in water (60 ml) was added. 
The solution was stirred at 60- 65 oC for 3 h. The solution was then cooled to room temperature 
and extracted using diethyl ether (2 x 70 ml). The organic layers were combined and washed with 
5% Na2CO3 solution. All the aqueous layers were then combined and acidified by slowly adding 
acetic acid (10%). A white precipitate was filtered and washed thoroughly with water. The solid 
was redissovled in THF and dried over anhydrous Na2SO4. The organic solvents were removed 
under reduced pressure to give the title product (3.64 g) in 74.7% yield. 1H NMR (CDCl3, 400 
MHz): 9.48 (1H, s), 7.40-7.44 (5H, m), 5.36 (2H, s), 2.30 (6H, s); 13C NMR (CDCl3, 100 MHz): 
165.7, 160.7, 135.7, 129.2, 128.7, 128.4, 128.4, 127.7, 122.5, 120.8, 66.5, 10.1; MS (ESI-TOF) 
m/z [M+H]+: 274.1076; calculated for C15H16NO4: 274.1074. 
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Benzyl 5-(N,N-dimethylcarbamoyl)-3,4-dimethyl-1H-pyrrole-2-carboxylate 6. 5-
((benzyloxy)carbonyl)-3,4-dimethyl-1H-pyrrole-2-carboxylic acid 5 (4.6 g, 16.8 mol) was added 
portionwise into thionyl chloride (65 ml) over 20 min. The mixture was stirred for 30 min at 40-
45 oC. The solvent was removed under reduced pressure to give an oily product. The oily residue 
was redissolved in anhydrous benzene (130 ml). Then, dimethylamine gas was passed into the 
mixture for 10 min, and the mixture was kept stirring for another 2 h. The reaction was monitored 
by TLC. After the reaction was completed, the organic solution was washed with water (100 ml), 
dilute acetic acid (10%) and water again (100 ml), then dried over anhydrous Na2SO4. The organic 
solvents were removed under reduced pressure to give a yellow oil. Further purification by silica 
gel chromatography with DCM/MeOH as eluents gave the yellow titled product (4.3 g, 85.1%). 
1H NMR: (CDCl3, 400 MHz): 9.05 (1H, s), 7.34-7.42 (5H, m), 5.31 (2H, s), 3.06 (6H, s), 2.28 (3H, 
s), 2.04 (3H, s); 13C NMR (CDCl3, 100 MHz): 164.7, 160.9, 136.1, 128.6, 128.2, 127.2, 126.3, 
120.6, 119.8, 66.0, 10.3, 10.3; MS (ESI-TOF) m/z [M+H]+: 301.1548; calculated for C17H21N2O3: 
301.1547. 
Benzyl 5-(4-ethyl-3,5-dimethyl-1H-pyrrole-2-carbonyl)-3,4-dimethyl-1H-pyrrole-2-
carboxylate 8. Benzyl 5-(N,N-dimethylcarbamoyl)-3,4-dimethyl-1H-pyrrole-2-carboxylate 6 
(1.808g, 6.02 mmol ) was dissolved in warm POCl3 (9.23g, 60.2 mmol) The mixture was stirred 
at 50 oC for 5 h and then cooled to room temperature. Excess POCl3 was removed by evaporation 
using a CH2Br2 chaser under reduced pressure to give a red oily product that was then redissolved 
in DCM (4 ml). A solution of 3-ethyl-2,4-dimethylpyrrole (0.82 ml, 6.02 mmol) in DCM (4 ml) 
was added into the mixture under argon. The mixture was then stirred at 30 oC overnight. The 
reaction was monitored by UV-Vis (reaction was stopped when extinctions at 351 nm/399 nm 
reached a maximum). A solution of sodium acetate (10 g) in water (25 ml) added into the mixture, 
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which was then refluxed for 2-3 h. After the mixture was cooled to room temperature, chloroform 
(50 ml × 3) was used to extract the organic components which were washed with water, aqueous 
Na2CO3 solution (10%), H2O again and finally dried over anhydrous NaSO4. The organic solvents 
were removed under reduced pressure and then the residue was crystallized from Et2O. Further 
purification by silica gel chromatography (DCM/MeOH as eluents) gave a pale yellow product 
(1.95 g), in 85.7% yield. 1H NMR: (CDCl3, 400 MHz): 9.20 (1H, s), 8.78 (1H, s), 7.35-7.44 (5H, 
m), 5.33 (2H, s), 2.38-2.42 (2H, q), 2.36 (3H, s), 2.31 (3H, s), 2.25 (3H, s), 2.15 (3H, s), 1.04-1.08 
(3H, t); 13C NMR (CDCl3, 100 MHz): 175.6, 161.2, 136.0, 133.0, 131.4, 128.6, 128.3, 128.2,127.8, 
127.7, 127.4, 125.4, 124.3, 120.4, 66.1, 17.3, 15.0, 11.5, 10.8, 10.3, 9.9; MS (ESI-TOF) m/z 
[M+H]+: 379.2017; calculated for C23H27N2O3: 379.2016.  
(4-Ethyl-3,5-dimethyl-1H-pyrrol-2-yl)(5-iodo-3,4-dimethyl-1H-pyrrol-2-yl)methanone 11. 
To a 250 ml flask equipped with a magnetic stirrer was added Pd/C (165 mg, 10%). The flask was 
evacuated and refilled with THF (10 ml) and then with H2. The mixture was stirred strongly for 
15 min under a H2 atmosphere. A THF (150 ml) solution of dipyrroketone 8 (1.65 g, 4.36 mmol) 
was added to the flask under H2. The mixture was stirred at room temperature for 12 h. The reaction 
was stopped when starting material had disappeared according to TLC. The palladium catalysts 
were filtered through a Celite cake and washed with THF (100 ml × 3). The organic solutions were 
combined and the solvents were removed under reduced pressure to yield a while solid. The solid 
products then were dissolved in a mixture of NaHCO3 (1.87 g, 22.3 mmol)/H2O (110 ml) and 
MeOH (44 ml). A solution of I2 (1.63 g, 6.42 mmol) in MeOH (26 ml) was added dropwise into 
the mixture at the room temperature and brown solids were precipitated out immediately. The 
mixture was stirring for another 2 h at the room temperature after the addition was completed. The 
precipitates were filtered and washed with water, saturated NaHCO3 (aq), water again and hexanes 
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to remove excess iodine. The solids were redissolved in DCM and dried over anhydrous Na2SO4. 
The organic solvents were removed under reduced pressure to give a pure pale yellow product 
(1.36 g, 84.2%). 1H NMR: (CDCl3, 400 MHz): 8.79 (1H, s), 8.64 (1H, s), 2.38-2.43 (2H, q), 2.45 
(3H, s), 2.17 (3H, s), 2.13 (3H, s), 2.00 (3H, s), 1.06-1.10 (3H, t); 13C NMR (CDCl3, 100 MHz): 
174.5, 133.6, 131.1, 126.9, 126.5, 126.4, 124.9, 124.8, 73.2, 17.3, 15.1, 11.9, 11.5, 11.2, 10.8; MS 
(ESI-TOF) m/z [M+H]+: 371.0613; calculated for C15H20IN2O: 371.0615. 
3,8-Dichloro-6-ethyl-1,5,7-trimethyl-BODIPY 1a-b. Iodo-dipyrroketone 11 (1.36 g, 3.67 mmol) 
was dissolved in chloroform (300 ml). The flask was evacuated and refilled with argon. Phosgene 
solution (15% in toluene, 26 ml) was added into the mixture and then it was stirred overnight at 
room temperature. The reaction was stopped when the starting materials were totally consumed. 
N2 was purged into flask to purge extra phosgene into a beaker containing saturated NaHCO3 
solution. The organic solvents were removed under reduced pressure to obtain red solids. The red 
solid was added into another 500 ml round-bottom flask equipped with a stirrer. The flask was 
evacuated and refilled with argon. Chloroform (300 ml) and N,N-diisopropylethylamine (3.32 g, 
25.7 mmol) was added under argon. The mixture was then stirred for 30 min. BF3
.OEt2 (5.2 g, 36.7 
mmol) was added into the mixture which was stirred for another 10 h. The organic solution was 
washed with water, saturated NaHCO3 solution and brine. After drying over anhydrous Na2SO4, 
the organic solvents were removed under reduced pressure. Further purification by silica-gel 
column chromatography with DCM/hexanes as the eluents gave the titled BODIPY 1a (0.99 g, 
78.2%) and its 8-monochloro-BODIPY byproduct (68 mg, 6%). For BODIPY 1a: 1H NMR 
(CDCl3, 400 MHz): 2.54 (3H, s), 2.40-2.45 (8H, m), 2.01(3H, s), 1.05-1.09 (3H, t); 
13C NMR 
(CDCl3, 100 MHz): 158.4, 140.4, 138.2, 137.5, 135.4, 135.2, 130.8, 127.6, 124.5, 17.1, 14.5, 14.2, 
14.1, 12.9, 8.9; MS (ESI-TOF) m/z [M+H]+ 344.0937; calculated for C15H17BCl2F2N2: 344.0939. 
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For the 8-monochloro-BODIPY byproduct 1b: 1H NMR (CDCl3, 400 MHz): 7.40 (1H, s), 2.53 
(3H, s), 2.40-2.45 (8H, m), 2.04(3H, s), 1.05-1.09 (3H, t); 13C NMR (CDCl3, 400 MHz): 157.8, 
140.6, 138.7, 137.5, 137.0, 134.6, 131.0, 129.2, 126.7, 17.1, 14.6, 14.1, 13.4, 12.9, 10.0; MS (ESI-
TOF) m/z [M+H]+ 310.1307; calculated for C15H19BClF2N2: 310.1329.  
General procedure for the preparation of BODIPY 12a-c. Into a 50 ml round-bottom flask was 
added 3,8-dichloro-5-methyl-BODIPY 1a (34.4 mg, 0.1 mmol) and Pd(PPh3)4 (10 mol%). The 
flask was then evacuated and refilled with argon 3 times. Dry toluene (30 ml) and organostannane 
regents (0.3 mmol) were introduced into the flask. The mixture was refluxed for 6 h under an argon 
atmosphere. The reaction was stopped when TLC showed the disappearance of starting materials. 
Toluene was removed under reduced pressure. A flash column (DCM as eluent) was used to 
separate the crude products. Further purification by using a silica gel column with DCM/hexanes 
or ethyl acetate/hexanes as the eluents gave the desired disubstituted products.  
BODIPY 12a: Yield: 37.7 mg, 85.6%; 1H NMR (CDCl3, 400 MHz): 7.50-7.55 (3H, m), 7.02-7.19 
(3H, m), 2.51(3H, s), 2.31-2.36 (2H, q), 1.97 (3H, s), 1.53 (6H, s), 0.99-1.03 (3H, t); 13C NMR 
(CDCl3, 100 MHz): 158.6, 145.4, 140.4, 138.2, 135.6, 134.9, 133.5, 133.0, 132.8, 132.1, 130.6, 
130.5, 128.1, 127.7, 127.7, 127.5, 127.0, 17.1, 14.4, 13.0, 11.3, 11.1, 10.4; MS (ESI-TOF) m/z 
[M+H]+ 440.1445; calculated for C23H23BF2N2S2: 440.1473. 
BODIPY 12b: Yield: 25.8 mg, 63.2%; 1H NMR (CDCl3, 400 MHz): 7.49-7.64 (3H, m), 6.44-6.59 
(3H, m), 2.57(3H, s), 2.32-2.38 (2H, q), 2.17 (3H, s), 1.52 (3H, s), 1.50 (3H, s), 1.01-1.05 (3H, t); 
13C NMR (CDCl3, 400 MHz): 157.9, 147.3, 146.0, 143.6, 142.5, 142.4, 139.2, 138.7, 134.4, 133.8, 
133.5, 127.7, 126.3, 115.2(t), 112.3, 111.7, 111.5, 17.1, 14.4, 13.0, 10.9, 10.4; MS (ESI-TOF) m/z 
[M+H]+ 408.1905; calculated for C23H23BF2N2O2: 408.193. 
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BODIPY 12c: Yield: 34.6 mg, 80.8%; 1H NMR (CDCl3, 400 MHz): 7.35-7.49 (10H, m), 2.46 
(3H, s), 2.27-2.33 (2H, q), 1.79 (3H, s), 1.32 (3H, s), 1.35 (3H, s), 0.96-0.99 (3H, t); 13C NMR 
(CDCl3, 100 MHz): 156.8, 153.2, 141.3, 139.8, 138.2, 135.8, 134.0, 132.9, 131.8, 130.9, 130.0, 
129.1, 128.9, 128.4, 128.3, 127.6, 126.4, 17.1, 14.4, 12.8, 12.1, 11.8, 9.7MS (ESI-TOF) m/z [M-
F]+ 408.2284; calculated for C27H26BFN2: 408.2282. 
General procedure for the preparation of BODIPY 13a-c. Into a 100 ml round-bottom flask 
was added BODIPY 1a (34.4 mg, 0.1 mmol) and Pd(PPh3)4 (10 mol%). The flask was then 
evacuated and refilled with argon 3 times. Dry toluene (60 ml) and organostannane regents (0.1 
mmol) were introduced into the flask. The mixture was refluxing at 80 oC under Ar. The reaction 
was stopped when TLC showed the disappearance of starting materials. Toluene was removed 
under reduced pressure. Silica gel flash column chromatography was used for purification of the 
products, elution with dichloromethane/hexanes or ethyl acetate/hexanes.  
BODIPY 13a: Yield: 33 mg, 84%; 1H NMR (CDCl3, 400 MHz): 6.99-7.52 (3H, m), 2.58(3H, s), 
2.31-2.37 (2H, q), 1.92 (3H, s), 1.52 (3H, s), 1.48 (3H, s), 1.00-1.03 (3H, t); 13C NMR (CDCl3, 
100 MHz): 159.4, 141.1, 139.0, 138.1, 135.1, 134.8, 133.4, 132.7, 130.2, 128.1, 127.7, 127.6, 
124.3, 17.1, 14.3, 13.0, 11.3, 11.1, 8.8; MS (ESI-TOF) m/z [M+H]+ 392.1208; calculated for 
C19H20BClF2N2S: 392.1206. 
BODIPY 13b: Yield: 29 mg, 77%; 1H NMR (CDCl3, 400 MHz): 6.45-7.64 (3H, m), 2.57(3H, s), 
2.32-2.38 (2H, q), 1.93 (3H, s), 1.52 (3H, s), 1.49 (3H, s), 1.01-1.05 (3H, t); 13C NMR (CDCl3, 
100 MHz): 160.3, 145.1, 142.8, 140.8, 139.3, 137.7, 135.1, 134.1, 130.6, 126.9, 124.3, 111.8, 
111.6, 17.1, 14.3, 13.1, 10.8, 10.6, 8.8; MS (ESI-TOF) m/z [M+H]+ 376.1410; calculated for 
C19H20BClF2N2O: 376.1434. 
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BODIPY 13c: Yield: 32.4 mg, 83. %; 1H NMR (CDCl3, 400 MHz): 7.28-7.50 (5H, m), 2.58(3H, 
s), 2.29-2.35 (2H, q), 1.90 (3H, s), 1.28 (3H, s), 1.30 (3H, s), 0.98-1.02 (3H, t); 13C NMR (CDCl3, 
100 MHz): 158.5, 140.8, 140.5, 138.4, 137.9, 135.1, 134.7, 132.2, 129.4, 129.2, 129.1, 128.1, 
124.0, 17.1, 14.4, 12.9, 12.1, 11.9, 8.8; MS (ESI-TOF) m/z [M-F]+ 366.1567; calculated for 
C21H22BClFN2: 366.1579; 
BODIPY 14: Into a 50 ml round-bottom flask was added BODIPY 7a (19.6 mg, 0.05 mmol) and 
Pd(PPh3)4 (10 mol%). The flask was then evacuated and refilled with argon 3 times. Dry toluene 
(20 ml) and tributyl-(2-furyl)stannane (0.1 mmol) were introduced into the flask. The mixture was 
refluxed for 6 h under Ar. The reaction was stopped when TLC showed the disappearance of 
starting materials. Toluene was removed under reduced pressure. A flash column (DCM as eluent) 
was used to give the crude products. Further purification by silica gel column chromatography 
with DCM/hexanes or ethyl acetate/hexanes as the eluents gave the desired disubstituted products. 
Yield: 19.3 mg, 91%; 1H NMR (CDCl3, 400 MHz): 7.46-7.53 (3H, m), 6.59-7.17 (3H, m), 2.57 
(3H, s), 2.3-2.37 (2H, q), 2.15 (3H, s), 1.52 (6H, s), 1.00-1.04 (3H, t); 13C NMR (CDCl3, 100 
MHz): 157.2, 147.2, 143.5, 141.8, 139.7, 139.0, 135.8, 134.5, 133.1, 132.8, 128.2, 127.8, 127.6, 
127.4, 114.9 (t), 112.2, 17.1, 14.4, 12.9, 11.1, 11.0, 10.9; MS (ESI-TOF) m/z [M+Na]+ 446.1517; 
calculated for C23H23BF2N2NaOS 446.1521. 
BODIPY 15: Into a 50 ml round bottom flask was added BODIPY 7b (18.8 mg, 0.05 mmol) and 
Pd(PPh3)4 (10 mol%). The flask was then evacuated and refilled with argon for 3 times. Dry 
toluene (20 mL) and 2-(tributylstannyl)thiophene (0.15 mmol) were introduced into the flask. The 
mixture was refluxed for 6 h under Ar. The reaction was stopped when TLC showed the 
disappearance of starting materials. Toluene was removed under reduced pressure. A flash column 
(DCM as eluent) was used to give the crude products. Further purification by silica gel column 
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with DCM/hexanes or ethyl acetate/hexanes as the eluents gave the desired disubstituted product. 
Yield: 19 mg, 89.6%; 1H NMR (CDCl3, 400 MHz): 7.5-7.66 (3H, m), 6.47-7.18 (3H, m), 2.51 (3H, 
s), 2.32-2.37 (2H, q), 1.99 (3H, s), 1.53 (6H, s), 1.00-1.04 (3H, t); 13C NMR (CDCl3, 100 MHz): 
159.4, 146.0, 145.8, 142.6, 140.0, 137.9, 134.8, 134.1, 132.8, 132.6, 130.6 (t), 127.8, 127.6, 127.1, 
127.0, 111.7, 112.5, 17.1, 14.4, 13.1, 10.7, 10.5, 10.4; MS (ESI-TOF) m/z [M+H]+ 424.1674; 
calculated for C23H24BF2N2OS: 424.1701;  
BODIPY 16: Into a 50 ml round-bottom flask was added meso-substituted BODIPY 7b (18.8 mg, 
0.05 mmol) and Pd(PPh3)4 (10 mol%). The flask was then evacuated and refilled with argon 3 
times. Dry toluene (4 ml) and trimethyl[(tributylstannyl)ethynyl]silane (0.06 mmol) were 
introduced into the flask. The mixture was refluxed for 6 h under an argon atmosphere. The 
reaction was stopped when TLC showed the disappearance of starting materials. Toluene was 
removed under reduced pressure. A flash column (DCM as eluent) was used to give the crude 
products. Further purification by silica gel column chromatography with DCM/hexanes or ethyl 
acetate/hexanes as the eluents gave the desired disubstituted product. Yield: 12.7 mg, 58%; 1H 
NMR (CDCl3, 400 MHz): 6.43-7.62 (3H, m), 2.59 (3H, s), 2.32-2.37 (2H, q), 1.99 (3H, s), 1.52 
(3H, s), 1.45 (3H, s), 1.00-1.04 (3H, t), 0.31 (9H, s); 13C NMR (CDCl3, 100 MHz): 162.1, 145.8, 
143.0, 141.1, 136.3, 135.8, 132.7, 132.6, 132.2, 126.9, 112.0, 111.8, 109.3, 97.3, 17.5, 14.6, 13.7, 
10.9, 10.7, 10.0, 0.2; MS (ESI-TOF) m/z [M+H]+ 438.2223; calculated for C24H30BF2N2OSi: 
438.2219; 
General procedure for the preparation of BODIPYs 17-19. Into a 5 ml round-bottom flask was 
added BODIPY 1a (17.2 mg, 0.05 mmol), nucleophile (1 - 10 equiv) and K2CO3 (13.8 mg, 0.1 
mmol). DCM (0.5 ml) was added into the flask. The mixture was stirred at room temperature. The 
reaction was stopped when TLC showed the disappearance of starting materials. The crude product 
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was subjected to a short flash column (DCM as eluents) to remove polar byproducts. Further 
purification by silica gel column chromatography with DCM/hexanes or ethyl acetate/hexanes as 
the eluents gave the desired mono-substituted products.  
BODIPY 17: Yield: 19.1 mg, 95%; 1H NMR (CDCl3, 400 MHz): 6.99-7.34 (5H, m), 2.57 (3H, s), 
2.34-2.38 (2H, q), 2.01 (3H, s), 1.98 (3H, s), 1.93 (3H, s), 1.01-1.04 (3H, t); 13C NMR (CDCl3, 
400 MHz): 158.6, 157.5, 150.5, 138.2, 137.8, 135.2, 133.9, 130.5, 128.3, 125.6, 123.5, 123.0, 
114.7, 16.9, 14.4, 13.0, 12.0, 11.7, 8.6; MS (ESI-TOF) m/z [M+H]+ 402.1564; calculated for 
C21H23BClF2N2O: 402.1591.  
BODIPY 18: Yield: 17.4 mg, 87%; 1H (400 MHz, CDCl3): 6.93-7.25 (5H, m), 6.55 (1H, s), 2.55 
(3H, s), 2.31-2.37 (2H, q), 1.98 (3H, s), 1.91 (3H, s), 1.89 (3H, s), 1.00-1.03 (3H, t); 13C (100 MHz, 
CDCl3): 153.5, 143.5, 140.6, 135.3, 134.9, 133.0, 132.6, 129.8, 127.2, 125.5, 122.8, 118.0, 17.0, 
14.7, 12.9, 12.8, 12.64, 8.8; MS (ESI-TOF) m/z [M+H]+: 401.1725; calculated for C21H24BClF2N3: 
401.1751.  
BODIPY 19: Yield: 24.2 mg, 93%; 1H (400 MHz, CDCl3): 7.05-7.22 (8H, m), 2.60 (3H, s), 2.36-
2.41 (5H, m), 2.31 (6H, s), 2.29 (3H, s), 1.72 (3H, s), 1.01-1.04 (3H, t); 13C (100 MHz, CDCl3): 
160.4, 143.6, 141.9, 138.2, 137.2, 136.3, 135.9, 134.3, 133.0, 132.8, 132.1, 131.7, 130.3, 129.8, 
129.4, 126.3, 21.1, 21.0, 17.2, 14.5, 14.4, 13.2, 10.1; MS (ESI-TOF) m/z [M+H]+: 520.2085; 
calculated for C29H32BF2N2S2: 520.2099. 
BODIPY 20: Into a 5 ml round-bottom flask was added BODIPY 13c (19.3 mg, 0.05 mmol), SH-
carborane (88 mg, 0.5 mmol) and K2CO3 (13.8 mg, 0.1 mmol). DCM (1 ml) was added into the 
flask. The mixture was then refluxed at room temperature. The reaction was quenched with H2O 
when TLC showed the disappearance of starting materials. DCM (10 ml × 3) was used to extract 
the organic components. Organic solvents were combined, dried over anhydrous Na2SO4 and 
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evaporated under reduced pressure to give crude products. Further purification by silica gel column 
chromatography with ethyl acetate/hexanes as the eluents gave the titled product (17.7 mg, 67.3%). 
1H NMR (400 MHz, CDCl3): 7.24-7.5 (5H, m), 1.76-3.34 (11 H, m) 2.63 (3H, s), 2.32-2.38 (2H, 
q), 2.04 (3H, s), 1.36 (3H, s), 1.29 (3H, s), 0.99-1.03 (3H, t); 13C NMR (100 MHz, CDCl3): 165.0, 
143.4, 141.6, 137.3, 135.5, 134.9, 134.7, 134.2, 133.3, 132.5, 129.4(t), 128.0, 127.9, 66.3, 66.2, 
17.1, 14.1, 13.6, 12.2, 12.1, 11.1; MS (ESI-TOF) m/z [M+H]+ 527.3512; calculated for 
C23H24B11F2N2S: 527.3520. 
BODIPY 21: Into a 50 ml round-bottom flask was added meso-substiutued BODIPY 17 (10 mg, 
0.025 mmol) and Pd(PPh3)4 (10 mol%). The flask was then evacuated and refilled with argon 3 
times. Dry toluene (20 ml) and 2-(tributylstannyl)thiophene (0.05 mmol) were introduced into the 
flask. The mixture was refluxed for 6 h under an argon atmosphere. The reaction was stopped 
when TLC showed the disappearance of starting materials. Toluene was removed under reduced 
pressure. A flash column (DCM as eluent) was used to obtain the crude products. Further 
purification by silica gel column chromatography with DCM/hexanes or ethyl acetate/hexanes as 
the eluents gave the desired products. Yield: 10.2 mg, 90.6%; 1H (400 MHz, CDCl3): 7.50-7.53 
(2H, m), 7.32-7.36 (2H, m), 7.17-7.19 (1H, m), 7.05-7.1 (3H, m), 2.50 (3H, s), 2.31-2.37 (2H, q), 
2.04 (3H, s), 2.02 (3H, s), 1.99 (3H, s), 0.99-1.03 (3H, t); 13C (100 MHz, CDCl3): 157.8, 157.7, 
150.9, 145.4, 137.4, 135.3, 133.6, 132.7, 130.4 (t), 130.1, 128.3, 127.6, 127.0 126.7, 123.0, 122.8, 
114.9, 17.0, 14.5, 13.0, 11.9, 11.7, 10.2; MS (ESI-TOF) m/z [M+H]+ 450.1831; calculated for 
C25H26BF2N2OS: 450.1858. 
BODIPY 22: Into a 50 ml round-bottom flask was added BODIPY 12c (21.4 mg, 0.05 mmol), 
some molecular sieves and methyl 4-formylanisole (68 mg, 0.5 mmol) in toluene (10 ml). p-TsOH 
(10 mg) and piperidine (0.1 ml) were added into the mixture. The mixture was stirred and refluxed 
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for 72 h under the argon atmosphere. The reaction was stopped when TLC showed the 
disappearance of starting materials. The mixture was cooled to room temperature and filtered to 
remove molecule sieves. The filtrate was poured into water (20 ml), and DCM (20 ml × 3) was 
used to extract the organic components. The organic solvents were combined, dried over 
anhydrous Na2SO4 and evaporated under reduced pressure to give crude products. Further 
purification by silica gel column chromatography with ethyl acetate/hexanes as the eluents gave 
the styryl-BODIPY dye 22 (14.2 mg, 52%). 1H (400Hz, CDCl3): 7.13-7.60 (14H, m), 6.85-6.87 
(2H, d), 3.83 (3H, s), 2.56-2.62 (2H, q), 1.80 (3H, s), 1.36 (6H, s), 1.13-1.16 (3H, t); 13C (400Hz, 
CDCl3): 160.3, 154.1, 152.1, 140.3, 140.1, 138.4, 136.2, 136.1, 133.9, 132.9, 132.8, 131.9, 130.0, 
129.1, 128.9, 128.5, 127.7, 127.2, 117.9, 114.1, 55.4, 18.4, 14.0, 12.2, 11.6, 9.8; MS (ESI-TOF) 
m/z [M+H]+ 545.2687; calculated for C35H33BF2N2O: 545.2685. 
BODIPY 24: Into a 50 ml round-bottom flask was added BODIPY 12c (21.4 mg, 0.05 mmol). 
The flask was then evacuated and refilled with argon 3 times. Dry toluene (10 ml) was added. The 
temperature was raised to 110 oC. A solution of DDQ (56.8 mg, 0.25 mmol) in toluene (10 ml) 
was added slowly into the mixture which was stirred and refluxed under an argon atmosphere. The 
reaction was stopped when TLC showed the disappearance of starting materials. Solvents were 
removed under reduced pressure to give crude products. Further purification by using a silica gel 
column or preparative TLC plates with ethyl acetate/hexanes as the eluents gave the compound 17 
(5.7 mg, 25.8% yield). 1H NMR (400Hz, CDCl3): 10.30 (1H, s), 7.37-7.59 (5H, m), 2.67-2.71 (2H, 
q), 1.84 (3H, s), 1.44 (3H, s), 1.31 (3H, s), 1.00-1.03 (3H, t); 13C (400Hz, CDCl3): 186.3, 164.5, 
144.7, 144.5, 141.2, 137.2, 136.3, 135.8, 134.9, 132.6, 131.5, 130.9, 130.0, 129.6, 129.5, 129.3, 
128.1, 127.8, 17.6, 14.3, 12.9, 10.7, 10.0; MS (ESI-TOF) m/z [M+H]+ 442.2145; calculated for 
C27H26BF2N2O: 442.2137. 
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2.6.2 Crystal data 
Diffraction data were collected at low temperature (90-105K) on either a Nonius 
KappaCCD diffractometer equipped with MoK radiation (=0.71073 Å) or a Bruker Kappa 
Apex-II DUO diffractometer equipped with Mo or CuK radiation (=1.54184 Å). Refinement 
was by full-matrix least squares using SHELXL, with H atoms in idealized positions, except for 
those on N in 8, 10, and 18, which were refined. BODIPYS 1a and 24 have two independent 
molecules, and 1b has four. 1a, 12b and 22 were nonmerohedral twins, and disorder was present 
in 1a, 12a-c, 14, 17 and 18. 1a and 24 were chloroform solvates. The absolute structures of both 
noncentrosymmetric crystals 1b and 13c were determined. Crystal data: For 1a: C15H17BCl2F2N2 
. 0.5 CHCl3, triclinic P-1, a=8.4888(3), b=13.9111(6), c=14.8676(6) Å, =86.609(3), =88.646(2), 
=89.580(2)°, Z=4, T=90K, R=0.067; 1b: C15H18BClF2N2, monoclinic P21, a=15.4384(5), 
b=11.5896(4), c=16.8479(5) Å, =99.215(2)°, Z=8, T=90K, R=0.047; 8: C23H26N2O3, monoclinic 
P21/n, a=7.7071(6), b=12.3770(9), c=21.4131(17) Å, =92.673(4)°, Z=4, T=100K, R=0.045; 10: 
[C23H26ClN2O2]Cl, triclinic P-1, a=8.1637(4), b=9.5889(5), c=13.6082(8) Å, =94.850(3), 
=97.737(2), =92.855(2)°, Z=2, T=100K, R=0.033; 12a: C23H23BF2N2S2, triclinic P-1, 
a=9.5771(14), b=10.3269(15), c=11.567(2) Å, =77.851(8), =66.885(6), =79.384(7)°, Z=2, 
T=100K, R=0.041; 12b: C23H23BF2N2O2, triclinic P-1, a=9.362(2), b=10.155(2), c=11.682(3) Å, 
=76.840(6), =66.796(6), =77.094(6)°, Z=2, T=90K, R=0.089; 12c: C27H27BF2N2, monoclinic 
P21/n, a=11.4039(6), b=7.9247(4), c=24.2010(12) Å, =91.650(3)°, Z=4, T=90K, R=0.047; 13c: 
C21H22BClF2N2, monoclinic Pc, a=7.6918(2), b=8.2818(2), c=14.8858(4) Å, =94.762(2)°, Z=2, 
T=105K, R=0.035; 14: C23H23BF2N2OS, triclinic P-1, a=9.5378(3), b=10.1969(3), c=11.5554(4) 
Å, =76.414(2), =66.800(2), =78.800(2)°, Z=2, T=90K, R=0.040; 15: C23H23BF2N2OS, triclinic 
P-1, a=9.4222(2), b=10.2488(2), c=11.6233(3) Å, =78.492(2), =66.845(2), =77.813(2)°, Z=2, 
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T=90K, R=0.043; 16: C24H29BF2N2OSi, monoclinic P21/c, a=6.9871(2), b=22.5959(8), 
c=14.6041(6) Å, =93.098(2)°, Z=4, T=90K, R=0.041; 17: C21H22BClF2N2O, triclinic P-1, 
a=9.4115(3), b=10.4033(4), c=11.3995(4) Å, =66.223(2), =77.459(2), =68.527(2)°, Z=2, 
T=90K, R=0.051;  18: C21H23BClF2N3, monoclinic C2/c, a=21.8367(10), b=8.9694(4), 
c=21.9939(8) Å, =114.299(2)°, Z=8, T=90K, R=0.050; 20: C23H33B11F2N2S, triclinic P-1, 
a=6.9030(7), b=12.0111(12), c=17.1906(14) Å, =77.599(7), =79.990(7), =83.195(7)°, Z=2, 
T=90K, R=0.070; 22: C35H33BF2N2O, triclinic P-1, a=11.5598(5), b=13.2476(6), c=19.1537(8) Å, 
=85.869(2), =86.135(2), =72.967(2)°, Z=4, T=90K, R=0.048;  24: C27H25BF2N2O . CHCl3, 
triclinic P-1, a=9.6902(5), b=10.7446(6), c=13.9386(8) Å, =68.727(3), =75.951(3), 
=73.728(3)°, Z=2, T=90K, R=0.037; CCDC 1038325-1038340 contain the supplementary 
crystallographic data for this Chapter. These data can be obtained, free of charge, from the 
Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
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CHAPTER 3: STEPWISE POLYCHLORINATION OF 8‑CHLORO-
BODIPY AND REGIOSELECTIVE FUNCTIONALIZATION OF 2,3,5,6,8-
PENTACHLORO-BODIPY* 
3.1 Introduction  
As described in the Chapter 1, halogenated BODIPYs are particularly attractive targets, 
which allow the introduction of a variety of functional groups to all seven carbon positions on the 
BODIPY core, via both nucleophilic metal-catalyzed cross-coupling and substitutions reactions.1 
On the other hand, halogenated BODIPYs were also widely applied to the synthesis of aryl-fused 
BODIPYs, preparation of fluorescent indicators, and photodynamic therapy (PDT) sensitizers, as 
shown in Chapter 1. In the last two decades, various halogenated BODIPY platforms has been 
reported, as shown in Figure 1.2-9 For example, BODIPY 1 is the first halogenated BODIPY that 
was reported in 1990;2 3,5-dichloro-BODIPY 23 were prepared by Dehean and coworkers in 2005  
 
Figure 3-1: Several halogenated BODIPYs 
 
* Reprinted (adpated) with permission from (Zhao, N.; Xuan, S.; Fronczek, F. R.; Smith, K. 
M.; Vicente, M. G. H., Stepwise Polychlorination of 8-Chloro-BODIPY and Regioselective 
Functionalization of 2,3,5,6,8-Pentachloro-BODIPY. J. Org. Chem. 2015, 80 (16), 8377-8383). 
Copyright (2016) American Chemical Society. 
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Figure 3-2: Halogenated BODIPYs prepared in Vicente group. 
 
and widely applied as fluorescent indicators (see Chapter 1); hexabromo-BODIPY 75-6 allowed for 
the full functionalization at all the pyrrolic positions. Generally, there are three main strategies to 
approach the synthesis of halogenated BODIPYs: (1) direct halogenation at the BODIPY core with 
suitable halogenation reagents; (2) halogenation at the dipyrromethane stage, and followed by 
oxidation and boron complexation; (3) halogenation at the pyrrole stage, followed by 
condensation, oxidation and a boron complexation. 
In our group, we are particular interested in the halogenated BODIPYs bearing an 8-chloro 
group. As described in the recent paper,10 there is the largest MO coefficients in the LUMO at the 
8-position. Thus, the introduction of functional groups at the 8-position will greatly affect the 
spectroscopic properties, such as the fluorescent quantum yields. Based on this strategy, our group 
reported the synthesis of the  BODIPYs 811, 912 and 1013 were all containing an 8-chloro group, 
and Pd(0) catalyzed coupling reactions and substitution reactions were used to investigated the 
reactivity and regioselectivity of the chloro groups at the BODIPY periphery. The decreased 
reactivity order for both nucleophilic addition-elimination and Stille cross coupling reactions was 
observed to be: 8-Cl >> 3,5-Cl, which allowed for regioselective functionalizations at the 8 and 
3,5-positions of the BODIPYs. However, new synthesis of higher halogenated BODIPYs were 
needed to further investigate the reactivity of the 1,2,6,7-positions. Herein, in this chapter, I 
focused on developing a convenient and quick method to afford polycholorinated (up to five halo 
groups) BODIPY dyes with a short reaction time.  
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3.2 Synthesis of Polychlorinated BODPYs 
This work started with the preparation of 8-chloro BODIPY 4 in three steps, as previous 
reported,9, 14-16 as shown in Scheme 3-1. The synthesis procedure involved condensation of pyrrole 
11 with thiophosgene, followed by oxidative hydrolysis, chlorination by phosgene, and boron 
complexation under the basic condition in a good overall yield. Treating BODIPY 4 with 10 equiv 
of NCS in THF at room temperature for  up to 24 hours did notyield the desired pentachloro 
BODIPY 13, as shown in Scheme 3-2. Separation via prep. TLC provided the mono-chlorinated 
BODIPY 14 as the major product with a 52% isolated yield. Increasing the temperature, reaction 
time, or the amount of NCS only provided complex mixtures of chlorinated products, probably as 
a result of the low reactivity of 4 under these chlorinating conditions, compared with 8-phenyl 
BODIPY.8 Therefore, we investigatedalternative methodologies for the regioselective 
polychlorination of BODIPY 4 using more reactive sources of Cl+, in particular 
trichloroisocyanuric acid (TCCA), inspired by the work reported by Mattos et al.17 In his work, we  
          
Scheme 3-1: Synthesis of 8-chloro BODIPY 4 
                     
Scheme 3-2: Chlorination of 8-chloro BODIPY 4 using NCS. 
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Scheme 3-3: Step-wise chlorination of 8-chloro BODIPY 4 using TCCA 
noticed deactived benzenes could be quickly brominated using tribromoisocyanuric acid (TBCA) 
under strong acid conditions, in 2 minutes. Therefore, we chose trichloroisocyanuric acid (TCCA) 
as the source of electrophilic Cl+ and acetic acid as the protic solvent to activate the TCCA. 
By treating BODIPY 4 with 1.33 equiv of TCCA (portion-wise) in acetic acid, 
monochlorination was achieved, yielding the dichloro product 14 in 10 min, in 83% yield, as 
shown in Scheme 3-3. The monochlorination only occurred at the 2,(6)-position and no other 
monochlorinated products were detected. By increasing the amount of TCCA to 2.33 equiv, the 
dichlorinated BODIPY 15 was formed as the major product in 83% isolated yield. By increasing 
the amount of TCCA to 3 equiv, the formation of the BODIPY 13 and 16 was clearly noticed, 
although BODIPY 15 was still the major product. However, further increasing the amount of 
TCCA, produced both BODIPYs 13 and 16 were generated at the same time, as seen by TLC It 
should be noted that it was difficult to separate 16 from 13 and 15 due to their very similar 
polarities. A long column eluted with CH2Cl2/hexanes provided pure compound 16 in only about 
15% yield. The trichlorination was first confirmed by HRMS (ESI-TOF) with a [M]- peak 
329.9094 (calcd. 329.9082).  By increasing the amount of TCCA to 5 equiv, TLC showed 
BODIPY 13 was formed and became the major product. Interestingly, we noticed that BODIPY 
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13 could be obtained in 81% yield after only 10 min by using 10 equiv TCCA. However, further 
increasing the amount of TCCA, even to the point of saturation did not provide a fully-chlorinated 
products. Also, extending the reacting time to 24 or up to 72 h, increasing the temperature to reflux 
for longer time, or using a more protic solvent (H2SO4) all led to the decomposition of the 
BODIPYs.  
The 1H NMR spectra of 4 and 13-16 were used to confirm the regioselectivity of the 
chlorination reactions, as shown in the Figure 3-3.  As reported,8, 18 the hydrogens at 3,5 positions 
appear the most downfield chemical shift while the protons at the 2,6 positions appear the most 
upfield chemical shift chemical shift. In addition, 2,6-positions are known to bear least positive 
charge,18 therefore electrophilic chlorination is expected to occur at 2,6-positions first. A 
comparison of the 1H NMR spectra of 4 and 14 showed the disappearance of a single proton δ at 
6.6 ppm in 14, both two protons in 15. The crystal structure of 15 (Figure 3-4) further confirmed 
that the two chloro groups were located at the 2,6-positions. In the 1H NMR spectra, the 
Figure 3-3: 1H NMR (400 MHz) of BODIPYs 4 and 13-16 in CDCl3 at room temperature.  
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Figure 3-4: X-ray structures of BODIPYs 4, 13, 15 and 16. 
characteristic peaks at 3,5- positions (δ ≈ 7.9 ppm) gradually disappeared from 14 to 13 and 16. It 
is should be noticed that the only singlets in the spectrum of 13 at δ ≈ 7.3 ppm belong to the 
hydrogens at 1,7-positions. 
The suitable crystals of BODIPYs 4, 13, 15 and 16 are grown by slow evaporation in 
CHCl3, which provided the direct evidence of the regioselectivity of the chlorination reactions. 
The results obtained are shown in Figure 3-4. The X-ray structure of 4 is in good agreement with 
the published 150K structure,19 with the 12 atoms of the C9BN2 BODIPY core having a mean 
deviation of only 0.008 Å from coplanarity. BODIPY 15 is disordered on a C2h site, which 
requires the C9BN2 core to be exactly planar in the crystal. In BODIPY 16, the mean deviation 
from coplanarity is only a little larger (≈ 0.015 Å). The two independent molecules of 13 are less 
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planar. One has a slightly bowed conformation with mean deviation (≈ 0.064 Å), and the B atom 
of the other one lies 0.110 Å out of the plane of the other eleven atoms. 
3.3 Reactivity of 2,3,5,6,8-Chloro Groups of BODIPY 13 
3.3.1 Suzuki Catalyzed Coupling Reactions of BODIPY 13 
Scheme 3-4: Suzuki coupling reactions of BODIPY 13. 
Due to various types of commercial available boronic acids and the mild reaction 
conditions, Suzuki cross-coupling20 reactions are particularly attractive for the functionalization 
of BODIPYs. Thus in this work, the Suzuki cross-coupling reaction was utilized to investigated 
the reactivity and regioseletivity of the different types of chloro groups of BODIPY 13. A Suzuki 
type coupling reaction between 2.2 equiv of 4-methoxyphenylboronic acid and BODIPY 13 in the 
presence of Pd(PPh3)4, toluene, and 1M Na2CO3(aq) with carefully monitoring the reaction by 
TLC, afforded only the mono-coupled BODIPY dye 17 in a 82% isolated yield. Interestingly, 
instead of increasing the efficiency, a larger amount of Pd(PPh3)4 (>20%) in the reaction led to 
decomposition of starting material, this may be due to the oxidation and reduction reactions 
between the electron deficient BODIPY 13 and the electron rich catalyst at high temperature. In 
the 1H NMR spectra, the singlet at δ ≈ 7.34 ppm assigned to the hydrogens at 1,7-positions showed 
the symmetric structure of  BODIPY 17, as shown in Figure 3-5. In addition, compared with 13, 
this singlet upfieldly shifted from δ 7.34 to 6.94 ppm, due to 1,7-protons located in the shielding  
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Figure 3-5: 1H NMR (400 MHz) spectra of BODIPY 13, 17 and 18 in CDCl3 or CD2Cl2 at room 
temperature.  
 
area of the 8-aryl group. The same type of reaction was used to investigated the regioselectivity 
between the α-(3,5)- and β-(2,6)- chloro groups. By treating BODIPY 17 with 10 equiv boronic 
acid (portion-wise) and monitoring by TLC, BOIDPY 18 could be obtained in 74% isolated yield. 
The regioselectivity of the cross-coupling reactions was further confirmed by X-ray analysis, as 
shown in Figure 3-6. In BODIPY 17, the B atom of the central ring lies 0.220 Å out of the C3N2 
plane, and the 8-phenyl ring forms a dihedral angle of 49.6° with it. BODIPY 18 has two 
independent molecules, both of which have the central C2N2B ring fairly planar, with the B atoms 
lying 0.102 and 0.123 Å out of the planes of the other 5 atoms. The 8-phenyl planes forms dihedral 
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angles of 49.5 and 50.2° with the central core planes, while the 3,5-phenyl groups form dihedral 
angles in the range 57.1-87.6° with them. 
However, under the same conditions, the global coupled product 19 could not be formed 
(Scheme 3-5). Several different conditions were investigated for the coupling reactions at the 2,6-
chloro groups, which are summarized in Table 1. A larger amount of boronic acids, up to 50 
equivalents, or longer reaction times, up to 48 hours, and stronger bases did not yielded the desired  
 
Figure 3-6: X-ray structures of 17 and 18. 
 
Scheme 3-5: Suzuki coupling reactions of BODPY 18. 
79 
Table 1: Optimized conditions of Suzuki coupling reactions of BODPY 18. 
 Solvent Catalyst Base Equiv of 
boronic acid 
Temp. (oC) Yield 
1 Toluene Pd(PPh3)4 1M Na2CO3 10-50 80-120 0 
2 Toluene Pd(PPh3)4 1M K2CO3 10-50 80-120 0 
3 Toluene/THF Pd(PPh3)4 1M Na2CO3 10-50 80-120 0 
4 Toluene Pd(dppf)Cl2 1M Na2CO3 10-50 80-120 0 
5 Toluene Pd(PCy3)G2 1M Na2CO3 10 Reflux 57 
 
2,6-dicoupled products. It may be due to the relative strong 2,6 “C-Cl” bonds, which lead to a more 
difficult  oxidative addition to palladium(0) complex. In the paper reported by Miyaura 2001,21 
ligand PCy3 can greatly increase the efficiency of the oxidative addition between Pd(0) and 
chlorobenzene. Inspired by their work, the globally coupled BODIPY 19 was synthesized as the 
major product in 57% yield from BODIPY 18, using commercial available 
chloro[(tricyclohexylphosphine-2-(2’-aminobiphenyl)palladium [Pd(PCy3)G2] as the catalyst, in 
the presence of 10 equiv of 4-methoxyphenylboronic acid, refluxing toluene.  
Figure 3-7: 1H NMR (400 MHz) of BODIPY 19 in CDCl3 at room temperature 
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The structure of the global coupled product 19 was confirmed by HRMS (ESI-TOF) with 
a [M]- peak 577.1182 (calcd. 577.1183). In the 1H NMR spectra, a slightly downfield shift of the 
1,7-hydrogens (from δ 6.9 to 7.0 ppm) was observed, as shown in Figure 3-8. It may be due to the 
1,7-hydrogens closely located by the unshielding area of the 2,6-phenyl groups. A suitable crystal 
was obtained by slow evaporation in the CHCl3, as shown in Figure 3-9.  In BODIPY 19, the 8-
phenyl group forms a dihedral angle of 50.1° with the BODIPY core plane, while 2,6-phenyl 
groups and 3,5-phenyl groups form dihedral angles of 20.7 and 33.5°, and 59.4 and 69.8° with it.  
                                                                     
Figure 3-8: X-ray structure of BODIPY 19. 
3.3.2 Suzuki Catalyzed Coupling Reactions of BODIPY 13 
Since base is not required, and the usual high yields,9, 11, 13 Stille cross-coupling22 reactions, 
these are also very attractive among the Pd(0)-catalyzed cross-coupling reactions. We recently 
reported that Stille cross-coupling reactions occur first at the most reactive 8-chloro site, followed 
by the 3(5)- (di)chloro groups.12-13 Therefore, Stille coupling reactions are also used to investigate 
the reactivity and regioselectivity of different chloro groups at the periphery of BODIPY 13. 
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Scheme 3-6: Stille cross-coupling reactions of BODIPY 13. 
Treatment of BODIPY 13 with 2.2 equiv of 2-(tributylstannyl)thiophene in the presence of 
Pd(PPh3)4 in refluxing toluene yielded only the 8-thienyl product 20 in high yield (87%), as shown 
in Scheme 3-6. Increasing the amount of 2-(tributylstannyl)thiophene to 10 equiv gave exclusively 
the 2,6-dichloro-BODIPY 21 in 77% yield. Further increasing the amount of 2-
(tributylstannyl)thiophene, up to 300 equiv, the reaction temperature, up to 130 C), and the 
reaction time, up to 72 h, did not produce the pentathienyl-BODIPY 22, only a trace amount of 
mono-2-coupled product, which was confirmed by HRMS. However, using Pd(PCy3)G2 as the 
catalyst, the globally coupled BODIPY 22 was successfully obtained as the major product in 57%  
yield. 
In the 1H NMR spectra, the singlet at δ 7.34 ppm of BODIPY 13 assigned to the hydrogens 
at the 1,7-positions appeared upfield shifted to 7.19 ppm for BODIPY 20 and  at 7.21 ppm for 
BODIPY 21, due to 1,7-hydrogens located at the shielded area of the 8-thienyl group.  
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Figure 3-9: X-ray structure of BODIPYs 20-22. 
Suitable crystals for X-ray analysis were obtained by slow evaporation in the CHCl3, as 
shown in Figure 3-9.  BODIPY 20 lies on a twofold axis in the crystal, necessitating disorder of 
the 8-thienyl group. The BODIPY core is in a slightly twisted conformation, with the C and N 
atoms of the C2N2B ring lying 0.038 Å out of the plane. The thiophene plane forms a dihedral 
angle of 37.7° with the C2N2B ring. BODIPY 21, as the hemi-toluene solvate, has four independent  
molecules, and five of the 12 thiophenes are disordered. The conformations of the four molecules 
are similar, with the planes of the 8-thienyl groups forming dihedral angles in the range 47.1-52.9° 
with the central C2N2B ring. Thienyl groups at the other positions form more variable dihedral 
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angles with the core, in the range 38.6-55.1°. BODIPY 22 also lies on a twofold axis in the crystal 
as 20, with two of the three independent thiophenes disordered. Similar to 20 and 21, the 8-thienyl 
forms a dihedral angle of 40.9° with the core. However, in contrast to 21, the 3,5-thienyl groups 
in BODIPY 22 are nearly orthogonal to the BODIPY core (84.0° of dihedral angle), while those 
at the 2,6-positions are nearly coplanar (18.5° of dihedral angle) to the core. 
3.3.3 Nucleophilic Substitution reactions of BODIPY 13 
Previous investigations showed the substitution reactions first occurs at the most reactive 
8-chloro site followed by the 3(5)-chloro site.12 Thus, in this work, nucleophilic substitution 
reactions were used to investigate the regioselectivity of pentachloro BODIPY 13. At room  
                       
Scheme 3-7: Nucleophilic substitution reactions of 13.  
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Figure 3-10: 1H NMR (400 MHz) spectra of 13, 23 and 24 in CDCl3 at room temperature. 
temperature, BODIPY 13 reacted with phenol (1.1 equiv) in the presence of K2CO3 to yield the 8-
phenoxy-BODIPY 23 in 85% yield, as shown in Scheme 3-7. Increasing the amount of phenol to 
10 equiv gave the 3,5,8-triphenoxy-BODIPY 24 in 91% yield, which was confirmed by 1H-NMR 
(see Figure 3-9) and HRMS. Further increasing the reaction time, the amount of phenol, or 
temperature did not produce the penta-substituted product 25, as reported.5  As shown in Figure 3-
10, the singlet at δ ≈ 7.34 ppm of BODIPY 13 assigned to the hydrogens at the 1,7-positions 
upfieldly shifted to δ 6.64 ppm for BODIPY 23 and δ 6.69 ppm BODIPY 24, due to the 1,7-protons 
located at the shield area of 8-phenoxyl group. A suitable crystal of 23 for X-ray analysis was 
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obtained by slow evaporation in the CHCl3, as shown in Figure 3-11. BODIPY 23 has a similar 
conformation as BODIPY 17, with the B atom lying 0.163 Å out of the C3N2 plane. The 8-phenyl 
ring forms a dihedral angle of 75.9° with the C3N2 plane.   
 
Figure 3-11: X-ray structure of BODIPY 23. 
3.3.4 Multifunctionalization of BODIPY 13 
    The multi-functionalization of BODIPY 13 via Stille and Suzuki cross-coupling 
reactions was performed, which is used to illustrate the versatility of 13, as shown in Scheme 3-8. 
First, a Suzuki cross-coupling reaction with 2.2 equiv of 4-methoxyphenylboronic acid and 13 
yielded BDOIPY 17 in 82% yield. Second, the 3,5,8-tri-coupled BODIPY 26 was obtained via a 
Stille cross coupling reaction with 10 equiv of tributyl(phenylethynyl)tin, in 77% yield. Finally, 
Treatment of 26 with 10 equiv of 2-(tributylstannyl)thiophene, catalysed by Pd(PCy3)G2, provided 
fully-coupled BODIPY 27 in 49% yield. 1H, 13C NMR, and HRMS were used to confirm the 
structures of BODIPY 26 and 27. In addition, the crystal structure of BODIPY 26 was obtained, 
as shown in Figure 3-12. The C3N2B core of 26 has the B atom 0.227 Å lying out of the plane with 
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the other 5 atoms, while there is a dihedral angle of 52.0° between the C3N2B core and the 8-phenyl 
group, dihedral angles of 13.7° and 48.7° between 3,5-substituents and the C3N2B core.  
                      
Scheme 3-8: The multi-functionalization of BODIPY 13. 
                                                                                            
Figure 3-12: X-ray structure of BODIPY 26.  
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3.4 Photophysical Properties  
The spectroscopic properties of BODIPYs 13-21, 23-24 and 26-27 in THF, and 22 in CH2Cl2, 
namely their maximum absorption (λabs) and fluorescence wavelengths (λem), Stokes shifts, molar 
extinction coefficients (log ε) and fluorescence quantum yields (Φf), are summarized in Table 2. 
Figures 3-13, 3-14, 3-15, and 3-16 show the normalized absorption and fluorescence spectra of all 
the new BODIPYs. Such BODIPYs showed the characteristic strong and narrow absorption bands 
(log ε = 3.9-4.9) and emission bands. The introduction of (1-4) chloro groups into the BODIPY 
core led to the moderate red-shifts (8-38 nm) in both the absorption and emission bands of 4,8 
while the introduction of phenyl, thienyl or ethynylphenyl groups at the 2,3,5,6,-positions causes 
the big red-shifts in both the absorption (up to 160 nm) and the emission bands (up to 176 nm) of 
BODIPY 13,  due to significant decreased the HOMO-LUMO gap.10, 12-13 On the other hand,  
Table 2. Spectroscopic properties of BODIPYs in THF at room temperature. 
 
aRhodamine 6G (0.88 in ethanol) was used as standard for 14, 23, and 24, rhodamine B (0.49 in 
ethanol) for 13, 15 and 16, crystal violet perchlorate (0.54 in methanol) for 18, and methylene blue 







Φf Stokes Shift 
(nm) 
14 510 4.73 538 0.71 28 
15 530 4.10 558 0.80 28 
16 535 4.47 561 0.51 26 
13 540 4.56 562 0.94 22 
20 543 4.29 571 0.07 28 
17 529 4.50 554 0.57 25 
  23 496 4.25 542 0.94 46 
21 622 4.06 673 0.03 51 
18 574 4.35 622 0.09 48 
24 500 4.68 541 0.64 41 
22b 638b 3.89b 704b 0.003b 66b 
19 615 4.78 647 0.33 32 
26 637 4.88 648 0.68 11 
27 700 4.53 738 0.03 38 
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Figure 3-13: Normalized UV-Vis spectra (a) and fluorescence spectra (b) of BODIPYs 14 
(green) and 16 (red) in THF at room temperature.  
 
  
Figure 3-14: Normalized UV-Vis spectra (a) and fluorescence spectra (b) of BODIPYs 13 
(yellow) and 15 (green) in THF at room temperature. 
 
    
Figure 3-15: Normalized UV-Vis spectra (a) and fluorescence spectra (b) of BODIPYs 20 
(green) and 21 (yellow) in THF and 22 (red) in DCM at room temperature. 
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Figure 3-16: Normalized UV-Vis spectra (a) and fluorescence spectra (b) of BODIPYs 17 
(green) 18 (blue) and 19 (red) in THF at room temperature. 
substitution with phenoxyl groups at the 8-position of BODIPY 13 caused pronounced slight blue-
shifts due to increase in the HOMO-LUMO gap, as reported.9, 11-12, 19, 24 I believe that there is 
largest MO coefficient in the LUMO at the 8-position, electron-donating group at this position 
cause blue-shift the BODIPY spectra.  
The range of Stokes shifts is in the range of 22-66 nm. As previously reported,12-13, 25-26 the 
largest Stokes shifts were observed for the 3,5- and 2,3,5,6-thienyl functionalized BODIPYs 21, 
22 and 27 due to increased geometry relaxation.27-28 BODIPY 26 with di-phenylethynyl groups at 
the 3,5-positions has the largest bathochromic shifts (112 nm) from BODIPY 17, which also gave 
the smallest Stokes shift (11 nm), as reported.29  
The quantum yields vary greatly among the different BODIPYs (0.003 – 0.94). The8-
phnoxyl BODIPY 23-24 provided the largest quantum yields (0.94) of all BODIPYs synthesized, 
while thienyl-functionalized BODIPYs 20-22 and 27 showed dramatically decreased the 
fluorescence quantum yields (< 0.1), which may be due to increased energy lost that resulting from 
free motion of all the thienyl groups.25-26  
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3.5 Conclusions 
A convenient stepwise chlorination method of “deactivated” BODIPYs was developed; 
this method used TCCA/AcOH at room temperature. Via this method, a versatile platform 
pentachloro BODIPY 13 was prepared, which was shown to undergo regioselective Stille and 
Suzuki cross-coupling reactions, first at the most reactive meso-8-, followed by the α-(3,5)-, and 
finally at the β-(2,6)-chloro groups. In addition, nucleophilic substitutions by use phenol as the 
nucleophiles took place first at the 8-position, followed by the 3,5-positions.  Under the same 
condition, however, the 2,6-chloro groups were unreactive.  
The regioselectivity of all the chlorination, Stille and Suzuki cross-coupling and 
nucleophilic substitution reactions was confirmed by X-ray crystallography analysis. Major 
conclusion from these studies showed pentathienyl-BODIPY 22 with the smallest dihedral angles 
(18.5°) for the 2,6-thienyls and the largest dihedral angles (84.0°) for the 3,5-thienyl. BODIPY 27 
was prepared by applying the methodologies developed via three-step synthesis. Such BODIPY 
absorbed (λmax = 700 nm) and emitted (λmax = 738 nm) both in the NIR region of the optical 
spectrum. We also noticed thienyl coupled at the 3,5- and/or 2,6-positions of BODIPYs gave the 
largest Stokes shifts, up to 100 nm, while thephenoxyl-subsitutued at the 8-position of BODIPY 
induced the highest fluorescence quantum yields .  
3.6 Experimental 
3.6.1 Synthesis 
General: All reagents and solvents were purchased from Sigma-Aldrich, Fisher Scientifics or Alfa 
Aesar as reagent grades and used without further purification. Argon was used to protect the air-
sensitive reactions. Analytical TLC (polyester backed, 60Å, 0.2 mm, precoated, Sorbent 
Technologies) was used to monitor the reactions. Column chromatography was performed on silica 
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gel (60Å, 230-400 mesh, Sorbent Technologies). All 1H NMR and 13C NMR spectra were obtained 
using Bruker AV-400 nanobay or AV-500 spectrometers (400 or 500 MHz for 1H NMR and 100 
or 125 MHz for 13C NMR) in CDCl3 or CD2Cl2 with trimethylsilane as an internal standard, at 
room temperature. Chemical shifts (δ) are given in parts per million (ppm) with CDCl3 (7.27 ppm 
for 1H NMR, 77.0 ppm for 13C NMR) and CD2Cl2 (5.32 ppm for 1H NMR, 53.4 ppm for 13C 
NMR). All high-resolution mass spectra (ESI-TOF) were obtained using a 6210 ESI-TOF mass 
spectrometer (Agilent Technologies). All UV-Visible spectra were recorded on a Varian Cary 50 
(solutions) spectrophotometer at room temperature. Fluorescence spectra were studied on a PTI 
QuantaMaster4/2006SE spectrofluorimeter corrected emission spectrum. A 10 mm path length 
quartz cuvette and spectroscopic grade solvents were used for the measurements. The 
determination of optical density (ε) was used the solutions with absorbance of λmax between 0.5—
1. The dilute solutions with absorbance of particular excitation wavelength between 0.02-0.05 
were used for fluorescence quantum yield measurement. Rhodamine 6G (0.95 in ethanol), 
rhodamine B (0.49 in ethanol) and crystal violet perchlorate (0.54 in methanol) were used as 
external standards for calculation of relative fluorescence quantum yields of BODIPYs. All 
fluorescence quantum yields (Φf) were determined using the following equation:
30 
Φx= Φs× (Fx/Fs)× (As/Ax)× (nx/ns)
2
 
where Φx and Φs are the fluorescence quantum yields of the test samples and standards; Fx and Fs 
are the areas under the test samples’ and standards’ emission peaks; Ax is the absorbance at which 
test samples were excited; As the absorbance at which stands were excited; nx and ns are refractive 
indexes of test sample and standards.  
General procedure for chlorination of BODIPY 4 
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8-Chloro BODIPY 4 (22.6 mg, 0.1 mmol) was dissolved in acetic acid (2 mL). TCCA was added 
portion-wise to the solution and the final mixture was stirred at room temperature for 10 min. TLC 
was used to monitor the reactions. The mixture was poured into water (200 mL) and extracted with 
CH2Cl2 (15 mL × 3). The organic layers were combined, washed with aqueous saturated NaHCO3 
and water, and then dried over anhydrous Na2SO4. The solvents were removed under reduced 
pressure and the resulting residue was purified by preparative TLC and column chromatography, 
using CH2Cl2/hexanes or ethyl acetate/hexanes for elution. 
2,8-Dichloro BODIPY 14: This compound was prepared using TCCA (31 mg, 0.133 mmol), 
yielding 21.6 mg, 83% of 14 (yellow solid), mp (°C) 143−144; 1H NMR (CDCl3, 400 MHz): δ = 
7.95 (s, 1H), 7.73 (s, 1H), 7.47 (s, 1H), 7.26 (s, 1H), 6.64 (s, 1H); 13C NMR (CDCl3, 125 MHz): δ 
= 147.1, 141.1, 141.0, 134.6, 132.3, 130.6, 125.1, 122.4, 120.0; HRMS (ESI-TOF) m/z 258.9919 
[M]-, calculated for C9H5BCl2F2N2: 258.9927.  
2,6,8-Trichloro BODIPY 15: This compound was prepared using TCCA (54 mg, 0.233 mmol), 
yielding 21.6 mg, 73% of 15 (red solid), mp (°C) 212-213; 1 H NMR (CDCl3, 400 MHz): δ = 7.78 
(s, 2H), 7.31 (s, 2H); 13C NMR (CDCl3, 125 MHz): δ = 143.2, 140.9, 132.9, 126.2, 123.5; HRMS 
(ESI-TOF) m/z 293.9502 [M]-, calculated for C9H5BCl3F2N2: 293.9501.  
2,3,6,8-Tetrachloro BODIPY 16: This compound was prepared using TCCA (93 mg, 0.4 mmol), 
yielding 4.9 mg, 15% of 16 (red solid), mp (°C) 208-209; 1H NMR (CD2Cl2, 400 MHz): δ = 7.78 
(s, 1H), 7.41 (s, 1H); 7.32 (s, 1H); 13C NMR (CD2Cl2, 125 MHz): δ = 143.7, 143.1, 139.4, 132.7, 
131.0, 126.5, 126.0, 123.7, 122.3; HRMS (ESI-TOF) m/z 329.9094 [M]-, calculated for 
C9H3BCl4F2N2: 329.9082.  
2,3,5,6,8-Pentachloro BODIPY 13: This compound was prepared using TCCA (0.23 g, 1 mmol) 
yielding 27.3 mg, 81% of 13 (red solid). mp (°C) 218-219;  1H NMR (CDCl3,  400 MHz): δ = 7.34 
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(s, 2H); 13C NMR (CDCl3, 125 MHz): δ = 144.0, 136.7, 130.4, 125.8, 122.7; HRMS (ESI-TOF) 
m/z 360.8754 [M]-, calculated for C9H2BCl5F2N2: 360.8758.  
General procedure for Stille cross-couplings of BODIPYs 
 To a 15 mL round-bottomed flask were added the starting BODIPY, organotin reagent and 3% 
mol of either Pd(PPh3)4 (for 20, 21, 26) or Pd(PCy3)G2 (for 22, 27). The flask was evacuated and 
refilled with nitrogen 4 times. Toluene (5 mL) was added and the final mixture was stirred and 
refluxed under N2. TLC was used to monitor the reactions. The toluene was removed under 
reduced pressure and the resulting residue was purified by preparative TLC and column 
chromatography using CH2Cl2/hexanes or ethyl acetate/hexanes for elution. 
8-Thienyl-2,3,5,6-tetrachloro BODIPY 20: This compound was prepared from BODIPY 13 
(18.2 mg, 0.05 mmol) and 2-(tributylstannyl)thiophene (37.3 mg, 0.1 mmol), yielding 17.2 mg, 
87% of 20 (red solid). mp (°C) 298-300;  1H NMR (CDCl3, 400 MHz): δ = 7.77-7.79 (q, 1H, 
3J(H,H)= 
4.0 Hz, 4J(H,H)= 1.1 Hz), 7.51-7.52 (q, 1H, 
3J(H,H)= 2.6 Hz, 
4J(H,H)= 1.1 Hz), 7.30-7.32 (q, 1H, 
3J(H,H)= 
3.7 Hz, 4J(H,H)= 1.3 Hz), 7.19 (s, 2H); 
13C NMR (CDCl3, 125 MHz): δ = 142.7, 136.2, 133.5, 132.4, 
132.3, 130.9, 128.7, 128.2, 121.8; HRMS (ESI-TOF) m/z 411.8959 [M]-, calculated for 
C13H5BCl4F2N2S: 411.8959.  
3,5,8-Trithienyl-2,6-dichloro BODIPY 21: This compound was prepared from BODIPY 20 
(20.5 mg, 0.05 mmol) and 2-(tributylstannyl)thiophene (187 mg, 0.5 mmol), yielding 19.1 mg, 
77% of 21 (dark blue solid). mp (°C) 255-257;  1H NMR (CDCl3, 400 MHz): δ = 7.94-7.95 (m, 
2H), 7.71-7.72 (m, 1H), 7.63-7.64 (m, 2H), 7.51-7.52 (m, 1H), 7.28-7.30 (m, 1H), 7.19-7.21 (m, 
overlap, 4H); 13C NMR (CDCl3, 125 MHz): δ = 147.4, 134.4, 134.0, 133.5(t), 133.1, 132.7, 131.0, 
130.8, 129.5, 128.5, 128.3, 127.6, 123.4; HRMS (ESI-TOF) m/z 504.9540 [M]-, calculated for 
C21H11BCl2F2N2S3: 504.9559.  
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2,3,5,6,8-Pentathienyl-BODIPY 22: This compound was prepared from BODIPY 21 (15.2 mg, 
0.03 mmol) and 2-(tributylstannyl)thiophene (112 mg, 0.3 mmol), yielding 10.3 mg, 57% of 22 
(dark green solid). mp (°C) 255-257; 1H NMR (CDCl3, 500 MHz): δ = 7.73-7.74 (m, 1H), 7.60-
7.61 (m, 1H), 7.54-7.55 (m, 2H), 7.51-7.52 (m, 2H), 7.30-7.32 (m, overlap, 3H), 7.23-7.24 (m, 
2H), 7.10-7.12 (m, 2H), 6.94-6.96 (m, 2H), 6.80-6.81 (m, 2H); 13C NMR (CDCl3, 125 MHz): δ = 
149.0, 135.6, 135.2, 134.7, 134.6, 132.6, 132.4, 130.9, 130.8, 129.7, 129.1, 128.2, 128.1, 127.3, 
127.2, 126.4, 125.6; HRMS (ESI-TOF) m/z 601.0086 [M]-, calculated for C29H17BF2N2S5: 
601.0093. 
General procedure for Suzuki cross-couplings of BODIPYs 
To a 15 mL round-bottomed flask were added the starting BODIPY and either 3 mol% of 
Pd(PPh3)4 (for 17, 18) or 3 mol% of Pd(PCy3)G2 (for 19). Toluene (4 mL) and 1M Na2CO3 (aq) 
(1 mL) were added under N2. 4-Methoxyphenylboronic acid was added portion-wise and the final 
mixture was stirred and refluxed under N2. TLC was used to monitor the reactions. The mixture 
was poured into water (20 mL) and extracted with CH2Cl2 (10 mL × 3). The organic layers were 
combined, washed with aqueous saturated brine, water and dried over anhydrous Na2SO4. The 
solvents were removed under reduced pressure and the resulting residue was purified by column 
chromatography using CH2Cl2/hexanes or ethyl acetate/hexanes for elution. 
8-(p-Methoxyphenyl)-2,3,5,6-tetrachloro-BODIPY 17: This compound was prepared from 
BODIPY 13 (18.2 mg, 0.05 mmol) and 4-methoxyphenylboronic acid (16.7 mg, 0.11 mmol), 
yielding 17.7 mg, 82% of 17 (orange-red solid). mp (°C) 234-236;  1H NMR (CDCl3, 400 MHz): 
δ = 7.64-7.67 (d, 2H, 3J(H,H)= 8.1 Hz ), 7.07-7.09 (d, 2H, 
3J(H,H)= 8.1 Hz), 6.94 (s, 2H), 3.91 (s, 3H); 
13C NMR (CDCl3, 100 MHz): δ = 162.9, 144.7, 141.5, 132.6, 131.4, 128.3, 124.0, 121.2, 114.5, 
55.7; HRMS (ESI-TOF) m/z 432.9574 [M-H]-; calculated for C16H9BCl4F2N2O: 432.9572.  
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3,5,8-tri(p-Methoxyphenyl)-2,6-dichloro-BODIPY 18: This compound was prepared from 
BODIPY 17 (21.7 mg, 0.05 mmol) and 4-methoxyphenylboronic acid (76 mg, 0.5 mmol), yielding 
21.4 mg, 74% of 18 (dark blue), mp (°C) 315-316;  1H NMR (CDCl3, 400 MHz): δ = 7.64-7.67 (d, 
4H, 3J(H,H)= 8.6 Hz ), 7.53-7.56 (d, 2H, 
3J(H,H)= 8.6 Hz), 7.08-7.10 (d, 2H, 
3J(H,H)= 8.5 Hz), 6.95-
6.98 (d, 4H, 3J(H,H)= 8.7 Hz), 6.91 (s, 2H), 3.94 (s, 3H), 3.85 (s, 6H); 
13C NMR (CDCl3, 125 MHz): 
δ = 161.9, 160.8, 154.0, 143.3, 132.8, 132.3, 131.9, 128.1, 126.0, 122.5, 121.7, 114.2, 113.5, 55.6, 
55.2; HRMS (ESI-TOF) m/z 577.1182 [M]-; calculated for C30H23BCl2F2N2O3: 577.1183.  
2,3,5,6,8-Penta(p-Methoxyphenyl)-BODIPY 19: This compound was prepared from BODIPY 
18 (17.4 mg, 0.03 mmol) and 4-methoxyphenylboronic acid (45 mg, 0.3 mmol) yielding 12.1 mg, 
56% of 19 (dark blue solid), mp (°C) 252-254; 1H NMR (CDCl3, 400 MHz): δ = 7.62-7.64 (d, 2H, 
3J(H,H)= 8.5 Hz ), 7.43-7.45 (d, 4H, 
3J(H,H)= 8.5 Hz), 7.07-7.09 (d, 2H, 
3J(H,H)= 8.5 Hz), 6.96-6.98 
(overlap, 6H), 6.84-6.86 (d, 4H, 3J(H,H)= 8.6 Hz), 6.72-6.74 (d, 4H, 
3J(H,H)= 8.6 Hz), 3.93 (s, 3H), 
3.82 (s, 6H), 3.76 (s, 6H); 13C NMR (CDCl3, 125 MHz): δ = 161.4, 160.1, 158.5, 155.5, 142.3, 
134.5, 133.9, 132.4, 132.0, 129.5, 127.7, 127.1, 126.8, 124.4, 113.9, 113.7, 113.4, 55.5, 55.2, 55.1; 
HRMS (ESI-TOF) m/z 721.2802 [M]+; calculated for C44H37BF2N2O5: 721.2800. 
General procedure for nucleophilic substitution of BODIPYs 
The starting BODIPY was dissolved in CH2Cl2 (1 mL) and CH3CN (1 mL). Phenol and Na2CO3 
(1 equivalents) were added and the solution stirred at room temperature. TLC was used to monitor 
the reactions. The mixture was poured into water (10 mL) and extracted with CH2Cl2 (10 ml × 3). 
The organic layers were combined, washed with aqueous saturated brine, water and dried over 
anhydrous Na2SO4. The solvents were removed under reduced pressure and the resulting residue 
was purified by column chromatography using CH2Cl2/hexanes or ethyl acetate/hexanes for 
elution. 
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8-Phenoxy-2,3,5,6-tetrachloro-BODIPY 23: This compound was prepared from BODIPY 13 
(18.2 mg, 0.05 mmol) and phenol (5 mg, 0.055 mmol), yielding 17.9 mg, 85% of 23 (orange-red 
solid). mp (°C) 198-199;  1H NMR (CDCl3, 400 MHz): δ = 7.51-7.55 (m, 2H), 7.42-7.45 (m, 1H), 
7.20-7.22 (d, 2H, 3J(H,H)= 8.4 Hz), 6.64 (s, 2H); 
13C NMR (CDCl3, 100 MHz): δ = 155.5, 155.4, 
139.2, 130.9, 127.5, 123.9, 123.6, 120.0, 119.4; HRMS (ESI-TOF) m/z 418.9413 [M]-; calculated 
for C15H7BCl4F2N2O: 418.9410. 
BODIPY 24: This compound was prepared from BODIPY 23 (12.6 mg, 0.03 mmol) and phenol 
(27 mg, 0.3 mmol), yielding 14.7, 91% of 24 (orange-red solid), mp (°C) 180-181;  1H NMR 
(CD2Cl2, 400 MHz): δ = 7.50-7.54 (t, 2H, 
3J(H,H)= 7.4 Hz), 7.33-7.41 (m, overlap, 6H), 7.28-7.30 
(d, 2H, 3J(H,H)= 7.9 Hz), 7.14-7.17 (t, 2H, 
3J(H,H)= 7.5 Hz),  7.04-7.06 (d, 4H, 
3J(H,H)= 8.0 Hz),  6.60 
(s, 2H); 13C NMR (CD2Cl2, 100 MHz): δ = 156.1, 155.8, 154.4, 153.8, 130.7, 129.7, 126.8, 124.3, 
119.4, 118.7, 117.0, 109.4; HRMS (ESI-TOF) m/z 535.0713 [M]-; calculated for 
C27H17BCl2F2N2O3: 535.0714. 
BODIPY 26: This compound was prepared from BODIPY 18 (21.7 mg, 0.05 mmol) and 
tributyl(phenylethynyl)tin (196 mg, 0.5 mmol), yielding 21.8 mg, 77% of 9 (dark-green solid), mp 
(°C) 248-250; 1H NMR (CDCl3, 400 MHz): δ = 7.74-7.76 (q, 4H, 
3J(H,H)= 5.7 Hz, 
3J(H,H)= 1.6 Hz 
), 7.48-7.50 (d, 2H, 3J(H,H)= 8.7 Hz), 7.40-7.45 (m, overlap, 6H), 7.06-7.08 (d, 2H, 
3J(H,H)= 8.7 Hz), 
6.86 (s, 2H), 3.93 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ = 162.3, 141.9, 135.7, 134.4, 132.6, 
132.4, 130.0, 128.5, 126.9, 126.7, 125.6, 121.9, 114.4, 107.2, 80.7, 55.6; HRMS (ESI-TOF) m/z 
565.0969 [M]-; calculated for C32H19BCl2F2N2O: 565.0972. 
BODIPY 27: This compound was prepared from BODIPY 26 (17 mg, 0.03 mmol) and 2-
(tributylstannyl)thiophene (112 mg, 0.3 mmol), yielding 9.7 mg, 49% of 27 (dark-green solid), mp 
(°C) 292-293; 1H NMR (CDCl3, 400 MHz): δ = 7.78-7.81 (m, 4H), 7.59-7.61 (m, 4H), 7.44-7.46 
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(m, overlap, 6H), 7.31-7.33 (m, 2H)  7.10-7.14 (m, 4H), 7.00 (s, 2H), 3.96 (s, 3H); 13C NMR 
(CDCl3, 125 MHz): δ = 162.0, 141.3, 136.3, 135.1, 134.7, 132.5, 132.2, 131.2, 129.8, 128.5, 127.5, 
126.3, 125.1, 125.0, 124.7, 122.5, 114.3, 106.4, 83.6, 55.6; HRMS (ESI-TOF) m/z 661.1493 [M]-
; calculated for C40H25BF2N2OS2: 661.1506. 
3.6.2 Crystal data 
Crystal structures were determined at low-temperature (90K except for 13) with MoK 
data from either a Bruker Kappa APEX-II DUO (for 4, 15, 16, 13, 20, 23, 26) or a Nonius 
KappaCCD (for 17, 18, 21, 22) diffractometer. Data for 19 were collected on a Bruker Kappa 
APEX-II DUO diffractometer with CuK radiation. For all structures, H atoms were located from 
difference maps but constrained in calculated positions during refinement. Refinement was by 
SHELX-97.17 For 15, the molecule is disordered on a 2/m (C2h) site. For 13, Z'=2, and the data 
were collected at T=160K, since a crystal-destroying phase change occurs around 150K. For 20, 
Z'=1/2 with the molecule on a twofold axis and the thiophene disordered. For 21, Z'=4, 5 of the 12 
independent thiophenes are disordered, as is one of the two independent toluene solvent molecules. 
For 18, Z'=2. In 22, Z'=1/2 with the molecule on a twofold axis and two of the three independent 
thiophenes disordered. CCDC 1053715-1053721 and CCDC 1401007-1401011 contain the 
supplementary X-ray data for this work. 
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CHAPTER 4: SYNTHESIS AND REGIOSELECTIVE 
FUNCTIONALIZATION OF PERHALOGENATED BODIPYS 
4.1 Introduction 
As discussed in the Chapters 1-3, halogenated BODIPYs are important synthetic targets 
for various applications. In the last two decades, with development of synthetic chemistry, the 
different halogen groups can be selectively introduced to all the different positions on the BODIPY 
platforms for further functionalizations.1 To the best of our knowledge, BODIPYs 12-3 and 24 with 
six chloro or bromo groups at all the pyrrolic positions and two fluoro atoms at the boron position 
have the most (8) halogen groups at the BODIPY cores. Such polyhalogenated BODIPYs were 
prepared by direct bromination of 8-phenyl BODPY, or by NCS or NBS halogenation at the 
precursor pyrrole or dipyrromethane stages, followed by (condensation), oxidation and boron 
complexation. In addition, the hexahalo-BODIPYs allowed for the regioselective substitution 
reactions at 1,3,5,7-positions and Suzuki cross-coupling reactions at the 1,2,3,5,6,7-positions. 
Thus, to enrich BODIPY chemistry, a series of global halogenated BODIPYs 3b-5b with nine 
halogen groups were prepared by using Br2 as the halogenation reagents for the first time. 
Investigation of reactivity via Stillecross-coupling and boron substitution reactions were 
conducted to show the regioselectivity under these reactions. 
                                                                                  
Figure 4-1: Structures of Hexahalogenated BODIPYs. 
* Reproduced from Ref. Zhao, N.; Xuan, S.; Byrd, B.; Fronczek, F. R.; Smith, K. M.; Vicente, M. 
G. H., Synthesis and regioselective functionalization of perhalogenated BODIPYs. Org. Biomol. 
Chem. 2016, 14, 6184-6188 with permission from the Royal Society of Chemistry. 
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4.2 Synthesis of Perhalogenated BODIPYs 
As discussed in Chapter 3, the starting BODIPYs 3-5a were prepared via chlorination using 
TCCA/AcOH of 8-chloro BODIPY5-7 in 73-83% yields.8 Due to the slight electron withdrawing 
effect of the 8-chloro group at the 8-position and bearing the most positive charge at the 1,7-
positions, further chlorination could not occur at the 1,7-positions using different types of 
chlorination conditions, including TCCA in H2SO4. Thus, Br2/CH2Cl2,
2 known a strong 
halogenation reagent, was selected for the global halogenation, as shown in Scheme 4-1. Treatment 
of 3a-5a with 200 equivalents of Br2 in CH2Cl2 at room temperature overnight afforded hepta-
halogenated BODIPYs 3b-5b as the only products, in 78-84% isolated yields. 1H NMR spectra of 
halogenation reagent, was selected for the global halogenation, as shown in Schemes 4-1, 4-2, and  
 
Scheme 4-1: Bromination of BODIPY 3a.  
 
Scheme 4-2: Bromination of BODIPY 4a.  
 
Scheme 4-3: Bromination of BODIPY 5a.  
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Figure 4-2: 1H NMR (400 MHz) spectra of BODIPY 5a and 5b in CDCl3 at room temperature. 
 
Figure 4-3: X-ray structures of BODIPY 3b-5b. 
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4-3. Treatment of 3a-5a with 200 equivalents of Br2 in CH2Cl2 at room temperature and stirring 
overnight afforded hepta-halogenated BODIPYs 3b-5b as the only products, in 78-84% isolated 
yields. The 1H NMR spectra of 3b-5b showed the complete disappearance of signals of all the 
pyrrolic hydrogens. For example, in the case of 5a, the signals of the 1,7-hydrogens at δ = 7.34 
ppm were disappeared in the spectra of 5b, as shown in Figure 4-2. Also, HRMS (ESI-TOF) 
spectra clearly showed the predicted isotopes of the halo groups of BODIPYs 3b-5b.  
Suitable crystals of 3b-5b were obtained by slow evaporation of CHCl3. The results were 
shown in Figure 4-3, which further confirms the formation of BODIPYs 3b-5b. In all three 
BODIPYs, the dipyrrole unit with 11 atoms is nearly planar. There are mean deviation 0.016 Å in 
3b, 0.035 Å in 4b and 0.035 Å in 5b. The boron atoms lie slightly out of this core planes by 0.171 
Å, 0.195 Å and 0.175 Å for 3b, 4b, and 5b, respectively. The C-Cl bonds in 3b-5b are in the range 
1.695(4) – 1.712(4) Å with a mean value of 1.703 Å, while C-Br distances are in the range 1.842(2) 
- 1.862(3) Å with a mean value of 1.853 Å.  
4.3 Functionalizationa of Perhalogenated BODIPYs 5b.  
Based on our previous results, chlorinated BODIPYs show high reactivity under 
substitution and Pd(0)-catalyzed Stille and/or Suzuki cross-coupling reactions.8-11 The regio-
selectivity of the chloro groups at different positions of the BODIPYs was investigated and showed 
to be in decreasing order: m-(8)-Cl > α-(3,5)-Cl > β-(2,6)-Cl,8-11 which allowed for the step-wise 
functionalization of BODIPYs at the 8-position, 3,5-positions, followed by the 2,6-positions. Due 
to the high selectivity observed for chlorinated BODIPYs, BODIPY 5b with the most chloro 
groups among the three perhalogenated BODIPYs, was chosen for investigation of the reactivity 
and regioselectivity of the different halogen groups.  
Since base is not required, the high yielding9, 12-13 Stille cross-coupling14 reactions are  
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very attractive among the Pd(0)-catalyzed cross-coupling reactions for BODIPY functionalization. 
By treating BODIPY 5b with 1 equivalent of 2-(tributylstannyl)thiophene or with 
tributylphenylstannane in the presence of Pd(PPh3)4 (3 mol%) in refluxing toluene, TLC and MS 
both showed a tri-coupled product as the major product, along with unreacted starting material 
after several hours. This may be due to similar reactivity of the 1,7-bromo and 8-chloro groups  
 
Scheme 4-2: Regioselective cross-coupling reactions of BODIPY 5b. 
under this type of reaction conditions. When 4 equivalents of stannane reagent was used, with 
refluxing overnight, the coupling reactions regioselectively occurred at 1,7,8-positions and tri-
coupled BODIPYs 6a-b were obtained as the major products, isolated in 57-71% yields, as shown 
in Scheme 4-2. 1,3,5,7,8-Pentaphenyl (thienyl)-2,6-dichloro-BODIPYs 7a-b were obtained in 75-
92% yield by treating BODIPYs 6a-b with 10 equivalents of stannane reagent under the same 
conditions. The compounds were characterized by 1H and 13C NMR, 11B NMR, and HRMS (ESI-
TOF).  
Suitable crystals of 6a, 6b, 7a and 7b were obtained by slow evaporation of CHCl3. The 
results are shown in Figure 4-4, directly confirming the regioselectivity of the Stille cross-coupling 
reactions on BODIPY 5b. In the structure of BODIPY 6a and 6b, the 12-atom core is nearly planar, 
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with mean deviation 0.021 Å and 0.049 Å. The three phenyl planes of 6a and three disordered 
thiophene rings of 6b form dihedral angles in the range 63.5-66.6° and 60.3-64.0° with it. 
BODIPYs 7a and 7b have the cores with similar conformation similar to those of 3b, 4b, and 5b. 
The B atoms of 7a and 7b lie 0.183 Å (average of two independent molecules) and 0.106 Å out of 
the core plane. The phenyl groups of 7a are disordered in one molecule and ordered in the other, 
in which they form dihedral angles (52.5-72.1°) with the core. Four of the five thiophene rings of 
BODIPY 7b are disordered. A small dihedral angle of 27.4° is formed between the ordered one 
and the BODIPY core. The disordered thienyl substituents with variable conformations form 
dihedral angles (52.2-73.2°) with the core. 
 
Figure 4-4: X-ray structures of 6a, 6b, 7a and 7b. 
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As discussed in the Chapter 3, Pd(PCy3)G2 can efficiently catalyzed the Stille cross- 
coupling reactions for 2,6-dichloro BODIPYs.8 Thus, as shown in Scheme 4-3, by treating 
BODIPY 7a with tributylphenyltin (up to 100 equiv) in the presence of Pd(PCy3)G2, BODIPY 8 
was formed as the major product in 30% yield, with trace amount of desired product 9 and a large 
amount of starting material. The formation of BODIPY 9 was confirmed by HRMS, as shown in 
Figure 4-5. Low yields of this reaction may be due to the steric interactions with different phenyl 
groups on BODPY 7a, as well as the relatively low reactivity of the tributylphenyltin.  
Scheme 4-3: Stille cross-cross coupling reactions of 7a. 
 
Figure 4-5: HRMS (ESI-TOF) spectra of BODIPY 9. 
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Scheme 4-4: Stille cross-cross coupling reaction of 7a with (tributylstannyl)thiophene 
 
Scheme 4-5: Stille cross-cross coupling reaction of 7b with (tributylstannyl)thiophene 
 
Figure 4-6: 1H NMR (400 MHZ) spectra of BODIPY 10 in CDCl3 at room temperature. 
More reactive and less bulky (tributylstannyl)thiophene was chosen for the Stille corss-coupling  
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reactions of BODIPY 7a, as shown in Scheme 4-4. The global coupling reaction was accomplished 
by using Pd(PCy3)G2 as the catalyst, in the presence of 10 equivalents of 2-
(tributylstannyl)thiophene to provide 2,6-dithienyl 1,3,5,7,8-pentaphenyl BODIPY 9 in good yield 
(76%). Similarly, under the same conditions, 1,2,3,5,6,7,8-heptathienyl BODIPY 10 was 
synthesized in an excellent yield (95%), as shown in Scheme 4-5. These hepta-functionalized 
BODIPY 9 and 10 were characterized by 1H NMR, 13C NMR, 11B NMR, and HRMS (ESI-TOF). 
For example, the 1H NMR spectra of BODIPY 10 was shown in Figure 4-6. All 12 groups of 
characteristic doublet-of-doublets from seven thienyl groups on the BODIPY 10 were clearly 
separated and shown in this spectra. Also, all the integration of those signals are matching well 
with the structures. For example, the 1H NMR spectra of BODIPY 10 is shown in Figure 4-6. All 
12 groups of characteristic doublet-doublet from seven thienyl groups on the BODIPY 10 are 
clearly seen in this spectra. Also, all the integration of those signals match well with the structures.  
Scheme 4-6: Boron substitution reaction of BODIPY 10 by using SnCl4. 
Additionally, the investigation of the functionalization at the boron position was conducted to 
achieve nona-functionalization. Based on a published procedure,15-17 BODIPY 10 were reacted 
with excess amount of trimethylsilyl cyanide catalyzed by tin (IV) chloride (SnCl4) in CH2Cl2, as 
shown in Scheme 4-6.  This reaction yielded the mono substituted product 12 after 30 minuites 
instead of the desired di-CN substituted product 11. The momo-substitution product was confirmed 
by the doublet at δ ≈ -5.5 ppm in the 11B NMR, as shown Figure 4-7. In order to obtain the BODIPY 
109 
11, a large excess of TMS-CN and SnCl4 were used, along with extend reaction times, but 
BODIPY 12 was the only product obtained in high yield (> 90%). This reaction under reflux for 2 
hours provided a small amount of diCN BODIPY 11 (yield: <5%), although the major product was 
still BODIPY 12. Thus, I believed the diCN-functionalization at the boron position of BODIPY 
11 was possible to achieve. A stronger Lewis acid (BF3•OEt2) with excess TMS-CN in CH2Cl2 
were used for this boron substitution reaction to provided 4,4’-diCN BODIPY 11 in 93% isolated 
yield. Similarly, 4,4’-diCN BODIPY 13 was obtained from BODIPY 9 in 92% yield under the 
same conditions, as shown in Scheme 4-8. A singlet (δ ≈ -16 ppm) in 11B NMR of 13 confirmed 











Figure 4-7: 11B NMR (128 MHz) spectra of BODIPYs 10-12 in CDCl3 at room temperature. 
 
 
Scheme 4-7: Boron substitution reaction of BODIPY 10 by using BF3•OEt2 
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Scheme 4-8: Boron substitution reaction of BODIPY 9 using BF3•OEt2/TMSCN 
4.4 Photophysical properties  










3b 556 5.02 572 0.17 16 
4b 553 5.01 568 0.14 15 
5b 546 4.87 560 0.18 14 
6a 549 4.77 563 0.57 14 
7a 564 4.85 596 0.39 32 
9 581 4.66 666 0.08 85 
13 585 4.48 676 0.06 91 
6b 572 4.72 580 <0.003 8 
7b 633 4.56 681 0.02 48 
10 643 4.74 713 0.007 70 
11 639 4.48 739 0.005 100 
 
aRhodamine B (0.4 in methanol)18 for 3-5b and 6a; cresyl violet (0.55 in methanol)19 was used as 
standard for 6b, 7a, 9, and 13; methylene blue (0.03 in methanol)19 for 7b and 10-11.  
 
The spectroscopic properties of BODIPYs 3b-5b, 6a, 6b, 7a, 7b, 9-11 and 13 in CH2Cl2 
namely their maximum absorption (λabs) and fluorescence wavelengths (λem), Stokes shifts, molar 
extinction coefficients (log ε) and fluorescence quantum yields (Φf), are summarized in Table 1. 
Figures 4-8, 4-9, and 4-10 show the normalized absorption and fluorescence spectra of all the new 
BODIPYs. Such BODIPYs show characteristic strong and narrow absorption bands (log ε = 4.48-
5.02) and emission bands. From BODIPY 3b to 5b, the decreasing numbers of bromo groups gave 
a slightly blue shift in both the absorption and emission due to the less electron-donating chloro  
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Figure 4-8: Normalized absorption (a) and fluorescence (b) spectra of BODIPYs 3b (red), 4b 
(blue), and 5b (yellow) in CH2Cl2 at room temperature. 
         
Figure 4-9: Normalized absorption (a) and fluorescence (b) spectra of BODIPYs 6a (yellow), 7a 
(red), 9 (blue), and 13 (purple) in CH2Cl2 at room temperature. 
          
Figure 4-10: Normalized absorption (a) and fluorescence (b) spectra of BODIPYs 6b (yellow), 
7b (red), 10 (blue), and 11 (purple) in CH2Cl2 at room temperature. 
112 
groups. Due to the big dihedral angles (60-67°), the introduction of phenyl and thienyl groups at 
the 1,7,8 -positions causes the moderate red-shifts (2-23 nm) in both absorption and emission 
bands of BODIPY 5b. On the other hand, as reported,9-10, 20-22 BODIPYs 7a and 7b with aryl-
functionalization at the 3,5-positions or the 2,6-positions provided the largest red-shifts, which 
may be due to the decreased HOMO-LUMO gap. For example, there is a red shift of 101 nm in 
the emission of 7b, compared with 6b.  
The Stokes shifts varied significantly (8-100 nm) depending on the different functional 
groups (Cl, Br, phenyl, CN and thienyl) on the BODIPYs. As reported,9-10, 20-22 compared with 
phenyl groups, the thienyl groups on the BODIPY core lead to large Stokes shifts (up to 85 nm for 
BODIPY 9), maybe due to increased geometry relaxation.23-24 However, the thienyl groups also 
greatly decrease the fluorescent quantum yields (< 0.1) due to the free rotation of thienyl groups 
causing increasing nonradiative process. Further introduction of two cyanide groups at the boron 
position of BODIPYs 11 and 13 caused increased Stokes shift (91 and 100 nm) and slightly 
decreased quantum yields. 
4.5 Conclusions 
The global halogenated BODIPYs 3-5b were synthesized in good yields, via bromination 
of chlorinated BODIPY 3a-5a. The regioselective nona-functionalization of BODIPY 5b was 
investigated via Pd(0)-catalyzed Stille cross-coupling and boron substitution reactions. The 
regioselectivity of the reactions was confirmed by X-ray crystallography and by 1H and 13C NMR 
spectroscopy and mass spectrometry, and showed the following order of increasing reactivity: 8-
Cl ≈ 1,7-Br > 3,5-Cl > 2,6-Cl  > 4,4’-F.  The thienyl-coupled BODIPYs showed the largest Stokes 
shifts, as well as the largest red-shifted absorptions and emissions. The nona-functionalized 
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BODIPY 11 and 13 had the largest Stokes shifts (91-100 nm). However, such BODIPYs displayed 
the lowest quantum yields (< 0.1).  
4.6 Experimental 
4.6.1 Synthesis 
General: All reagents and solvents were purchased from Sigma-Aldrich, Fisher Scientifics or Alfa 
Aesar as reagent grades and used without further purification. Argon was used to protect the air-
sensitive reactions. Analytical TLC (polyester backed, 60Å, 0.2 mm, precoated, Sorbent 
Technologies) was used to monitor the reactions. Column chromatography was performed on silica 
gel (60Å, 230-400 mesh, Sorbent Technologies). All 1H NMR, 13C NMR and 11B NMR spectra 
were obtained using Bruker AV-400 nanobay or AV-500 spectrometers (400 MHz or 500 MHz 
for 1H NMR and 100 or 125MHz for 13C NMR) and AV-400 III (128 MHz for 11B NMR) in CDCl3 
with trimethylsilane as an internal standard, at room temperature. Chemical shifts (δ) are given in 
parts per million (ppm) with CDCl3 (7.27 ppm for 
1H NMR, 77.0 ppm for 13C NMR) and CD2Cl2 
(5.32 ppm for 1H NMR, 53.4 ppm for 13C NMR). All high-resolution mass spectra (ESI-TOF) 
were obtained using a 6210 ESI-TOF mass spectrometer (Agilent Technologies). All UV-Visible 
spectra were recorded on a Varian Cary 50 (solutions) spectrophotometer at room temperature. 
Fluorescence spectra were studied on a PTI QuantaMaster4/2006SE spectrofluorimeter corrected 
emission spectrum. A 10 mm path length quartz cuvette and spectroscopic grade solvents were 
used for the measurements. For the determination of quantum yields, dilute solutions with different 
absorbance between 0.02-0.08 at the particular excitation wavelength were used. Molar absorption 
coefficients (ε) was determined from the plots of integrated absorbance vs concentrations. 
Rhodamine B in methanol (0.4),18 crystal violet perchlorate in methanol (0.55 in methanol),19 and 
methylene blue (0.03 in methanol)19 were used as external standards for all the BODIPY 
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derivatives. The following equation was used for the calculations of the relative fluorescence 
quantum yields (Φf):
25 
Φs = Φst × (Gradx/Grandst) × (nx
2/nst
2) 
where Φ and n are the fluorescence quantum yields and refractive indexes, respectively; Grad 
represents gradient of integrated fluorescence intensity vs absorbance at the particular wavelength, 
subscripts s and x refer to the standards and the tested samples.  
BODIPY 3-5a were synthesized according to a published procedure.8 
General procedure for BODIPY 3-5b: 
BODIPY 3-5a (0.1 mmol) was dissolved in 2 ml DCM. Br2 (1.02ml, 20 mmol) was added into the 
flask. The mixture was stirred at room temperature overnight. TLC was used to monitor the 
reaction. The mixture was poured into saturated Na2S2O3 (aq) (100 ml) and extracted by CH2Cl2 
(20 ml* 3). The organic layers were combined and washed with brine then water. The solvent were 
removed under reduced pressure. The residue was purified by using column chromatography 
(CH2Cl2/Hexanes 1:1 as eluents) to provide the pure compounds.  
BODIPY 3b: Yield: 58 mg, 83%; 1H NMR (400 MHz, CDCl3): no peaks; 
13C NMR (125 MHz, 
CDCl3): 138.1, 134.6, 129.9, 122.5, 118.4; 
11B NMR (128 MHz, CDCl3) δ -0.17 (t, J(B,F) = 26.9 
Hz); HRMS (ESI-TOF) m/z 692.4972 [M]-; calculated for C9BBr6ClF2N2: 692.4948.  
BODIPY 4b: Yield: 47.6 mg, 78%; 1H NMR (400 MHz, CDCl3): no peaks; 
13C NMR (125 MHz, 
CDCl3) δ 138.6, 132.3, 128.9, 128.7, 119.2; 
11B NMR (128 MHz, CDCl3) δ -0.19 (t, J(B,F) = 27.1 
Hz); HRMS (ESI-TOF) m/z 604.5946 [M]-; calculated for C9BBr4Cl3F2N2: 604.5958. 
BODIPY 5b: Yield: 43.8 mg, 84%; 1H NMR (400 MHz, CDCl3): no peaks; 
13C NMR (125 MHz, 
CDCl3) δ 142.5, 138.8, 126.8, 125.4, 119.6; 
11B NMR (128 MHz, CDCl3) δ -0.31 (t, J(B,F) = 26.4 
Hz); HRMS (ESI-TOF) m/z  516.6980 [M]-; calculated for C9BBr2Cl5F2N2: 516.6968 . 
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General procedure for BODIPY 6a-b 
BODIPY 5b (15.7 mg, 0.03 mmol) and Pd(PPh3)4 (3 mol%) were added into a 25 ml round-
bottomed flask. The flask was evacuated and refilled with nitrogen for three times. Toluene (5 ml) 
and organostananne reagents (0.14 mmol, 4 equiv) were purged into the flask, and the mixture was 
heated to 90-100 oC and stirred for 6 hours. The reaction was stopped when 6a-b was showed as 
major products according to TLC. The solvents were removed under reduced pressure. Then, the 
crude product was purified by using column chromatography (Ethyl acetate/Hexanes 1: 10 as 
eluents) to provide the desired products.  
BODIPY 6a: Yield: 8.9 mg, 57%; 1H NMR (500 MHz, CDCl3) δ 6.94-6.97 (m, 2H), 6.87–6.90 
(m, 4H), 6.63–6.68 (m, 7H), 6.42–6.45 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 146.3, 143.7, 
142.3, 131.2, 131.0, 129.5, 129.3, 129.2, 128.9, 127.5, 127.4, 126.8, 121.9; 11B NMR (128 MHz, 
CDCl3) δ 0.13 (t, J(B,F) = 27.7 Hz); HRMS (ESI-TOF) m/z  555.0100 [M]
-; calculated for 
C27H15BCl4F2N2: 555.0092. 
BODIPY 6b: Yield: 12.3 mg, 71%; 1H NMR (400 MHz, CDCl3) δ 7.17-7.18 (dd, J(H,H) = 5.1, 1.2 
Hz, 2H), 6.93-6.94 (dd, J(H,H) = 5.0, 1.3 Hz, 1H), 6.67-6.70 (m, 3H), 6.45-6.46 (dd, J(H,H) = 3.6, 1.2 
Hz, 2H), 6.30-6.32 (dd, J(H,H) = 5.0, 3.6 Hz, 1H); 
13C NMR (125 MHz, CDCl3) δ 143.0, 138.3, 
136.8, 134.0, 131.5, 130.6, 130.4, 130.3, 129.4, 127.9, 126.8, 126.6, 123.4; 11B NMR (128 MHz, 
CDCl3) δ -0.02 (t, J(B,F) = 27.5 Hz); HRMS (ESI-TOF) m/z  572.8774 [M]
-; calculated for 
C21H9BCl4F2N2S3: 572.8779. 
General procedure for BODIPY 7a-b 
BODIPY 6a-b (0.02 mmol) and Pd(PPh3)4 (3 mol%) were added into a 25 ml round-bottomed 
flask. The flask was evacuated and refilled with nitrogen for three times. Toluene (5 ml) and 
organostananne reagents (0.2 mmol, 10 equiv) were purged into the flask, and the mixture was 
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reflux overnight. The reaction was stopped when 6a-b was showed as major products according 
to TLC. The solvents were removed under reduced pressure. Then, the crude product was purified 
by using column chromatography (Ethyl acetate/Hexanes 1: 4 as eluents) to provide the desired 
products.  
BODIPY 7a: Yield: 9.6 mg, 75%; 1H NMR (400 MHz, CDCl3) δ 7.70-7.72 (m, 4H), 7.44-7.48 
(m, 6H), 6.88-6.95 (m, 6H), 6.79-6.81 (m, 2H), 6.73-6.76 (m, 4H), 6.62-6.64 (m, 1H), 6.45-6.48 
(m, 2H); 13C NMR (125 MHz, CDCl3) δ 153.6, 147.2, 143.1, 132.5, 131.2, 130.7, 130.2, 130.1, 
129.8, 129.7, 129.6, 129.0, 127.9, 127.3, 126.9, 126.7, 123.4; 11B NMR (128 MHz, CDCl3) δ 0.62 
(t, J(B,F) = 30.0 Hz); HRMS (ESI-TOF) m/z  639.1475 [M]
-; calculated for C39H25BCl2F2N2: 
639.1498. 
BODIPY 7b: Yield: 12.4 mg, 92%; 1H NMR (500 MHz, CDCl3) δ 7.90-7.91 (dd, J(H,H) = 3.8, 1.2 
Hz, 2H), 7.64-7.65 (dd, J(H,H) = 5.1, 1.2 Hz, 2H), 7.20-7.22 (dd, J(H,H) = 5.0, 3.8 Hz, 2H), 7.16-7.17 
(dd, J = 5.1, 1.2 Hz, 2H), 6.91-6.92 (dd, J(H,H) = 5.0, 1.2 Hz, 1H), 6.66 – 6.68 (m (overlap), 3H), 
6.46-6.47 (dd, J(H,H) = 3.6, 1.2 Hz, 2H), 6.28-6.30 (dd, J(H,H) = 5.0, 3.5 Hz, 1H); 
13C NMR (125 
MHz, CDCl3) δ 146.8, 137.0, 136.0, 133.67(t, overlap), 133.62, 132.6, 132.5, 131.5, 130.9, 129.5, 
129.25, 129.21, 127.5, 127.1, 126.6, 126.3, 125.8; 11B NMR (128 MHz, CDCl3) δ 0.76 (t, J(B,F) 
=30.7 Hz); HRMS (ESI-TOF) m/z  668.9313 [M]-; calculated for C29H15BCl2F2N2S5: 668.9319. 
General procedure for BODIPY 9-10 
BODIPY 7a-b (0.02 mmol) and Pd(PCy3)G2 (3 mol%) were added into a 25 ml round-bottomed 
flask. The flask was evacuated and refilled with nitrogen for three times. Toluene (5 ml) and 2-
(tributylstannyl)-thiophene (74.6 mg, 0.2 mmol) were purged into the flask, and the mixture was 
reflux overnight. The reaction was stopped when 9-10 was showed as major products according to 
TLC. The solvents were removed under reduced pressure. Then, the crude product was purified 
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by using column chromatography (Ethyl acetate/Hexanes 1: 2 as eluents) to provide the desired 
products.  
BODIPY 9: Yield: 11.2 mg, 76%; 1H NMR (400 MHz, CDCl3) δ 7.49-7.51 (m, 4H), 7.30-7.39 
(m, 6H), 6.93-6.94 (dd, J(H,H) = 5.1, 1.2 Hz, 2H), 6.77-6.88 (m, 8H), 6.65-6.67 (m, 4H), 6.58-6.62 
(m (overlap), 3H), 6.42-6.45 (m, 2H), 6.12-6.13 (dd, J(H,H) = 3.6, 1.2 Hz, 2H). 
13C NMR (125 MHz, 
CDCl3) δ 156.1, 147.4, 143.9, 134.22, 134.19, 132.2, 131.5, 131.3, 130.6, 130.4, 130.1, 129.1, 
128.6, 128.0, 127.8, 127.7, 127.2, 126.5, 126.3, 126.1, 125.7; 11B NMR (128 MHz, CDCl3) δ 0.85 
(t, J = 30.3 Hz); HRMS (ESI-TOF) m/z 735.2011 [M]-; calculated for C47H31BF2N2S2: 735.2032. 
BODIPY 10: Yield: 14.6 mg, 95%; 1H NMR (500 MHz,CDCl3) δ 7.65-7.66 (m, 2H), 7.45-7.46 
(dd, J(H,H) = 5.1, 1.2 Hz, 2H), 7.19-7.20 (dd, J(H,H) = 5.1, 1.2 Hz, 2H), 7.06-7.08 (dd, J(H,H) = 5.0, 
3.7 Hz, 2H), 6.99-7.00 (dd, J(H,H) = 5.1, 1.2 Hz, 2H), 6.88-6.89 (dd, J(H,H) = 5.0, 1.3 Hz, 1H), 6.82-
6.83 (dd, J(H,H) = 5.1, 3.6 Hz, 2H), 6.66-6.67 (dd, J(H,H) = 3.6, 1.3 Hz, 1H), 6.58-6.59 (dd, J(H,H) = 
3.6, 1.2 Hz, 1H), 6.53-6.55 (dd, J(H,H) = 5.1, 3.5 Hz, 1H), 6.36-6.37 (dd, J(H,H) = 3.5, 1.2 Hz, 2H), 
6.25-6.27 (dd, J(H,H) = 5.1, 3.6 Hz, 1H); 
13C NMR (125 MHz, CDCl3) δ 149.4, 137.7, 137.4, 134.3, 
134.1, 133.41, 133.37, 133.0(t), 132.1, 131.2, 130.53, 130.50, 130.2, 129.4, 129.2, 129.0, 127.1, 
126.5, 126.3, 126.2; 11B NMR (128 MHz, CDCl3) δ 0.96 (t, J(B,F) =30.7 Hz); HRMS (ESI-TOF) 
m/z 764.9862 [M]-; calculated for C37H21BF2N2S7: 764.9853. 
General procedure for BODIPY 11 and 13 
BODIPY 9-10 (0.01 mmol) was dissolved in dry CH2Cl2 (2 ml). BF3
.OEt2 (12.3 µl, 0.1 mmol) and 
trimethylsilyl cyanide (26.8 µl, 0.2 mmol) were added into the flask. The mixture was stirred at 
room temperature for 1h. The reaction was quenched with H2O (2ml), and extract byCH2Cl2 (20 
ml* 3). The organic layers were combined and washed with brine then water. The solvent were 
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removed under reduced pressure. The residue was purified by using column chromatography 
(CH2Cl2/Hexanes 2:1 as eluents) to provide the pure compounds. 
BODIPY 13: Yield: 6.9 mg, 92%; 1H NMR (400 MHz, CDCl3) δ 7.60-7.63 (m, 4H), 7.41-7.46 
(m, 6H), 6.93-6.95 (dd, J(H,H) = 5.1, 1.2 Hz, 2H), 6.88-6.92 (m, 2H), 6.81-6.85 (m, 6H), 6.68-6.70 
(m, 4H), 6.62-6.66 (m, 1H), 6.56-6.59 (dd, J(H,H) = 5.1, 3.7 Hz, 2H), 6.46-6.50 (m, 2H), 6.14-6.16 
(dd, J(H,H) = 3.7, 1.2 Hz, 2H).
 13C NMR (125 MHz, CDCl3) δ 157.1, 148.4, 144.7, 133.5, 133.1, 
131.1, 130.9, 130.7, 130.4, 130.1, 129.7, 129.3, 129.0, 128.37, 128.0, 127.5, 126.8, 126.7, 126.1; 
11B NMR (128 MHz, CDCl3) δ -16.30 (s); HRMS (ESI-TOF) m/z 749.2126 [M]
-; calculated for 
C49H31BN2S2: 749.2125. 
BODIPY 11: Yield: 7.3 mg, 93%; 1H NMR (400 MHz,CDCl3) δ 7.80-7.81 (dd, J(H,H) = 3.7, 1.2 
Hz, 2H), 7.57-7.59 (dd, J(H,H) = 5.1, 1.2 Hz, 2H), 7.17-7.20 (dd, J(H,H) = 5.0, 3.7 Hz, 2H), 7.15-7.17 
(dd, J(H,H) = 5.1, 1.2 Hz, 2H), 7.06-7.08 (dd, J(H,H) = 5.0, 1.2 Hz, 2H), 6.94-6.96 (dd, J(H,H) = 5.0, 
1.3 Hz, 1H), 6.77-6.79 (dd, J(H,H) = 5.1, 3.6 Hz, 2H), 6.71-6.72 (dd, J(H,H) = 3.6, 1.3 Hz, 1H), 6.59-
6.61 (dd, J(H,H) = 5.1, 3.5 Hz, 2H), 6.54-6.56 (dd, J(H,H) = 3.7, 1.2 Hz, 2H), 6.43-6.44 (dd, J(H,H) = 
3.6, 1.2 Hz, 2H), 6.30-6.32 (dd, J(H,H) = 5.0, 3.6 Hz, 1H); 
13C NMR (125 MHz, CDCl3) δ 150.5, 
139.7, 137.7, 133.85, 133.77, 133.4, 132.8, 132.24, 132.22, 131.2, 130.8, 129.8, 129.6, 129.4, 
129.2, 127.6, 127.4, 127.3, 126.6, 126.5, 126.4; 11B NMR (128 MHz, CDCl3) δ -16.12 (s); HRMS 
(ESI-TOF) m/z 778.9926 [M]-; calculated for C39H21BN4S7: 778.9946. 
4.6.2 Crystal data 
Crystal structures of 3b, 4b, 5b, 6a, 6b, 7a and 7b were determined from data collected at 
T=90K using MoK radiation (CuK for 7a) on Bruker Apex-II or Nonius KappaCCD 
diffractometers. 3b has 13% Br substituted in the Cl site at the meso position. 6b has all three 
thiophenes disordered and 7b has 4 of the 5 thiophenes disordered. 7a has two independent 
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molecules, one of which has all phenyl groups ordered while the other has 4 of the 5 disordered. 
Crystal data: 3b, C9BBr6.13Cl0.87F2N2, monoclinic, a = 8.4388(3), b = 8.4196(2), c = 21.5892(6) 
Å,  = 99.574(2)°, space group P21/n, Z = 4, 29024 reflections measured, max = 36.4°, 7099 unique 
(Rint = 0.036), which were used in all calculations, final R = 0.028 (5672 I>2(I) data ), wR(F
2)  
0.057 (all data), CCDC 1453168; 4b, C9BBr4Cl3F2N2, monoclinic, a = 8.3531(5), b = 8.5259(5), 
c = 20.7030(15) Å,  = 99.009(5)°, space group P21/n, Z = 4, 39613 reflections measured, max = 
40.0°, 9029 unique (Rint = 0.036), final R = 0.030 (7111 I>2(I) data ), wR(F
2)  0.055 (all data) , 
CCDC 1453169; 5b, C9BBr2Cl5F2N2, triclinic, a = 8.775(2), b = 9.170(3), c = 9.710(3) Å, α = 
98.378(17),  = 106.86(2), γ = 105.71(2)°, space group P-1, Z = 2, 6598 reflections measured, max 
= 28.3°, 3450 unique (Rint = 0.025), final R = 0.035 (2962 I>2(I) data ), wR(F
2)  0.086 (all data), 
CCDC 1453170; 6a, C27H15BCl4F2N2, monoclinic, a = 12.0397(3), b = 9.5581(2), c = 21.4720(5) 
Å,  = 105.7660(10)°, space group P21/n, Z = 4, 22356 reflections measured, max = 28.7°, 6116 
unique (Rint = 0.043), final R = 0.039 (4471 I>2(I) data ), wR(F
2)  0.086 (all data) CCDC 
1453171; 6b, C21H9BCl4F2N2S3, triclinic, a = 10.0519(9), b = 10.7177(9), c = 11.8528(10) Å, α = 
102.040(4),  = 91.199(4), γ = 91.199(4)°, space group P-1, Z = 2, 36429 reflections measured, 
max = 33.2°, 8575 unique (Rint = 0.029), final R = 0.042 (7372 I>2(I) data ), wR(F
2)  0.132 (all 
data), CCDC 1453172; 7a, C39H25BCl2F2N2, monoclinic, a = 26.1253(10), b = 12.6428(5), c = 
18.6230(7) Å,  = 91.840(2)°, space group P21/c, Z = 8,  34476 reflections measured, max = 61.0°, 
9079 unique (Rint = 0.039), final R = 0.044 (7087 I>2(I) data ), wR(F
2)  0.117 (all data), CCDC 
1453173; 7b, C29H15BCl2F2N2S5, monoclinic, a = 9.9110(2), b = 24.3651(5), c = 12.2192(3) Å,  
= 110.9070(10)°, space group P21/c, Z = 4,  41084 reflections measured, max = 28.4°, 6904 unique 
(Rint = 0.038), final R = 0.114 (5832 I>2(I) data ), wR(F
2) 0.296 (all data), CCDC 1453174. 
120 
4.7 References 
1. Lakshmi, V.; Rajeswara Rao, M.; Ravikanth, M., Org. Biomol. Chem. 2015, 13 (9), 2501-
2517. 
2. Jiao, L.; Pang, W.; Zhou, J.; Wei, Y.; Mu, X.; Bai, G.; Hao, E., J. Org. Chem. 2011, 76 
(24), 9988-9996. 
3. Lakshmi, V.; Ravikanth, M., J. Org. Chem. 2011, 76 (20), 8466-8471. 
4. Duran-Sampedro, G.; Agarrabeitia, A. R.; Garcia-Moreno, I.; Costela, A.; Bañuelos, J.; 
Arbeloa, T.; López Arbeloa, I.; Chiara, J. L.; Ortiz, M. J., Eur. J. Org. Chem. 2012, 2012 (32), 
6335-6350. 
5. Fischer, H.; Orth, H., Justus Liebigs Annalen der Chemie 1933, 502 (1), 237-264. 
6. Ballantine, J. A.; Jackson, A. H.; Kenner, G. W.; McGillivray, G., Tetrahedron 1966, 22, 
Supplement 7 (0), 241-259. 
7. Plater, M. J.; Aiken, S.; Bourhill, G., Tetrahedron 2002, 58 (12), 2405-2413. 
8. Zhao, N.; Xuan, S.; Fronczek, F. R.; Smith, K. M.; Vicente, M. G. H., J. Org. Chem. 2015, 
80 (16), 8377-8383. 
9. Wang, H.; Fronczek, F. R.; Vicente, M. G. H.; Smith, K. M., J. Org. Chem. 2014, 79 (21), 
10342-10352. 
10. Zhao, N.; Vicente, M. G. H.; Fronczek, F. R.; Smith, K. M., Chem. Eur. J. 2015, 21, 6181-
6192. 
11. Xuan, S.; Zhao, N.; Zhou, Z.; Fronczek, F. R.; Vicente, M. G. H., J. Med. Chem. 2016, 59 
(5), 2109-2117. 
12. Leen, V.; Yuan, P.; Wang, L.; Boens, N.; Dehaen, W., Org. Lett. 2012, 14 (24), 6150-6153. 
13. Wang, H.; Vicente, M. G. H.; Fronczek, F. R.; Smith, K. M., Chem. Eur. J. 2014, 20 (17), 
5064-5074. 
14. Espinet, P.; Echavarren, A. M., Angew. Chem. Int. Ed. 2004, 43 (36), 4704-4734. 
15. Li, L.; Nguyen, B.; Burgess, K., Bioorg. Med. Chem. Lett. 2008, 18 (10), 3112-3116. 
16. Nguyen, A. L.; Bobadova-Parvanova, P.; Hopfinger, M.; Fronczek, F. R.; Smith, K. M.; 
Vicente, M. G. H., Inorg. Chem. 2015, 54 (7), 3228-3236. 
121 
17. Nguyen, A. L.; Fronczek, F. R.; Smith, K. M.; Vicente, M. G. H., Tetrahedron Lett. 2015, 
56 (46), 6348-6351. 
18. Casey, K. G.; Quitevis, E. L., The Journal of Physical Chemistry 1988, 92 (23), 6590-6594. 
19. Olmsted, J., The Journal of Physical Chemistry 1979, 83 (20), 2581-2584. 
20. Chen, Y.; Zhao, J.; Guo, H.; Xie, L., J. Org. Chem. 2012, 77 (5), 2192-2206. 
21. Chen, Y.; Zhao, J.; Xie, L.; Guo, H.; Li, Q., RSC Adv. 2012, 2 (9), 3942-3953. 
22. Rihn, S.; Retailleau, P.; Bugsaliewicz, N.; Nicola, A. D.; Ziessel, R., Tetrahedron Lett. 
2009, 50 (50), 7008-7013. 
23. Brizet, B.; Desbois, N.; Bonnot, A.; Langlois, A.; Dubois, A.; Barbe, J.-M.; Gros, C. P.; 
Goze, C.; Denat, F.; Harvey, P. D., Inorg. Chem. 2014, 53 (7), 3392-3403. 
24. Xu, H.-J.; Bonnot, A.; Karsenti, P.-L.; Langlois, A.; Abdelhameed, M.; Barbe, J.-M.; Gros, 
C. P.; Harvey, P. D., Dalton Trans. 2014, 43 (22), 8219-8229. 
25. Gorka, A. P.; Nani, R. R.; Zhu, J.; Mackem, S.; Schnermann, M. J., J. Am. Chem. Soc. 











CHAPTER 5: SYNTHESIS AND ELECTROPOLYMERIZATION OF A 
SERIES OF 2,2’-(ORTHO-CARBORANYL) BISTHIOPHENES 
5.1 Introduction 
Since conducting polymers were first reported by MacDiarmid, Heeger, and Shirakawa in 
1977,1-2 an intensive research about various types of conducting materials, including 
polythiophene (PTh), polypyrrole (PPy), and polyaniline (PANI), has been dedicated to this special 
area.3 During those studies, several challenges are remained, including poor environmental thermal 
and oxidative stabilities, and short lifetime during the process of charge-discharge. Such 
challenges have hindered the commerciality of conducting polymers4  
Carboranes5 that contains carbon and boron atoms, which belongs to a class of boron 
clusters. There are several types of The neutral isomeric carboranes ortho-, meta-, and para-
C2B10H12 1-3, and the negatively charged nido-C2B9H12
- 4, and the closo-CB11H12
-
 5 carboranes, 
as shown in Figure 1. This special clusters have several different unique physical and chemical 
properties, such as high thermostability, electro-deficiency, and hydrophobicity, which have led to 
their broad applications in various disciplines, including in catalysis, molecular recognition, cancer  
Figure 5-1: Neutral, anionic nido and closo- carboranes. 
* Reproduced from Zhao, N.; Fabre, B.; Bobadova-Parvanova, P.; Fronczek, F. R.; Vicente,  M. 
G. H. Synthesis and electropolymerization of a series of 2,2’-(ortho-carboranyl) bisthiophenes. 
Submitted. 
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therapy treatments, and in electronics.5-7 These distinctive clusters are readily and easily 
synthesized and functionalized. For example, the carbon atoms in these clusters are usually treated 
as convenient sites for introducing other organic molecules. In recent years, the synthesis of 
carborane-containing polymers8-9 has attracted intense attention, as well as their investigation for 
applications as conducting,10 pre-ceramic,11 luminescent,12-13 and thermally robust14-15 materials.   
Multiple methodologies for incorporating carboranes into polymers can be found in the 
literature: (1) [Co(C2B9H11)2]
- 6 can be used as doping agent in the process of monomer 
electropolymerization16-19; (2) anion [Co(C2B9H11)2]
- 6 also can be introduced at the 2-position20 
or N-position21 in pyrrole monomers, (e.g. 7) which can be electropolymerized to the self-doped 
polymers; (3) neutral carboranes (o-, m-, p-) can be introduced to 2-,22-23 3-, or 4- positions24-27 of 
pyrroles or thiophenes for electropolymerizations under suitable conditions; (4) thiophene or 
pyrrole monomers can be copolymerized with carborane containing monomers by 
electrochemical21, 28 or chemical29-30 methods for the carborane-incorporation into the main chain.  
Carborane-containing monomers and conducting polymers usually possess several 
improved properties. For example, carborane-containing monomers with enhanced oxidation 
potentials can more easily overcome the “polythiophene paradox”,31 and the generated polymers 
have remarkable thermal and chemical stability. However, several challenges in this area remain. 
Among them, significant decreased conductivity, and blue-shifted π - π* transition band from the 
                     
Figure 5-2: Structures of compounds 7-9. 
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UV-vis spectraare often observed. For example,  the conductivity of poly(8) (10-2 S cm-1)25 and 
poly(9) (20 S cm-1)22 was much lower than that of unsubstituted polypyrrole (200 S cm-1) and 
polythiophene (100 S cm-1), respectively.32 The steric hindrance and less conjugated backbones 
caused by the electron-withdrawing carborane groups may be a possible reason for this observed 
phenomenon. Besides, some monomers containing carborane groups located very close to the 
aromatic rings failed to electropolymerized.23-24, 26-27 
On the other hand, polymeric materials with specific properties (e.g. photovoltaic 
properties and controlled length of the main chain) could be prepared by polymerization of well-
designed and synthesized structurally-modified π-conjugated oligomers.33-34 As we know, during 
electropolymerization of thiophene monomers, oligomers with higher oxidation potential are 
usually generated.31 Such oligomers always caused in the generated materials significantly 
deteriorated chemical and mechanical properties. However, short-chain oligomers (such as tetra-
thiophenes) can overcome the “polythiophene paradox” and be polymerized to more defined 
polymeric materials, but may show decreased conductivity.35-37 In the last two decades, a range of 
thiophene oligomers34 and pyrrole oligomers38-40 have been synthesized and reported. The 
versatility of oligomer over monomer allow for a better control of the number and ratio of different 
components in the final products.34 
Previous work in our group showed the high conductivity and lifetime, with high thermal 
stability and enhanced oxidation resistance, of poly(ortho-carboranylbisthiophene) 9.22 Thus, in 
this Chapter, a new series of derivatives of ortho-carboranyl-bisthiophene contianing thienyl, 
vinyl, and pyrrole groups at the 5- or 5,5’-positions was synthesized and investigated. Due to 
decreased steric hindrance and electronic effect induced by the carborane clusters, such 
modifications were expected to lead to more conjugated main chains and more aerated polymer 
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structures. On the other hand, pyrrolic groups in the oligomers and polymers are reported to 
stabilize the radical cations formed during electropolymerization, which led to a π-π intermolecular 
dimerizations.41-42 This type of phenomena may bring supramolecular π-dimers with enhanced 
conductivity.42-44 Thus, we anticipate compound 12a with electron-rich N-methylpyrrolic groups 
at the 5,5’-positions will be easier to polymerize to form a more conductive material.  
5.2 Synthesis and Characterization of ortho-carboranyl-bisthiophenes  
2,2’-Carboranyldithiophene 9 was synthesized by using a slightly modified procedure from 
that reported, in 30% overall yield,22-23 as shown in Scheme 5-1. Commercially available 2-
iodothiophene reacted with 2-[(trimethylsilyl)ethynyl]-thiophene in the presence of 1,8-
diazabicycloundec-7-ene (DBU) and bis(triphenylphosphine)-palladium(II) dichloride and 
copper(I) iodide  to yield 2,2’-ethylenedithiophene in 87% yield.45 Reaction between 2,2’-
ethylenedithiophene and decaborane in the presense of diethyl sulfide and toluene provdie the 
desired precursor 2,2’-carboranyldithiophene 9 in moderate yield (35%),22-23 as shown in Scheme 
5-2.  
Scheme 5-1: Synthesis of carboranyl-bisthiophenes 9. 
                                     
Scheme 5-2: Synthesis of brominated carboranyl-bisthiophenes 13a-b. 
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Due to the strong electron-withdrawing effect of the carborane group, the α-positions of 
2,2’-carboranyldithiophene 9 are significantly deactivated toward bromination. Therefore, high 
temperature and polar solvents are necesasry for the reaction to occur. Bromination of 2,2’-
carboranyldithiophene 9 using 6 equivalents of NBS in chloroform (CHCl3) and acetic acid 
(AcOH) (1:1), at 130 oC overnight, produced the dibromo product 13a in 76% yield, as shown in 
Scheme 5-1.46 However, no bromination reaction occured at lower temperature, or using DMF, 
CCl4, THF or only CHCl3 as the solvent. Also, the mixtures of multiple brominated products were 
obtained by using pure acetic acid as the only solvent at 110 oC.46 However, using lower 
temperatures, or different amounts of NBS, or different ratios of CHCl3/AcOH (e.g. 2 :1)  
 







                 
Figure 5-4: X-ray structures of 10a and 10b. 
decreased the yield of dibromo product 13a,  but increased the yield of the mono-brominated 
product 13b side-product. For example, 13b was obtained as the major product in 50% yield, along 
with 15% of 13a, under the similar conditions, with 3 equivalents of NBS at 110 oC. As shown in 
Figure 5-3, the 1H NMR provided direct evidence of sucessful bromination of 9. Compound 13a 
with a symmetric system showed two groups of characristic doublet-of-doublets at the thiophene 
at δ = 6.84 and 6.89 ppm, while 13b with an unsymmetric structure displayed five sets of doublet-
doublet at δ = 6.79, 6.86, 6.92, 7.20, 7.25 ppm, repectively.  
Suitable crystals of 13a and 13b were obtained by slow evaporation in hexanes. The results 
are displayed in Figure 5-4. Compound 13a contains four independent molecules, two of which 
have the S atoms from thiophenes relatively syn (approximate Cs symmetry). In these two 
molecules, there are 63.8 and 72.3º dihedral angles formed by the thiophene planes. Each of the 
other two independent molecules have one disordered thiophene into both anti and syn 
conformations,but the dominant conformer is anti (approximate symmetry C2). In the disordered 
molecules, there are 63.5 and 66.2º of the dihedral angles that forming by the thiophene planes. 
13b 13a 
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The distances of carborance C-C bonds are in the range of 1.732(4)-1.734(4) Å. On the other hand, 
compound 13b has only one independent molecule lying on a crystallographic two-fold axis. Thus 
a dihedral angle of 54.2º for the thiophenes are anti formed, and showed a exact C2 symmetry. The 
distances of carborance C-C bond is 1.7338(13), which is longer than an alkyne triple bond 
distance (1.2130(10) Å).  
The reactivity of newly generated dibromo-carboranylbisthiophene 13b was firstly 
investigated by Sonogashira cross-coupling reactions, as shown in Scheme 5-3. The Sonogashira  
 
Scheme 5-3: Sonogashira cross-coupling reaction of 13a. 
 
Figure 5-5: X-ray structures of 14. 
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type reaction between 13a and ethynyltrimethylsilane (5 equiv.) in the presence of  
bis(triphenylphosphine)palladium(II) dichloride (Pd(PPh3)2Cl2) and copper(I) iodide (CuI) as the 
catalysts, produced the corresponding di-ethynyl product 14, in 80% yield. A suitable crystal of 
14 for X-ray analysis was obtained by slow evaporation in hexanes. The result is displayed in 
Figure 5-5. Compound 14 lies on a crystallographic two-fold axis. The anti thiophenes form a 
dihedral angle of 54.2o. The distance of the C-C bond  in the carborane is 1.7338(13) Å.  
On the other hand, the reactivity of newly generated dibromo carboranylthiophene 13a and 14b 
were investigated by Stille cross-coupling reactions, as shown in Scheme 5-3. The Stille type 
reactions of 13a with 3 equivalents of 1-methyl-2-(tributylstannyl)pyrrole, 2-
(tributylstannyl)thiophene or tributyl(vinyl)tin in the presence of 
tetrakis(triphenylphosphine)palladium (0) as the catalyst, and in refluxing toluene for 2-4 hours 
yielded di(thienyl-N-methylpyrrole)-o-carborane 15a, di(bisthienyl)-o-carborane 15b and  di(2’-
vinylthienyl)-o-carborane 16a, respectively, in good to excellent yields (68%-95%). Besides, the 
same type of reaction between 13b and tributyl(vinyl)tin produced the corresponding mono-vinyl  
 
 
Scheme 5-4: Stille cross-coupling reactions of 13a. 
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Figure 5-6: 1H NMR (400 MHz) of 16a in CDCl3 at room temperature. 
product 16b in 75% yiled. These new carboranylthiophenes were characterized by 1H NMR, 13C 
NMR and mass spectrometry. For example, the 1H NMR of compound 16a displayed the 
characteristic doublet-of-doublets of the thiophene rings, as well as the broad peaks belonging to 
the carborane groups. The signals of the vinyl groups also were also assigned in the spectra, as 
seen in Figure 5-6 with the doublet-of-doublet of Ha splitting by Hb and Hc at the 5,5’-divinyl 
groups. 
Suitable crystals of 15a-b and 16a-b for X-ray analysis were obtained by slow evaporation 
in hexanes. The results are displayed in Figure 5-7. Compounds 15a and 15b both have approximate 
C2 symmetry, with the thiophene planes forming dihedral angles of 52.6 and 61.6o. The thiophene and N-
methylpyrrole rings of 15a have their S and N atoms anti, with N-C-C-S torsion angles of 164.04(11) and 
151.81(12)º. The distance of C-C bond of the carborane is 1.753(2) Å.  Both the terminal thiophenes of 15b 
are disordered, presenting both syn and anti bisthiophenes. The distance of C-C at the carborane is 1.730(11) 






                        
Figure 5-7: X-ray structures of 15a-b and 16a-b. 
planes, and the vinyl groups are syn to the S atoms of thiophene. The distance of C-C bond of the carborane 
is 1.7364(14) Å.  The thiophene rings of 16b are anti and form a dihedral angle of 58.6o, the vinyl group is 
syn to the S atom of the thiophene, and the distance of C-C at the carborane is 1.740(2) Å. 
5.3 Electrochemistry of the Monomers and Their Corresponding Polymer Films  
The electrochemical experiments of 15a, 15b, 16a, and 16b were performed by Dr. Bruno 
Fabre (Universite de Rennes, France). The cyclic voltammetry (CV) characterization of the o-
carboranes derivatives 15a-b and 16a-b at 5 mM in anhydrous dichloromethane (CH2Cl2) and 
Bu4NPF6 (2 x 10
-1 M) (except for 15a examined in acetonitrile and Bu4NPF6 (0.1 M)) displayed 
two irreversible oxidation peaks when cycled between 0.0 and 2.2 V vs Ag/Ag+ 10-2 M (Figure 5-
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8a and Table 1). As we know, there are no oxidization of unsubstituted carboranes under these 
electrolytic conditions, these can be assigned to the process of the oxidation of the aromatic rings 
into radical cation species. Furthermore, the decresing order of the anodic potentials of these 
systems were found as 16a  16b > 15b > 15a, in perfect agreement with the trend that reported 
for the electrochemical oxidation of the corresponding aromatic rings without the substitution of 
carborane, namely2-vinylthiophene47 > bithiophene48 > 2-(2-thienyl)-1H-pyrrole.49-50 For 
compound 15a, the oxidation processes at 0.74 V can be assigned to the oxidation of the pyrrole 
rings, while the oxidation processes at 1.30 V can be assigned to the oxidation of the thiophene 
rings, respectively.  
We next investigated the electrochemical behavior of these systems under the scanning at 
the negative potentials. As shown in Figure 5-8, two quasi-reversible closely spaced systems 
around -1.40 V were shown during the reduction process, which can be evidently verified on the 
backward scans of the corresponding time semi-derivative curves, as shown in Figure 5-8b. Such  
 
Figure 5-8: (a) Cyclic voltammograms at 0.1 V s-1 of different o-carborane derivatives (5 mM) in 
CH2Cl2 + Bu4NPF6 (0.2 M) (for 15b, 16a and 16b) or CH3CN + Bu4NPF6 (0.1 M) (for 15a). (b) 






Table 1. Cyclic voltammetry data of the o-carboranyl derivatives (5 mM) in CH3CN or CH2Cl2 medium. 
Potential scan rate: 0.1 V s-1. All potentials are reported vs. 10-2 M Ag+/Ag. 
 Monomer Polymer 
Eox/ V
a Ered / V
b Eox / V
c Ered / V
d 
15ae 0.74; 1.30 -1.42 0.40; 0.75 -1.50 
15bf 1.32; 1.68 -1.39 0.95; 1.30 -1.36 
16af 1.56; 1.93 -1.40 —g —g 
16bf 1.58; 1.96 -1.43 —g —g 
a Irreversible anodic peak potentials corresponding to the monomer oxidation. b Formal potential 
corresponding to the quasi-reversible reduction step. c Formal potential corresponding to the 
reversible p-doping/undoping of the electrogenerated polymer (average of anodic and cathodic 
peak potentials).d Formal potential corresponding to the reduction of the carborane (average of 
anodic and cathodic peak potentials. g No conducting polymer film was electrogenerated; electrode 
passivation was observed. ). f in CH2Cl2 + Bu4NPF6 (0.2 M) 
phenomena is due to the reduction of the carborane to form the radical anion and dianion backward 
scans of the corresponding time semi-derivative curves, as shown in Figure 5-8b. Such phenomena 
is due to the reduction of the carborane to form the radical anion and dianion species, as reported.51-
52 These studies discussed above suggest that the electronic charge of these o-carboranes 
derivatives is located within the carborane cage.52 In addition, due to similar geometry of these 
molecules with o-carborane, same potential for the four molecules was observed during the 
cathodic process.  
Among all these carboranyl compounds, only 15a and 15b led to the formation of a 
conducting polymer deposit on the electrode surface during the electrochemical oxidation. Such 
films could be successfully electrogenerated either potentiostatically or potentiodynamically with 
no obvious effect of the electropolymerization method on their respective electrochemical 
responses. Figure 5-9 shows the results of representative cyclic voltammograms corresponding to 
the potentiodynamical electropolymerization of compounds 15a and 15b. As shown in the Figure, 
the growth of a conducting deposit onto the electrode surface could be verified by the progressive 
increase of both anodic and cathodic currents with the number of scans. On the other hand, 
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electropolymerization of compounds 16a and 16b did not yield a desired conducting polymer 
deposit on the electrode, whatever the tested experimental conditions, including different oxidation 
potentials, monomer concentrations, electrochemical technique and solvents. A poorly 
electroactive film was electrogenerated instead, which led to the progressive passivation of the 
electrode surface. This phenomenon may be due to vinyl groups at the 5,5’-positions of the 
thiophene rings that might inhibit the electropolymerization process. 
Figure 5-9: Successive cyclic voltammograms of 15a (a) and 15b (b) at 5 mM in CH3CN + 0.1 
M Bu4NPF6 (a) or CH2Cl2 + Bu4NPF6 (0.2M) (b) Potential scan rate: 0.1 V s
-1. 
The newly generated polymer films, poly(15a) and poly(15b), were tested in a monomer-
free electrolytic medium, as shown in Figure 5-10. As shown in the Table 1, p-doping/undoping 
of the expected conjugated segments for poly(15a) and poly(15b) corresponds to two broad 
reversible redox processes, which were namely 2, 2'-bi-1H-pyrrole, 1, 1'-dimethyl-1,6-di-2-
thienyl, and quaterthienyl units, respectively. The linear correlation between the anodic peak 
current intensities corresponding to these two systems of 15a and 15b (Ipa
1 and Ipa
2) and the 
potential scan rate v was observed, as reported for surface-immobilized electroactive species.53 In 
addition, the estimation of the relatively low doping level δ54 of poly(15a) and poly(15b) was 
obtained as 0.10-0.15 and 0.15-0.20 positive charge per monomer unit, compared with  
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Figure 5-10: Electrochemical responses of the electrogenerated poly(15a) (a) and poly(15b) (b) films at 
0.1 V s-1 with the corresponding Ipa - v plots for the two anodic processes (insets). Electrolyte: CH3CN + 
Bu4NPF6 (0.1 M) (a) or CH2Cl2 + Bu4NPF6 (0.2 M) (b). The consumed electropolymerization charges are 
20 (a) and 64 mC cm-2 (b). 
unsubstituted poly(2-(2-thienyl)-1H-pyrrole)49 and polythiophene.37 Such results suggested the 
lower oxidation level of both polymers, which can further verify that incorporated carborane 
groups of 15a and 15b were crucial on the ion transport in these films.   
A reversible system at -1.50 and -1.36 V is shown in Figure 5-10 for both poly(15a) and 
poly(15b), in the cathodic potential range. Such system corresponds to the reduction of the 
incorporated carborane groups in the polymer. The linear correlation between the peak currents 
ascribed to this system and the potential scan rate v was observed during the polymer redox 
process. However, during the electropolymerization reaction, the redox signature of the carborane 
groups became less and less evident, as the film thickness increased resulting from the anodic 
charge. Such attractive effects of the film thickness on the electroactivity of the surface-confined 
reducible pair have previously been reported by our group with polythiophenes containing in-chain 
cobaltabisdicarbollide centers.20 It should be noted that the polymer was in its neutral reduced state 
(e.g. electronically insulating state) during the cathodic process occurring within a potential range. 
As a result, the insulating polymer matrix’s carborane is expected to be reduced by electron 
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hopping onto the electrode surface. Electroneutrality of the material is achieved by cation 
migration through the film. For the thick films, a large amount of carboranes within the film is not 
electrochemically active due to the electrolyte cations’ lack of access to them. 
5.4 Computational Studies 
In order to better understanding of the properties, both the monomers and the dimers of 
carboranyl-bisthiophenes 15a-b and 16a-b were modeled computationally, by Dr. Peita 
Bobadova-Parvanova (Rockhurst University, USA).The results from these studies were shown in 
Figure 5-11, showing the energies and the form of their frontier molecular orbitals (MO). The 
HOMO and LUMO of 2,2’-carboranyldithiophene 9 are also provided for better comparison with 
other derivatives. Generally, all compounds displayed similar orbitals: little contribution of 
carborane cages was observed to both HOMO and LUMO. There is -bonding character for C-C 
atoms and mostly non-bonding character for the rest of the atoms in the backbone in the HOMO, 
while there is bonding character between adjacent thiophene units and carborane groups on the  
Figure 5-11: Frontier orbitals of carboranyl-bisthiophenes 15a-b, and 16a-b. 2,2’-
carboranyldithiophene 9 is given for comparison. Energies in a.u. 
16a 16b 15b 15a 
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Table 2: Band gap energies, syn-anti difference energies, and energies of dimerization and 
intracyclization for carboranyl-bisthiophenes 9, 15a-b and 16a-b. 
Compound Band Gap (eV) Esyn-anti (kcal/mol) Edimer(kcal/mol) Eintracycl(kcal/mol) 
9 5.11    
15a 3.68 0.27 7.81 8.05 
15b 3.78 0.39 8.30 7.93 
16a 4.11 0.39 1.53 7.61 
16b 4.30    
 
LUMO. Compared to 9, functional groups at the 5- or 5,5’-positions gave a destabilization effect 
of HOMO by 0.5 to 1.4 eV, which is showing a decreasing order: pyrrole >  thienyl > vinyl. Such 
trend is in an agreement with that observed in the electrochemical characterization. There is only 
a small effect in the range of 0.1-0.4 eV on the LUMO. Consequently, the trend of resulting band 
gaps for all substituted carboranyl-bisthiophenes follows the trend of HOMO destabilization, and 
smaller band gaps of all the other compounds is shown in Table 2 with the effect being most 
pronounced for 15a (≈ 1.4 eV) than compound 9. 
The energy difference between the anti and syn comformers of 15a-b and 16a is also 
shown in Table 2. The syn conformers are more stable with a very small energy difference 
(< 0.5 kcal/mol), which is consistent with the X-ray analysis. Such finding is also in 
agreement with the calculations of compound 9 and its meta, and para analogues, as 
previously reported.23  
The energies required for formation of the dimer (namely Edimer) and the energy required 
for intracyclization (namely Eintracycl) are also listed in the last two columns of Table 2. 
Compounds 15a and 15b have similarrequired energies for dimerization as that of 9, which are 
around 8 kcal/mol. Interestingly, it appears the dimerization of 16a is more easy to achieve, since 
the dimerization energy is affected by the vinyl substitution with a more pronounced effect. As 
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reported,23 intramolecular cyclization in the early stage is another possible mechanism for the 
polymerization. As shown in Table 2, no significant differences of Eintracycl among pyrrole, 
thienyl, vinyl, or unsubstituted carboranyl-bisthophenes are observerd, which are in the range of 7 
to 8 kcal/mol.  All planar structures of such compounds are obtained as previously reported for 
9.23   
5.5 Synthesis of a Carborane-containing Tetrasulfido Annulene 
The synthesis of porphyrin isomers, such as porphycene and corrphycene, and of extended 
and contracted porphyrins and corroles, have been active areas of research in the last decades, due 
to the unique properties of these systems, and their potential applications in various areas as 
porphyrin biomimetics. Herein, in this Section, the synthesis of first carborane-fused porphyrin 
analogue was attempted via a Sonogashira palladium-catalyzed cross-coupling reaction as shown 
in Scheme 5-5. Such carborane-containing macrocycle could add insight into the “aromaticity” of 
the ortho-carborane cluster, since the “C-C” bond of the ortho-carborane would replace the “C=C” 
bridge in the tetrasulfido annulene, allowing further investigations of the effect of ortho-carborane 
on a conjugated system of an annulene. 
The deprotection of 14 was performed using potassium carbonate, rather than TBAF, to 
minimize deboronation of the ortho-carborane cage. Potassium carbonate was added to a solution 
of compound 14 in methanol/hexanes (1:1) at 0 oC and the reaction was monitored by 1H-NMR. 
After 2 h, the cleavage of the TMS groups was completed to give compound 17 in 74% yield, and 
no nido-carborane side product was detected. The Sonogashira coupling reaction of 13a and 17 
under similar conditions gave only trace amount of the carborane-containing tetrasulfido annulene 
19. Due to the potential deboronation reaction during the Sonogashira coupling in the presence of 
TEA, inorganic bases, including NaHCO3 and K2CO3 were used instead. In addition, the coupling  
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Scheme 5-5: Synthesis of carborane-containing tetrasulfido annulene 19. 
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reaction was performed at different temperatures (from room temperature to 80 oC) and the 
reaction time was varied (from 2h to overnight), but only trace amounts of annulene 19 were 
isolated. The MALDI-TOF spectrum of the purified product, shown in Figure 3, shows the base 
peak at m/z 648.243 corresponding to [M-B]+. 
The computiation studies of this reaction were conducted by Danile LaMaster in my group. 
The low yield of annulene 19 is probably a reflection of the spatial constraints of the alkynes. By 
altering the orientation of the sulfurs, either up or down, five different conformations of annulene 
19, shown in Figure 5-13, are possible. In the optimized annulene structures, the alkynes were bent 
at both ends by between 8.1° and 11.8°.  The rigidity of the sp-hybridized systems also causes a 
 
Figure 5-13 : Space-filling models of the the five conformations of compound 19.  Conformation 
A is the most stable.  
 
 
Figure 5-14: Dihedral angle of interest (α) is the angle between the planes defined by carbons 









Table 3: Absolute Values of Compounds 18A-E and 19A-E Internal Dihedral Angles 
Angle Compoound 
Conformation 
A B C D E 
α 
18 99.6° 92.0° 99.6° 99.6° 92.8° 
19 71.2° 43.9° 71.7° 58.5° 48.1° 
β 
18 94.6° 90.2° 94.8° 93.6° 93.3° 
19 70.3° 43.4° 72.1° 73.6° 48.2° 
γ 
18 94.4° 90.4° 98.9° 94.8° 96.6° 
19 71.0° 44.0° 72.0° 49.8° 48.2° 
δ 
18 101.9° 90.3° 99.3° 101.9° 92.4° 
19 70.2° 43.2° 71.6° 50.9° 48.1° 
 
distortion in the dihedral (torsion) angles between the alpha carbons of the thiophene rings and the 
carborane carbons (depicted in Figure 5-14 and the angles are listed in Table 3).  This distortion 
forces the thiophene Cα-Ccarb. bond out of the plane of the ring which causes the p-orbitals of the 
alpha carbons to rotate out of plane with each other just enough to maintain the σ-bond; however 
this rotation decreases orbital overlap between the p-orbitals of the thiophenes’ α- and β- C atoms 
which decreases the aromatic stabilization of the rings. 
To evaluate the destabilization due to ring strain, the formation enthalpies, ∆Hf
°(298K), 
and heats of combustion, ∆Hc
°(298K), of the five macrocycles (19A-E) and their syn mono-
coupled precursors (18A-E) were modelled computationally. The calculated ∆Hc
°(298K)  are 
based on complete combustion reactions. While use of isodesmic and homodesmic reactions in 
calculating formation enthalpies will yield more accurate results, they could not be used as 
experimental data for carboranes is not available due to the variation in the carboranes’ combustion 
products based on other atoms present. The results of the thermodynamics study are summarized 
in Table 4 below. It was found that the macrocycles have almost as much strain energy as a benzyne  
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ring. We believe this to be the reason the annulene appears in MS (MALDI) but is not stable 
enough for purification. 











18A -7823.7177 -4899.3961 
29.2790 
19A -7721.7612 -4928.6750 
18B -7824.1885 -4898.9252 
34.4081 
19B -7717.1029 -4933.3333 
18C -7824.5855 -4898.5283 
30.8280 
19C -7721.0800 -4929.3562 
18D -7823.2842 -4899.8296 
31.2889 
19D -7719.3178 -4931.1184 
18E -7824.3685 -4898.7453 
30.5495 
19E -7721.1414 -4929.2948 
Benzene -1240.4062 -694.7953 
38.0562 
Benzyne -1056.9950 -732.8516 
Note: Benzene & benzyne are included as a standard reference for comparison. 
 
5.6 Conclusion 
A new series of o-carborane containing thiophene oligomers were synthesized in good yields from 
5,(5’)-(di)bromo-2,2’-carboranyldithiophene 13a-b viapalladium(0)-catalyzed Sonogashira and 
Stille cross-coupling reactions. Such new compounds were well characterized by 1H and 13C NMR 
and MS. Seven X-ray structures were obtained to further confirm the regioselectivity of the 
reactions and the solid state confirmations of the molecules.  
The electrochemical characterization of these compounds were performed and showed the 
decreased anodic potential in the following order: 16a  16b > 15b > 15a, which agrees well with 
the trend observed from DFT calculations. Moreover, poly(15a) and poly(15b) could be 
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successfully electro-generated from 15a and 15b under suitable conditions. Compared with the 
parent conducting polymers, the lower doping levels δ determined for both newly generated 
polymers suggest the notable effect of the incorporated carborane clusters. DFT calculations also 
showed low energy required for the intramolecular cyclization of 15a and 15b, which may lead to 
more organized structures of the generated polymers. Therefore, both carborane-functionalized 
poly(15a) and poly(15b) are promising candidates of conducting materials with enhanced 
chemical and thermal stabilities.  
Finally, the synthesis of first carborane-fused porphyrin analogue 19 was attempted 
under various conditions, and the MALDI was obtained to confirm the formation. However, 
such a reaction gave a very low yields, may due to a large steric strain, which was 
investigated by computational studies.  
5.6 Experimental 
5.6.1 Synthesis 
General: All the reagents and solvents were purchased from VWR, Fisher or Sigma-Aldrich 
without further purification. All the reactions were monitored by Sorbent TLC using 0.2 mm silica 
gel or neutral alumina with UV- 254/366 nm. Silica gel (230×400 mesh) and neutral alumina (50-
200 µm, Act. I) for column chromatography were purchased from Sorbent. All NMR spectra were 
collected using a Bruker AV-400 MHz, AV-500 MHz or DPX-400 MHz NMR spectrometers in 
CDCl3 at room temperature. The chemical shifts (δ) are reported in ppm with CDCl3 (δ = 7.27 ppm 
for 1H NMR and 77.0 ppm for 13C NMR) as reference. All mass spectra were collected using an 
Agilent 6210 ESI-TOF MS, Varian Saturn 2000 Ion Trap with CP 3800 GC MS and Applied 
Biosystems QSTAR for MALDI.  
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2,2’-o-Carboranyl-bisthiophene 9 was synthesized using a slightly modified published 
procedure.22 
5,5’-Dibromo-2,2’-Co-arboranyl-bisthiophene 13a: To a 50 mL flask equipped with a 
magnetic stirrer were added 9 (630 mg, 2.04 mmol) and NBS (2.18 g, 12.24 mmol). The 
flask was evacuated and refilled with argon 3 times. Chloroform (15 mL) and acetic acid 
(10 mL) were added into the flask. The mixture was stirred and refluxed overnight under 
Ar. The reaction was stopped when starting material disappeared, according to TLC. After 
cooling to room temperature, the mixture was poured into water. Dichloromethane (30 mL 
× 3) was used to extract the organic components. The organic layers were combined and 
washed with saturated aqueous NaHCO3 and brine. The organic layer was dried using dry 
sodium sulfate then the solvents were removed under reduced pressure. The residue was 
purified by silica gel column chromatography using hexane as the eluent, to give 13a as a 
white solid product (722.9 mg, 76% yield). mp 99-100 oC. 1H NMR (400 MHz, CDCl3) δ 
6.94-6.95 (d, J = 4.0 Hz, 1H), 6.84-6.85 (d, J = 4.0 Hz, 1H), 1.60-3.50 (br, 10 H); 13C NMR 
(400 MHz, CDCl3): 135.6, 132.8, 130.3, 116.8, 80.0; MS (GC-MS) m/z [M]
+ 466.0, 
calculated for C10H14B10Br2S2  466.0. 
5-Bromo-2,2’-o-Carboranyl-bisthiophene 13b: A similar procedure as that described 
above was used, starting from 9 (257 mg, 0.83 mmol), NBS (443 mg, 2.49 mmol), 
chloroform (4 mL), and acetic acid (4 mL). The mixture was stirred and refluxed overnight 
under Ar. After cooling to room temperature, the mixture was poured into water, extracted 
with dichloromethane (10 mL × 3) and the organic layers washed with saturated aqueous 
NaHCO3 and brine. The resulting residue was purified by silica gel column 
chromatography using hexane as the eluent to give 13b as a white solid (160.8 mg, 50%). 
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mp 107-108 oC. 1H NMR (400 MHz, CDCl3) δ 7.23-7.25 (dd, J = 5.2, 1.2 Hz, 1H), 7.19-
7.20 (dd, J = 3.7, 1.2 Hz, 1H), 6.92-6.93 (d, J = 4.0 Hz, 1H), 6.85-6.87 (dd, J = 5.1, 3.8 Hz, 
1H), 6.79-6.80 (d, J = 4.0 Hz, 1H), 1.60-3.50 (br,10H); 13C NMR (CDCl3, 400Hz): 135.9, 
134.5, 132.7, 132.6, 130.0, 129.7, 127.2, 116.4, 80.8, 80.0; MS (GC-MS) m/z [M]+ 387.3, 
calculated for C10H15B10BrS2 387.1.  
2,2’-o-Carboranyldi(2-trimethylsilylethynylthiophene) 14: To a 25 mL flask equipped 
with a magnetic stirrer were added 13a (92.3 mg, 0.2 mmol), Pd(PPh3)2Cl2 (27 mg, 6 mol%) 
and CuI (14 mg, 10 mol%). The flask was evacuated and refilled with argon 3 times. Dry 
diethylamine (DEA) (5 mL) and ethynyltrimethylsilane (58.9 mg, 0.6 mmol) were added 
into the flask. The mixture was stirred at 60 oC under argon for 2 h. The reaction was 
stopped when all the starting material disappeared according to TLC. After cooling to room 
temperature, the solvent was removed under reduced pressure. The catalysts were removed 
by filtration through a pad of silica gel and washed with dichloromethane. The organic 
solvents were removed under reduced pressure and the resulting residue was purified by 
silica gel column chromatography using hexane as the eluent, to give 14 as a white solid 
(132.6 mg, 80%). mp 140-141 oC. 1H NMR (400 MHz, CDCl3) δ 7.00 (d, J = 3.9 Hz, 1H), 
6.92 (d, J = 3.9 Hz, 1H), 1.60-3.50 (10H, br), 0.23 (s, 18H); 13C NMR (400 MHz, CDCl3): 
134.9, 132.3, 132.1, 127.4, 101.7, 96.0, 80.3, -0.3; MS (GC-MS) m/z [M]+ 500.8, calculated 
for C20H32B10Si2S2 501.2. 
General procedure for Stille reactions 
Into a 100 ml flask equipped with a magnetic stirrer were added 13a or 13b (0.1 mmol) and 
Pd(PPh3)4 (12 mg, 10 mol%). The flask was evacuated and refilled with argon 3 times. 
Toluene (10 ml) and stannane reagent (3 equiv for the synthesis of 15a,b and 16a, or 1.5 
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equiv for synthesis of 16b) were added into the flask. The mixture was stirred and refluxed 
for 2-4 h under nitrogen. The reaction was stopped when starting material disappeared 
according to TLC. The catalysts were removed by filtration through a pad of celite and 
washed with dichloromethane. The solvents were removed under reduced pressure. The 
residue was purified by silica gel column chromatography using hexane/dichloromethane 
as the eluents to give the desired products. 
Di(thienyl-N-methylpyrrole)-o-carborane 15a: 44.3 mg, 95%; mp 152-154 oC; 1H NMR 
(400 MHz, CDCl3) δ 7.14 (d, J = 3.9 Hz, 2H), 6.73 (d, J = 3.9 Hz, 2H), 6.67 (m, 2H), 6.26 
(dd, J = 3.7, 1.7 Hz, 2H), 6.11 (dd, J = 3.6, 2.8 Hz, 2H), 3.60 (s, 6H), 1.60-3.50 (10H, br); 
13C NMR (CDCl3, 100Hz): 139.3, 133.0, 132.7, 125.8, 125.1, 124.0, 110.8, 108.2, 81.6, 
35.3; HRMS (ESI-TOF) m/z [M+H]+ 468.2595, calculated for C20H26N2S2B10 468.2600. 
Di(bisthienyl)-o-carborane 15b: 43.5 mg, 92%; mp 172-174 oC;  1H NMR (400 MHz, 
CDCl3) δ 7.22–7.24 (m, 2H), 7.12-7.13 (m, 2H), 7.09-7.10 (d, J = 3.9 Hz, 2H), 6.98-7.00 
(dd, J = 5.0, 3.7 Hz, 2H), 6.88 (d, J = 3.9 Hz, 2H), 1.60-3.50 (br, 10H); 13C NMR (126 
MHz, CDCl3) δ 141.5, 135.8, 133.2, 132.8, 128.0, 125.7, 124.8, 123.3, 81.4;  MALDI-TOF 
m/z [M+H]+ 473.138 , calculated for C18H20S4B10 473.143.  
5,5’-Divinyl-2,2’-Carboranyldithiophene 16a: 24.5 mg, 68%; mp 144-147 oC; 1H NMR 
(400 MHz, CDCl3) δ 7.02-7.03 (d, J = 3.9 Hz, 2H), 6.68-6.69 (d, J = 3.8 Hz, 2H), 6.56-
6.63 (dd, J = 17.4, 10.9 Hz, 2H), 5.51-5.56 (d, J = 17.4 Hz, 2H), 5.17-5.20 (d, J = 10.9 Hz, 
2H), 1.60-3.50 (br, 10H); 13C NMR (126 MHz, CDCl3) δ 146.7, 132.9, 132.7, 129.0, 125.4, 
115.5, 81.3. MS (GC-MS) m/z [M]+ 360.5, calculated for C14H20B10S2 360.2. 
5-Vinyl-2,2’-Carboranyldithiophene 16b: 25.1 mg, 75%; mp 91-93 oC; 1H NMR (CDCl3, 
400 Hz) δ 7.19–7.22 (m, 2H), 7.01-7.02 (d, J = 3.8 Hz, 1H), 6.83-6.85 (dd, J = 5.0, 3.9 Hz, 
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1H), 6.66-6.67 (d, J = 3.8 Hz, 1H), 6.55-6.62 (dd, J = 17.4, 10.9 Hz, 1H), 5.50-5.54 (d, J = 
17.4 Hz, 1H), 5.16-5.19 (d, J = 10.9 Hz, 1H), 1.60-3.50 (br, 10H); 13C NMR (CDCl3, 100 
Hz) δ 146.6, 134.8, 133.0, 132.7, 132.6, 129.5, 129.0, 127.1, 125.3, 115.5, 81.0;  MS (GC-
MS) m/z [M]+ 334.3, calculated for C12H18B10S2 334.2. 
5.6.2 Crystal data 
Diffraction data for 13a, 13b, 14, 15a, 16a and 16b were collected at T=100K on a Brüker 
Kappa Apex-II DUO diffractometer equipped with MoK radiation and a Triumph curved 
monochromator (CuK radiation from a microfocus source for 15b).  For 15b, data were 
from a Nonius KappaCCD diffractometer with MoK radiation at T=90K. In 13a, there 
are four independent molecules, and for two of them, disorder exists in the conformation 
of one of the bromothiophenes. A similar disorder exists for the nonbrominated thiophene 
of 13b, and for the terminal thiophenes in 15b. In 14, the molecule lies on a crystallographic 
twofold axis. CIFs are provided as supplementary material. CCDC deposition numbers are 
1012320-1012322 for 13a, 13b, 14, and 1484163-1484166 for 15a, 15b, 16a, and 16b, 
respectively. 
5.6.3 Electrochemical Characterizations 
Tetra-n-butylammonium hexafluorophosphate Bu4NPF6 was purchased from Fluka (puriss, 
electrochemical grade). Anhydrous dichloromethane (less than 50 ppm water from Merck) 
and acetonitrile (anhydrous, >99.8%, from Sigma-Aldrich) were used as received. The 
electrolytic medium was dried in situ over activated, neutral alumina from Aldrich. 
Alumina was previously activated at 450°C under vacuum for several hours. Linear 
potential cyclic voltammetry experiments were performed with an Autolab PGSTAT 30 
potentiostat from Eco Chemie B.V., equipped with General Purpose Electrochemical 
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System GPES software. The working electrode was a 1 mm-diameter platinum disk (area: 
0.8 mm2) and the counter electrode was a glassy carbon rod. Potentials were relative to the 
system 10-2 M Ag+ | Ag in acetonitrile and the ferrocene/ferrocenium couple in CH2Cl2 + 
0.2 M Bu4NPF6 was observed at E°’ = 0.19 V vs this reference. All electrochemical 
measurements were carried out inside a home-made Faraday cage at room temperature 
(202°C) and under a constant flow of argon. 
5.6.4 Computer Modeling for Section 5-4 
The geometries of all structures were optimized without symmetry constraints using B3LYP/6-
31+G(d,p) level calculations. The hybrid Becke’s Three Parameter DFT Functional was used.55-
56 The solvent effects were taken into account using the Polarized Continuum Model (PCM).57-58 
All calculations were performed using the Gaussian 09 program package.59  
5.6.5 Computer Modeling for Section 5-5  
The structures investigated were optimized, without symmetry constraints, using the NWChem 
6.3 software package,60 with density functional theory and the B3LYP hybrid functional55-56 and 
the 6-31+G** basis set obtained from the EMSL Basis Set Exchange.61-62  Vibrational frequency 
analysis calculations both confirmed all structures were at energetic minima and provided the 
necessary thermodynamic data.  The vibrational frequencies were scaled by a factor of 
0.964._ENREF_6_6363 The formation enthalpies, ΔfH°, at both 0K and 298K, were calculated as 
follows:  
∆𝒇𝑯
°(𝑴, 𝟐𝟗𝟖𝑲) = ∆𝒇𝑯
°(𝑴, 𝟎𝑲) + 𝑯𝒄𝒐𝒓𝒓










∑𝑫𝟎(𝑴) = ∑ 𝜺𝟎(𝑿) − 𝜺𝟎(𝑴) − 𝜺𝒛𝒑𝒆(𝑴)
𝒂𝒕𝒐𝒎𝒔
 Eq3 
where H°corr is the thermal correction to the enthalpy, Σ D0 is the atomization energy, ε0 is the total 
electronic energy, and εZPE is the zero-point vibrational energy.  The atomic formation enthalpies 
and thermal corrections to the enthalpy used were experimental data.64 Calculations were 
performed on the Louisiana State University: High Performance Computing Department’s 
SuperMike-II cluster.  It should be noted that the mono-coupled structures used in the calculations 
are not the same as what would have been obtained experimentally. To simplify the calculations 
and reduce the computational cost, the remaining bromine atom was replaced with a hydrogen. 
Effects of the solvent continum were not taken into account nor were effects of the additional two 
hydrogens on the mono-coupled systems versus the macrocycles since it was consistent through 
all six systems and the reference system.   
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APPENDIX A: CHARACTERIZATION DATA FOR COMPOUNDS IN 
CHAPTER 2 
Figure A1: 1H NMR spectra of pyrrole 2b 
 




Figure A3: 1H NMR spectra of pyrrole 2c 
  




Figure A5: 1H NMR spectra of pyrrole 8 
 




Figure A7: 1H NMR spectra of compound 11 
 





Figure A9: 1H NMR spectra of BODIPY 1a 
 





Figure A11:1H NMR spectra of BODIPY 1b 
 




Figure A13: 1H NMR spectra of BODIPY 12a 
 





Figure A15: 1H NMR spectra of BODIPY 12b 
 





Figure A17: 1H NMR spectra of BODIPY 12c 
 






Figure A19: 1H NMR spectra of BODIPY 13a 
 





Figure A21: 1H NMR spectra of BODIPY 13b 
 





Figure A23: 1H NMR spectra of BODIPY 13c 
 





Figure A25: 1H NMR spectra of BODIPY 14 
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Figure A27: 1H NMR spectra of BODIPY 15 
 





Figure A29: 1H NMR spectra of BODIPY 16 
 





Figure A31: 1H NMR spectra of BODIPY 17 
 





Figure A33: 1H NMR of BODIPY 18 
 





Figure A35: 1H NMR spectra of BODIPY 19 
 




Figure A37: 1H NMR spectra of BODIPY 20 
 





Figure A39: 1H NMR spectra of BODIPY 21 
 





Figure A41: 1H NMR spectra of BODIPY 22 
 





Figure A43: 1H NMR spectra of BODIPY 24 
 
Figure A44: 13C NMR spectra of BODIPY 24 
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APPENDIX B: CHARACTERIZATION DATA FOR COMPOUNDS IN 
CHAPTER 3 
Figure B1: 1H NMR of BODIPY 14 
 
 







Figure B3: 1H NMR of BODIPY 15 
 
 








Figure B5: 1H NMR of BODIPY 16 
 
 








Figure B7: 1H NMR of BODIPY 13 
  
 







Figure B9: 1H NMR of BODIPY 20 
 
 








Figure B11: 1H NMR of BODIPY 20 
 
 







Figure B13: 1H NMR of BODIPY 22 
 
 




















Figure B17: 1H NMR of BODIPY 18 
 
 








Figure B19: 1H NMR of BODIPY 19 
 
 




Figure B21: 1H NMR of BODIPY23 
 
 







Figure B23: 1H NMR of BODIPY 24 
 
 





Figure B25: 1H NMR of BODIPY 26 
 
 





Figure B27: 1H NMR of BODIPY 27 
 
 




APPENDIX C: CHARACTERIZATION DATA FOR COMPOUNDS IN 
CHAPTER 3 
Figure C1: 13C NMR of BODIPY 3b 
 
























Figure C4: 1H NMR of BODIPY 6a 
 
 






Figure C6: 1H NMR of BODIPY 7a 
 
 






Figure C8: 1H NMR of BODIPY 9  
 








Figure C10: 1H NMR of BODIPY 13  
 








Figure C12: 1H NMR of BODIPY 6b  
 
 









Figure C14: 1H NMR of BODIPY 7b  
 
 








Figure C16: 1H NMR of BODIPY 10  
 
 









Figure C18: 1H NMR of BODIPY 11  
 
 









Figure C20: 11B NMR of BODIPY 3b 
 
 




Figure C22: 11B NMR of BODIPY 5b 
 
 




Figure C24: 11B NMR of BODIPY 13 
 
 





Figure C26: 11B NMR of BODIPY 6a  
 
 





Figure C28: 11B NMR of BODIPY 7b  
 
 











APPENDIX D: CHARACTERIZATION DATA FOR COMPOUNDS IN 
CHAPTER 4 
Figure D1: 1H NMR of compound 10a 
 




Figure D3: 1H NMR of compound 10b 
 
 




Figure D5: 1H NMR of compound 11 
 
 




Figure D7: 1H NMR of compound 12a 
 
 




Figure D9: 1H NMR of compound 12b 
 
 




Figure D11: 1H NMR of compound 13a 
 
 




Figure D13: 1H NMR of compound 13b 
 
 
Figure D14: 13C NMR of compound 13b 
 
213 
2. Copy of MS spectra  
 
 
Figure D15: (a) GC-MS copy of Compound 10a; (b) Predicted mass spectra of Compound of 
10a. 
 
Figure D16: (a) GC-MS copy of Compound 10b; (b) Predicted mass spectra of Compound of 
10b. 
 
Figure D17: (a) GC-MS copy of Compound 11; (b) Predicted mass spectra of Compound of 11. 
 
 
a                                                           b 
a                                                           b 
a                                                           b 
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Figure D18: (a) MS(ESI-TOF) copy of Compound 12a; (b) Predicted mass spectra of 
Compound of 12a. 
 
 
Figure D19: (a) MS(MALDI-TOF) copy of Compound 12b; (b) Predicted mass spectra of 
Compound of 12b. 
 
 
Figure D20: (a) GC-MS copy of Compound 13a; (b) Predicted mass spectra of Compound of 
13a. 
 
a                                                         b 
a                                                           b 




Figure D21: (a) GC-MS copy of Compound 13b; (b) Predicted mass spectra of Compound of 
13b. 
  
a                                                           b 
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